What Schools Are Affiliated With Eric Topol

Eric Topol is affiliated with the following schools: Harvard University, University of Vermont, University of Kentucky, University of Alberta, Queen's University at Kingston, Baylor College of Medicine, United States Military Academy, University of New Mexico, University of Toronto, University of Virginia, Baylor University, University of Florida, Case Western Reserve University, University of Washington, University of Pittsburgh, University of Florida College of Medicine, University of Rochester, University of Cincinnati, Boston University, University of Sydney, University of Michigan, Icahn School of Medicine at Mount Sinai, Cardiff University, University System of Maryland, Duke University, Brown University, University of Minnesota, University of California, Riverside, Georgetown University, University of Barcelona

Eric Topol | Academic Influence

Eric Topol's AcademicInfluence.com Rankings

Eric Topol

Medical

#22

World Rank

#46

Historical Rank

#16

USA Rank

Cardiology

World Rank

Historical Rank

USA Rank

medical Degrees

Download Badge

Medical

Why Is Eric Topol Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Eric Jeffrey Topol is an American cardiologist, scientist, and author. He is the founder and director of the Scripps Research Translational Institute, a professor of Molecular Medicine and Executive Vice-President at Scripps Research Institute, and a senior consultant at the Division of Cardiovascular Diseases at Scripps Clinic in La Jolla, California. He is editor-in-chief of Medscape and theheart.org. He has published three bestseller books on the future of medicine: The Creative Destruction of Medicine , The Patient Will See You Now , and Deep Medicine: How Artificial Intelligence Can Make Healthcare Human Again . He was commissioned by the UK from 2018–2019 to lead planning for the National Health Service's future workforce, integrating genomics, digital medicine, and artificial intelligence.

(See a Problem?)

Eric Topol's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients (1994) (3667)
An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. (1993) (3530)
Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. (2002) (3094)
The effect of digoxin on mortality and morbidity in patients with heart failure. (1997) (2495)
High-performance medicine: the convergence of human and artificial intelligence (2019) (2313)
Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. (2006) (2183)
2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Ass (2012) (2042)
ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). (2003) (1549)
Prevalence of conventional risk factors in patients with coronary heart disease. (2003) (1472)
Risk of cardiovascular events associated with selective COX-2 inhibitors. (2001) (1389)
ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). (2002) (1373)
Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group. (1990) (1312)
Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy (2003) (1310)
Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial. (2003) (1177)
Our preoccupation with coronary luminology. The dissociation between clinical and angiographic findings in ischemic heart disease. (1995) (1166)
Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention. (1998) (1116)
Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials (2003) (1099)
Human genetic variation and its contribution to complex traits (2009) (1074)
Prognostic value of myeloperoxidase in patients with chest pain. (2003) (1074)
A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease. (2003) (1056)
Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial. (2011) (1036)
Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. GUSTO-I Investigators. (1995) (1025)
Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. (2004) (1024)
Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade (1998) (979)
Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators. (2000) (970)
The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke (2004) (960)
A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction. (1987) (955)
Prevalence of Asymptomatic SARS-CoV-2 Infection (2020) (948)
Textbook of Cardiovascular Medicine (1997) (940)
Association between myeloperoxidase levels and risk of coronary artery disease. (2001) (922)
Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: noninvasive tests of atherosclerotic burden: Writing Group III. (2000) (897)
Sex, clinical presentation, and outcome in patients with acute coronary syndromes. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes IIb Investigators. (1999) (897)
The personal and clinical utility of polygenic risk scores (2018) (891)
Psychological predictors of heart disease: a quantitative review. (1987) (861)
Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries. (1996) (849)
Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: results at six months (1994) (844)
Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials (2002) (840)
Variability in platelet responsiveness to clopidogrel among 544 individuals. (2005) (806)
Assessing the impact of population stratification on genetic association studies (2004) (806)
Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine. (1995) (790)
Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators. (1999) (777)
Recognition of the importance of embolization in atherosclerotic vascular disease. (2000) (776)
Effect of Antihypertensive Agents on Cardiovascular Events in Patients With Coronary Disease and Normal Blood Pressure The CAMELOT Study: A Randomized Controlled Trial (2004) (740)
Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty. (1988) (726)
A comparison of directional atherectomy with coronary angioplasty in patients with coronary artery disease. The CAVEAT Study Group. (1993) (702)
Randomized, Placebo-Controlled Trial of Platelet Glycoprotein IIb/IIIa Blockade With Primary Angioplasty for Acute Myocardial Infarction (1998) (691)
State of Telehealth. (2016) (688)
Common vs. rare allele hypotheses for complex diseases. (2009) (671)
Cardiac Troponin T Levels for Risk Stratification in Acute Myocardial Ischemia (1996) (671)
A comparison of deep learning performance against health-care professionals in detecting diseases from medical imaging: a systematic review and meta-analysis. (2019) (667)
Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization. (2001) (666)
Evaluation of next generation sequencing platforms for population targeted sequencing studies (2009) (647)
Risk factors, angiographic patterns, and outcomes in patients with ventricular septal defect complicating acute myocardial infarction. GUSTO-I (Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries) Trial Investigators. (2000) (630)
N‐Terminal Pro‐Brain Natriuretic Peptide and Other Risk Markers for the Separate Prediction of Mortality and Subsequent Myocardial Infarction in Patients With Unstable Coronary Artery Disease: A Global Utilization of Strategies To Open occluded arteries (GUSTO)‐IV Substudy (2003) (627)
Clinical Experience With the Palmaz‐Schatz Coronary Stent: Initial Results of a Multicenter Study (1991) (625)
Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial. (2007) (625)
Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials. (2005) (621)
Protein carbamylation links inflammation, smoking, uremia and atherogenesis (2007) (611)
The restenosis paradigm revisited: an alternative proposal for cellular mechanisms. (1992) (604)
Failing the public health--rofecoxib, Merck, and the FDA. (2004) (604)
Cause of death in clinical research: time for a reassessment? (1999) (579)
Critical issues in peripheral arterial disease detection and management: a call to action. (2003) (578)
Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction: results from the global use of strategies to open occluded arteries in Acute Coronary Syndromes (GUSTO-IIb) trial. (1999) (574)
Myonecrosis after revascularization procedures. (1998) (572)
Effect of muraglitazar on death and major adverse cardiovascular events in patients with type 2 diabetes mellitus. (2005) (560)
The "disease-prone personality". A meta-analytic view of the construct. (1987) (558)
ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). (2002) (557)
Does childhood personality predict longevity? (1993) (553)
Risk of cardiovascular events associated with selective COX-2 inhibitors☆ (2002) (546)
Prognostic value of the admission electrocardiogram in acute coronary syndromes. (1999) (540)
Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteins (2004) (540)
Textbook of Interventional Cardiology (1999) (538)
The emerging field of mobile health (2015) (527)
Effect of direct-to-consumer genomewide profiling to assess disease risk. (2011) (524)
The n-of-1 clinical trial: the ultimate strategy for individualizing medicine? (2011) (523)
Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk. (2008) (522)
Hypertensive hypertrophic cardiomyopathy of the elderly. (1985) (522)
9p21 DNA variants associated with Coronary Artery Disease impair IFNγ signaling response (2011) (521)
The Oxford Handbook of Health Psychology (2013) (511)
Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. GUSTO-I Investigators. (1995) (507)
Electrocardiographic diagnosis of evolving acute myocardial infarction in the presence of left bundle-branch block. GUSTO-1 (Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries) Investigators. (1996) (499)
Platelet GPIIb-IIIa blockers (1999) (497)
Virtual health care in the era of COVID-19 (2020) (486)
Sex differences in mortality following acute coronary syndromes. (2009) (483)
Encyclopedia of mental health (1998) (483)
Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial. (2001) (481)
Applications of digital technology in COVID-19 pandemic planning and response (2020) (473)
Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial. (2004) (459)
Facilitated PCI in patients with ST-elevation myocardial infarction. (2008) (456)
Common Variants in KCNN3 are Associated with Lone Atrial Fibrillation (2010) (454)
Artificial intelligence versus clinicians: systematic review of design, reporting standards, and claims of deep learning studies (2020) (444)
Pharmacodynamics of chimeric glycoprotein IIb/IIIa integrin antiplatelet antibody Fab 7E3 in high-risk coronary angioplasty. (1994) (440)
Long-term relations of personality and health: dynamisms, mechanisms, tropisms. (2000) (439)
Time from symptom onset to treatment and outcomes after thrombolytic therapy. GUSTO-1 Investigators. (1996) (438)
Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial (2001) (431)
Scientific and therapeutic advances in antiplatelet therapy (2003) (430)
Platelet Glycoprotein IIb/IIIa Inhibitors Reduce Mortality in Diabetic Patients With Non–ST-Segment-Elevation Acute Coronary Syndromes (2001) (429)
Can mobile health technologies transform health care? (2013) (422)
Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial. (2004) (418)
Coronary angioplasty volume-outcome relationships for hospitals and cardiologists. (1997) (418)
Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer’s disease (2013) (418)
Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. TAMI Study Group. (1990) (414)
Cell adhesion molecules in coronary artery disease. (1994) (413)
Adapting to Artificial Intelligence: Radiologists and Pathologists as Information Specialists. (2016) (413)
Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus. (2002) (407)
Health Status and the Five-factor Personality Traits in a Nationally Representative Sample (2006) (406)
Platelet Reactivity and Cardiovascular Outcomes After Percutaneous Coronary Intervention: A Time-Dependent Analysis of the Gauging Responsiveness With a VerifyNow P2Y12 Assay Impact on Thrombosis and Safety (GRAVITAS) Trial (2011) (400)
Mutation of MEF2A in an Inherited Disorder with Features of Coronary Artery Disease (2003) (399)
Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. Evaluation of Platelet IIb/IIIa Inhibition in Stenting Investigators. (1999) (399)
Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions. (1996) (398)
Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: a randomized controlled trial. (2012) (397)
Personality, well-being, and health. (2014) (393)
Consensus recommendations for the management of chronic heart failure: Introduction (1999) (391)
Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized, placebo-controlled trial. (1984) (389)
Combined accelerated tissue-plasminogen activator and platelet glycoprotein IIb/IIIa integrin receptor blockade with Integrilin in acute myocardial infarction. Results of a randomized, placebo-controlled, dose-ranging trial. IMPACT-AMI Investigators. (1997) (387)
Influence of Diabetes Mellitus on Clinical Outcome in the Thrombolytic Era of Acute Myocardial Infarction (1997) (387)
ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina). (2003) (387)
Do conscientious individuals live longer? A quantitative review. (2008) (386)
A variant of the gene encoding leukotriene A4 hydrolase confers ethnicity-specific risk of myocardial infarction (2006) (383)
Meta-analysis of randomized and registry comparisons of ticlopidine with clopidogrel after stenting. (2002) (383)
Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-I trial experience. The GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. (1995) (376)
Increased Mortality With Oral Platelet Glycoprotein IIb/IIIa Antagonists: A Meta-Analysis of Phase III Multicenter Randomized Trials (2001) (368)
Expert consensus document American College of Cardiology / European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy (2003) (367)
Illusion of Reperfusion Does Anyone Achieve Optimal Reperfusion During Acute Myocardial Infarction? (1993) (367)
Clinical outcomes of therapeutic agents that block the platelet glycoprotein IIb/IIIa integrin in ischemic heart disease. (1998) (367)
Multicenter investigation of coronary stenting to treat acute or threatened closure after percutaneous transluminal coronary angioplasty: clinical and angiographic outcomes. (1993) (365)
Comparison of 24-hour Holter monitoring with 14-day novel adhesive patch electrocardiographic monitoring. (2014) (365)
Atrial fibrillation in the setting of acute myocardial infarction: the GUSTO-I experience. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries. (1997) (365)
Use of medical resources and quality of life after acute myocardial infarction in Canada and the United States. (1994) (357)
Abrupt vessel closure complicating coronary angioplasty: clinical, angiographic and therapeutic profile. (1992) (355)
American College of Cardiology/Society for Cardiac Angiography and Interventions Clinical Expert Consensus Document on cardiac catheterization laboratory standards. A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. (2001) (353)
Abciximab reduces mortality in diabetics following percutaneous coronary intervention. (2000) (352)
International, randomized, controlled trial of lamifiban (a platelet glycoprotein IIb/IIIa inhibitor), heparin, or both in unstable angina (1998) (351)
Pathway analysis of seven common diseases assessed by genome-wide association. (2008) (350)
Long-term Protection From Myocardial Ischemic Events in a Randomized Trial of Brief Integrin β3 Blockade With Percutaneous Coronary Intervention (1997) (347)
Understanding and Assessing Nonverbal Expressiveness: The Affective Communication Test. (1980) (345)
Clinical trials of restenosis after coronary angioplasty. (1991) (341)
Stroke after thrombolysis. Mortality and functional outcomes in the GUSTO-I trial. Global Use of Strategies to Open Occluded Coronary Arteries. (1995) (341)
Bivalirudin versus heparin during coronary angioplasty for unstable or postinfarction angina: Final report reanalysis of the Bivalirudin Angioplasty Study. (2001) (338)
Predictors and impact of major hemorrhage on mortality following percutaneous coronary intervention from the REPLACE-2 Trial. (2007) (337)
Regional variation across the United States in the management of acute myocardial infarction. GUSTO-1 Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. (1995) (333)
Analysis of risk of bleeding complications after different doses of aspirin in 192,036 patients enrolled in 31 randomized controlled trials. (2005) (332)
2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: executive summary: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American College of Physi (2012) (331)
Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: results from a multicentre randomised trial (1999) (330)
Predicting Patient Satisfaction from Physicians’ Nonverbal Communication Skills (1980) (328)
Profound inhibition of platelet aggregation with monoclonal antibody 7E3 Fab after thrombolytic therapy. Results of the Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) 8 Pilot Study. (1993) (321)
Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study (2001) (318)
Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus: results of the EPISTENT (Evaluation of platelet IIb/IIIa inhibitor for stenting trial) diabetic substudy. (1999) (314)
Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial. (1999) (311)
Evaluation of Combination Thrombolytic Therapy and Timing of Cardiac Catheterization in Acute Myocardial Infarction: Results of Thrombolysis and Angioplasty in Myocardial Infarction–Phase5 Randomized Trial (1991) (306)
Patients with peripheral arterial disease in the CHARISMA trial. (2008) (304)
Peripheral vascular complications after conventional and complex percutaneous coronary interventional procedures. (1992) (302)
Angiographic findings and outcome in diabetic patients treated with thrombolytic therapy for acute myocardial infarction: the GUSTO-I experience. (1996) (301)
Activated partial thromboplastin time and outcome after thrombolytic therapy for acute myocardial infarction: results from the GUSTO-I trial. (1996) (301)
Age and outcome with contemporary thrombolytic therapy. Results from the GUSTO-I trial. Global Utilization of Streptokinase and TPA for Occluded coronary arteries trial. (1996) (300)
Advancing social and economic development by investing in women's and children's health: a new Global Investment Framework (2013) (296)
Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction. (2002) (294)
Value of serial troponin T measures for early and late risk stratification in patients with acute coronary syndromes. The GUSTO-IIa Investigators. (1998) (293)
Platelet glycoprotein IIb/IIIa receptor inhibition in non-ST-elevation acute coronary syndromes: early benefit during medical treatment only, with additional protection during percutaneous coronary intervention. (1999) (292)
A randomized controlled trial of intravenous tissue plasminogen activator and early intravenous heparin in acute myocardial infarction. (1989) (291)
Propensity Analysis of Long-Term Survival After Surgical or Percutaneous Revascularization in Patients With Multivessel Coronary Artery Disease and High-Risk Features (2004) (291)
Effect of a Home-Based Wearable Continuous ECG Monitoring Patch on Detection of Undiagnosed Atrial Fibrillation: The mSToPS Randomized Clinical Trial (2018) (289)
Balloon angioplasty for the treatment of lesions in saphenous vein bypass grafts. (1993) (289)
Single Nucleotide Polymorphisms in Multiple Novel Thrombospondin Genes May Be Associated With Familial Premature Myocardial Infarction (2001) (287)
Lack of Adverse Clopidogrel–Atorvastatin Clinical Interaction From Secondary Analysis of a Randomized, Placebo-Controlled Clopidogrel Trial (2003) (286)
Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group. (1993) (286)
Analysis of Coronary Angioplasty Practice in the United States With an Insurance‐Claims Data Base (1993) (286)
Sustained local delivery of dexamethasone by a novel intravascular eluting stent to prevent restenosis in the porcine coronary injury model. (1997) (285)
Deep learning-enabled medical computer vision (2021) (284)
Cardiac troponin T levels for risk stratification in acute myocardial ischemia. GUSTO IIA Investigators. (1996) (280)
Incremental Prognostic Value of Elevated Baseline C-Reactive Protein Among Established Markers of Risk in Percutaneous Coronary Intervention (2001) (277)
Nonverbal Behavior: A Functional Perspective. (1984) (276)
Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators. (1996) (271)
The importance of phase information for human genomics (2011) (271)
Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of the Platelet Integrin Glycoprotein IIb/IIIa Blocker Integrelin in Elective Coronary Intervention (1995) (271)
Toward a new frontier in myocardial reperfusion therapy: emerging platelet preeminence. (1998) (266)
Restenosis After Placement of Palmaz‐Schatz Stents in Native Coronary Arteries: Initial Results of a Multicenter Experience (1992) (266)
Childhood conscientiousness and longevity: health behaviors and cause of death. (1995) (266)
Troponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndrome: a GUSTO-IV substudy. (2003) (265)
Current role of platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes. (2000) (262)
Frontiers in interventional cardiology. (1998) (261)
Early and Sustained Survival Benefit Associated With Statin Therapy at the Time of Percutaneous Coronary Intervention (2002) (261)
2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physi (2012) (257)
Psychosocial and behavioral predictors of longevity. The aging and death of the "termites". (1995) (257)
Long-term protection from myocardial ischemic events in a randomized trial of brief integrin beta3 blockade with percutaneous coronary intervention. EPIC Investigator Group. Evaluation of Platelet IIb/IIIa Inhibition for Prevention of Ischemic Complication. (1997) (255)
Outmigration for coronary bypass surgery in an era of public dissemination of clinical outcomes. (1996) (254)
Acute Coronary Syndromes in the GUSTO-IIb Trial Prognostic Insights and Impact of Recurrent Ischemia (1998) (252)
Comparison of sibrafiban with aspirin for prevention of cardiovascular events after acute coronary syndromes: a randomised trial (2000) (252)
Multiple vessel coronary angioplasty: classification, results, and patterns of restenosis in 494 consecutive patients. (1987) (246)
Direct thrombin inhibitors in acute coronary syndromes: principal results of a meta-analysis based on individual patients' data (2002) (246)
Personality and health, subjective well-being, and longevity. (2010) (245)
Wearable sensor data and self-reported symptoms for COVID-19 detection (2020) (243)
Myeloperoxidase and Plasminogen Activator Inhibitor 1 Play a Central Role in Ventricular Remodeling after Myocardial Infarction (2003) (243)
Evaluation of paradoxic beneficial effects of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: mechanism of the "smoker's paradox" from the GUSTO-I trial, with angiographic insights. Global Utilization of Streptokinase and Tissue-Plasminogen Activator for Occluded (1995) (241)
Corrigendum: Microdroplet-based PCR enrichment for large-scale targeted sequencing (2010) (239)
Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci. (2012) (238)
Rimonabant for prevention of cardiovascular events (CRESCENDO): a randomised, multicentre, placebo-controlled trial (2010) (238)
Death Following Creatine Kinase-MB Elevation After Coronary Intervention: Identification of an Early Risk Period: Importance of Creatine Kinase-MB Level, Completeness of Revascularization, Ventricular Function, and Probable Benefit of Statin Therapy (2002) (237)
Defining the Optimal Activated Clotting Time During Percutaneous Coronary Intervention: Aggregate Results From 6 Randomized, Controlled Trials (2001) (237)
Microdroplet-based PCR amplification for large scale targeted sequencing (2009) (234)
Immediate improvement of dysfunctional myocardial segments after coronary revascularization: detection by intraoperative transesophageal echocardiography. (1984) (233)
Benefit of Glycoprotein IIb/IIIa Inhibition in Patients With Acute Coronary Syndromes and Troponin T–Positive Status: The PARAGON-B Troponin T Substudy (2001) (233)
Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial). (2004) (233)
Premature myocardial infarction novel susceptibility locus on chromosome 1P34-36 identified by genomewide linkage analysis. (2004) (232)
Bleeding complications with the chimeric antibody to platelet glycoprotein IIb/IIIa integrin in patients undergoing percutaneous coronary intervention. EPIC Investigators. (1995) (231)
Experimental models of coronary artery restenosis. (1992) (231)
Individualized Medicine from Prewomb to Tomb (2014) (231)
The QUinapril Ischemic Event Trial (QUIET): evaluation of chronic ACE inhibitor therapy in patients with ischemic heart disease and preserved left ventricular function. (2001) (229)
Personality: Classic Theories and Modern Research (1998) (227)
Use of A Direct Antithrombin, Hirulog, in Place of Heparin During Coronary Angioplast (1993) (227)
Superiority of Clopidogrel Versus Aspirin in Patients With Prior Cardiac Surgery (2001) (227)
Cardiogenic shock in patients with acute ischemic syndromes with and without ST-segment elevation. (1999) (224)
Lack of Benefit From Intravenous Platelet Glycoprotein IIb/IIIa Receptor Inhibition as Adjunctive Treatment for Percutaneous Interventions of Aortocoronary Bypass Grafts: A Pooled Analysis of Five Randomized Clinical Trials (2002) (223)
Personality and mortality risk across the life span: the importance of conscientiousness as a biopsychosocial attribute. (2007) (222)
Coronary arterial thrombolysis with combined infusion of recombinant tissue-type plasminogen activator and urokinase in patients with acute myocardial infarction. (1988) (221)
Clinical experience with the Palmaz-Schatz coronary stent. (1991) (221)
Effects of a 5-lipoxygenase-activating protein inhibitor on biomarkers associated with risk of myocardial infarction: a randomized trial. (2005) (221)
Impact of an aggressive invasive catheterization and revascularization strategy on mortality in patients with cardiogenic shock in the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO-I) trial. An observational study. (1997) (220)
Effects of platelet glycoprotein IIb/IIIa receptor blockade by a chimeric monoclonal antibody (abciximab) on acute and six-month outcomes after percutaneous transluminal coronary angioplasty for acute myocardial infarction. EPIC investigators. (1996) (220)
Comparison of the ABC/2 estimation technique to computer-assisted volumetric analysis of intraparenchymal and subdural hematomas complicating the GUSTO-1 trial. (1998) (219)
AI in health and medicine (2022) (219)
Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention (1999) (218)
Relation of Inflammation and Benefit of Statins After Percutaneous Coronary Interventions (2003) (218)
Incidence and Clinical Course of Thrombotic Thrombocytopenic Purpura Due to Ticlopidine Following Coronary Stenting (1999) (217)
New atrial fibrillation after acute myocardial infarction independently predicts death: the GUSTO-III experience. (2000) (215)
Incomplete Inhibition of Thromboxane Biosynthesis by Acetylsalicylic Acid: Determinants and Effect on Cardiovascular Risk (2008) (215)
34th Bethesda Conference: Task force #1--Identification of coronary heart disease risk: is there a detection gap? (2003) (215)
Prevalence of Asymptomatic SARS-CoV-2 Infection (2021) (214)
A Randomized Trial of Late Reperfusion Therapy for Acute Myocardial Infarction (1992) (213)
Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction. ReoPro and Primary PTCA Organization and Randomized Trial (RAPPORT) Investigators. (1998) (212)
Influence of blockade at specific levels of the coagulation cascade on restenosis in a rabbit atherosclerotic femoral artery injury model. (1995) (212)
Facilitation of early percutaneous coronary intervention after reteplase with or without abciximab in acute myocardial infarction: results from the SPEED (GUSTO-4 Pilot) Trial. (2000) (211)
Prognostic importance of physical examination for heart failure in non-ST-elevation acute coronary syndromes: the enduring value of Killip classification. (2003) (211)
Impression formation: the role of expressive behavior. (1986) (211)
Personality, type A behavior, and coronary heart disease: the role of emotional expression. (1987) (211)
Multivessel coronary artery disease: a key predictor of short-term prognosis after reperfusion therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group. (1991) (208)
Local drug delivery for the prevention of restenosis. Fact, fancy, and future. (1994) (207)
Selection of patients with acute myocardial infarction for thrombolytic therapy. (1990) (207)
Chronic Stable Angina (2005) (205)
A comparison of reteplase with alteplase for acute myocardial infarction. (1998) (204)
Sustained ventricular arrhythmias in patients receiving thrombolytic therapy: incidence and outcomes. The GUSTO Investigators. (1998) (204)
Evidence for prevention of death and myocardial infarction with platelet membrane glycoprotein IIb/IIIa receptor blockade by abciximab (c7E3 Fab) among patients with unstable angina undergoing percutaneous coronary revascularization. EPIC Investigators. Evaluation of 7E3 in Preventing Ischemic Compl (1997) (204)
ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). (2002) (202)
A randomized controlled trial of hospital discharge three days after myocardial infarction in the era of reperfusion. (1988) (198)
A multicenter, randomized, placebo-controlled trial of a new form of intravenous recombinant tissue-type plasminogen activator (activase) in acute myocardial infarction. (1987) (196)
Impact of body mass index on outcome after percutaneous coronary intervention (the obesity paradox). (2002) (196)
Optimal timing for the initiation of pre-treatment with 300 mg clopidogrel before percutaneous coronary intervention. (2006) (196)
Association between CK-MB elevation after percutaneous or surgical revascularization and three-year mortality. (2002) (195)
Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: rationale and design of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial. (2004) (195)
The Proportion of SARS-CoV-2 Infections That Are Asymptomatic (2021) (194)
Influence of diabetes mellitus on clinical outcomes across the spectrum of acute coronary syndromes. Findings from the GUSTO-IIb Study (2000) (193)
Individual Differences and Cues to Deception (1983) (193)
Harnessing wearable device data to improve state-level real-time surveillance of influenza-like illness in the USA: a population-based study. (2020) (192)
Psychosocial factors in sunbathing and sunscreen use. (1987) (192)
Impact of Patient and Target-Vessel Characteristics on Arterial and Venous Bypass Graft Patency: Insight From a Randomized Trial (2007) (190)
Benefit of Clopidogrel Over Aspirin Is Amplified in Patients With a History of Ischemic Events (2004) (190)
Randomized, Double-Blind, Placebo-Controlled, International Trial of the Oral IIb/IIIa Antagonist Lotrafiban in Coronary and Cerebrovascular Disease (2003) (189)
Sociodemographic and psychosocial factors in childhood as predictors of adult mortality. (1995) (189)
Effects of AGI-1067 and Probucol After Percutaneous Coronary Interventions (2003) (188)
Incidence and Predictors of Bleeding After Contemporary Thrombolytic Therapy for Myocardial Infarction (1997) (186)
Prognostic significance of elevated troponin I after percutaneous coronary intervention. (2002) (183)
Aspirin to Prevent Cardiovascular Disease: The Association of Aspirin Dose and Clopidogrel With Thrombosis and Bleeding (2009) (183)
Multicenter Validation of the Diagnostic Accuracy of a Blood-Based Gene Expression Test for Assessing Obstructive Coronary Artery Disease in Nondiabetic Patients (2010) (183)
Bivalirudin with planned or provisional abciximab versus low-dose heparin and abciximab during percutaneous coronary revascularization: results of the Comparison of Abciximab Complications with Hirulog for Ischemic Events Trial (CACHET). (2002) (183)
Local intraluminal infusion of biodegradable polymeric nanoparticles. A novel approach for prolonged drug delivery after balloon angioplasty. (1996) (183)
Relation of Clinical Presentation, Stenosis Morphology, and Operator Technique to the Procedural Results of Rotational Atherectomy and Rotational Atherectomy–Facilitated Angioplasty (1994) (182)
The efficacy and safety of short- and long-term dual antiplatelet therapy in patients with mild or moderate chronic kidney disease: results from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial. (2008) (182)
Whole-Genome Sequencing of a Healthy Aging Cohort (2016) (181)
Toward the quiescent coronary plaque. (1993) (180)
Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. (1997) (179)
Low Molecular Weight Heparin in Prevention of Restenosis After Angioplasty: Results of Enoxaparin Restenosis (ERA) Trial (1994) (179)
Thrombosis of a flexible coil coronary stent: frequency, predictors and clinical outcome. (1993) (178)
Genetic susceptibility to myocardial infarction and coronary artery disease. (2006) (176)
Effect of age on outcome with primary angioplasty versus thrombolysis. (1999) (175)
Clinical and therapeutic profile of patients presenting with acute coronary syndromes who do not have significant coronary artery disease.The Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) Trial Investigators. (2000) (174)
Use of intraaortic balloon counterpulsation in patients presenting with cardiogenic shock: observations from the GUSTO-I Study. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries. (1997) (172)
A multicenter, randomized trial of coronary angioplasty versus directional atherectomy for patients with saphenous vein bypass graft lesions. CAVEAT-II Investigators. (1995) (172)
Cardiogenic shock complicating acute coronary syndromes (2000) (171)
Determinants of the use of coronary angiography and revascularization after thrombolysis for acute myocardial infarction. (1996) (171)
Long-term angiographic and clinical outcome after implantation of a ballon-expandable stent in the native coronary circulation☆ (1994) (171)
Marital history at midlife as a predictor of longevity: alternative explanations to the protective effect of marriage. (1996) (171)
Receptor for AGE (RAGE) Mediates Neointimal Formation in Response to Arterial Injury (2003) (171)
Conscientiousness, health, and aging: the life course of personality model. (2014) (170)
Direct thrombin inhibitors in cardiovascular medicine. (1994) (170)
Identification of four gene variants associated with myocardial infarction. (2005) (169)
Personality and disease. (1990) (169)
Cardiogenic shock complicating acute myocardial infarction: predictors of death. GUSTO Investigators. Global Utilization of Streptokinase and Tissue-Plasminogen Activator for Occluded Coronary Arteries. (1999) (169)
Recombinant hirudin for unstable angina pectoris. A multicenter, randomized angiographic trial. (1994) (168)
Continuous 12‐Lead ST‐Segment Recovery Analysis in the TAMI 7 Study Performance of a Noninvasive Method for Real‐Time Detection of Failed Myocardial Reperfusion Detection of Failed Myocardial Reperfusion (1993) (168)
Foundations of health psychology (2007) (167)
Towards precise classification of cancers based on robust gene functional expression profiles (2005) (166)
Long-term mortality benefit with abciximab in patients undergoing percutaneous coronary intervention. (2001) (163)
Intensive statin therapy--a sea change in cardiovascular prevention. (2004) (163)
Hemorrhagic complications associated with the use of intravenous tissue plasminogen activator in treatment of acute myocardial infarction. (1988) (163)
Characteristics and outcome of patients in whom reperfusion with intravenous tissue-type plasminogen activator fails: results of the Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) I trial. (1988) (162)
Relationship Between Activated Clotting Time and Ischemic or Hemorrhagic Complications: Analysis of 4 Recent Randomized Clinical Trials of Percutaneous Coronary Intervention (2004) (162)
Clinical, physiologic, anatomic and procedural factors predictive of restenosis after percutaneous transluminal coronary angioplasty. (1991) (162)
Sustained suppression of ischemic complications of coronary intervention by platelet GP IIb/IIIa blockade with abciximab: one-year outcome in the EPILOG trial. Evaluation in PTCA to Improve Long-term Outcome with abciximab GP IIb/IIIa blockade. (1999) (162)
Prognostic value of ST segment depression in acute coronary syndromes: insights from PARAGON-A applied to GUSTO-IIb. PARAGON-A and GUSTO IIb Investigators. Platelet IIb/IIIa Antagonism for the Reduction of Acute Global Organization Network. (2001) (161)
Need to test the arterial inflammation hypothesis. (2002) (160)
Novel wireless devices for cardiac monitoring. (2014) (160)
From myocardial salvage to patient salvage in acute myocardial infarction: the role of reperfusion therapy. (1989) (160)
Predictors of long-term outcome after crush stenting of coronary bifurcation lesions: importance of the bifurcation angle. (2006) (159)
Myeloperoxidase-Generated Oxidants Modulate Left Ventricular Remodeling but Not Infarct Size After Myocardial Infarction (2005) (159)
Atenolol use and clinical outcomes after thrombolysis for acute myocardial infarction: the GUSTO-I experience. Global Utilization of Streptokinase and TPA (alteplase) for Occluded Coronary Arteries. (1998) (158)
Risk stratification with a point-of-care cardiac troponin T test in acute myocardial infarction. GUSTOIII Investigators. Global Use of Strategies To Open Occluded Coronary Arteries. (1999) (156)
Prediction of infarct coronary artery recanalization after intravenous thrombolytic therapy. (1987) (156)
A Polymorphism in the Protease-Like Domain of Apolipoprotein(a) Is Associated With Severe Coronary Artery Disease (2007) (156)
The HOPE (Heart Outcomes Prevention Evaluation) Study: the design of a large, simple randomized trial of an angiotensin-converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events. The HOPE study investigators. (1996) (155)
End-systolic volume index at 90 to 180 minutes into reperfusion therapy for acute myocardial infarction is a strong predictor of early and late mortality. The Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I Angiographic Investigators. (1997) (155)
Multicenter study of percutaneous transluminal angioplasty for right coronary artery ostial stenosis. (1987) (155)
The influence of peripheral arterial disease on outcomes: a pooled analysis of mortality in eight large randomized percutaneous coronary intervention trials. (2006) (155)
Minimum information about clinical artificial intelligence modeling: the MI-CLAIM checklist (2020) (155)
Occurrence and clinical significance of thrombocytopenia in a population undergoing high-risk percutaneous coronary revascularization. Evaluation of c7E3 for the Prevention of Ischemic Complications (EPIC) Study Group. (1998) (154)
Clinical significance of thrombocytopenia during a non-ST-elevation acute coronary syndrome. The platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial experience. (1999) (154)
Does creatinine kinase-MB elevation after percutaneous coronary intervention predict outcomes in 2005? Periprocedural cardiac enzyme elevation predicts adverse outcomes. (2005) (153)
Platelet Glycoprotein IIb/IIIa Inhibitors: Recognition of a Two-Edged Sword? (2002) (152)
Platelet glycoprotein IIb/IIIa inhibition in acute coronary syndromes. Gradient of benefit related to the revascularization strategy. (2002) (152)
Relationship between antecedent angina pectoris and short-term prognosis after thrombolytic therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group. (1990) (152)
Personality and Healthy Sleep: The Importance of Conscientiousness and Neuroticism (2014) (151)
Gender and acute myocardial infarction: is there a different response to thrombolysis? (1997) (151)
Local delivery of dexamethasone for prevention of neointimal proliferation in a rat model of balloon angioplasty. (1994) (150)
Bivalirudin and Provisional Glycoprotein IIb/IIIa Blockade Compared With Heparin and Planned Glycoprotein IIb/IIIa Blockade During Percutaneous Coronary Intervention (2003) (150)
Influence of donor age on induced pluripotent stem cells (2016) (150)
Frequency and long-term impact of myonecrosis after coronary stenting. (2002) (150)
Effect of individual differences in nonverbal expressiveness on transmission of emotion (1981) (149)
Effect of platelet glycoprotein IIb/IIIa integrin blockade on activated clotting time during percutaneous transluminal coronary angioplasty or directional atherectomy (the EPIC trial). Evaluation of c7E3 Fab in the Prevention of Ischemic Complications trial. (1995) (149)
Effect of clopidogrel added to aspirin before percutaneous coronary intervention on the risk associated with C-reactive protein. (2001) (149)
Initial report of the National Registry of Elective Cardiopulmonary Bypass Supported Coronary Angioplasty. (1990) (148)
A Life Course Perspective on Childhood Cheerfulness and its Relation to Mortality Risk (2002) (148)
Personality and health: A lifespan perspective. (2008) (148)
Major clinical events after coronary stenting. The multicenter registry of acute and elective Gianturco-Roubin stent placement. The Gianturco-Roubin Intracoronary Stent Investigator Group. (1994) (147)
Variations in Patient Management and Outcomes for Acute Myocardial Infarction in the United States and Other Countries: Results From the GUSTO Trial (1995) (146)
Is Pocket Mobile Echocardiography the Next-Generation Stethoscope? A Cross-sectional Comparison of Rapidly Acquired Images With Standard Transthoracic Echocardiography (2011) (146)
Predictors of cardiogenic shock after thrombolytic therapy for acute myocardial infarction. (2000) (146)
Hemodynamic effects of nitroglycerin and long-acting nitrates. (1985) (146)
Evaluation of individualized clopidogrel therapy after drug-eluting stent implantation in patients with high residual platelet reactivity: design and rationale of the GRAVITAS trial. (2009) (145)
Cardiac rupture associated with thrombolytic therapy: impact of time to treatment in the Late Assessment of Thrombolytic Efficacy (LATE) study. (1995) (145)
Prediction of 1-year survival after thrombolysis for acute myocardial infarction in the global utilization of streptokinase and TPA for occluded coronary arteries trial. (2000) (145)
Multi-year follow-up of abciximab therapy in three randomized, placebo-controlled trials of percutaneous coronary revascularization. (2002) (145)
Sustained Ventricular Arrhythmias Among Patients With Acute Coronary Syndromes With No ST-Segment Elevation: Incidence, Predictors, and Outcomes (2002) (144)
Economic assessment of platelet glycoprotein IIb/IIIa inhibition for prevention of ischemic complications of high-risk coronary angioplasty. EPIC Investigators. (1996) (144)
Nonverbal display of emotion in public and in private: self-monitoring, personality, and expressive cues. (1991) (143)
Effects of reteplase and alteplase on platelet aggregation and major receptor expression during the first 24 hours of acute myocardial infarction treatment. GUSTO-III Investigators. Global Use of Strategies to Open Occluded Coronary Arteries. (1998) (143)
Reduction in complications of angioplasty with abciximab occurs largely independently of baseline lesion morphology. EPIC and EPILOG Investigators. Evaluation of 7E3 for the Prevention of Ischemic Complications. Evaluation of PTCA To Improve Long-term Outcome with abciximab GPIIb/IIIa Receptor Block (1998) (143)
The myth of the myocardial 'infarctlet' during percutaneous coronary revascularization procedures. (1996) (143)
Abstract 3999: Baseline Proton Pump Inhibitor Use is Associated with Increased Cardiovascular Events With and Without the Use of Clopidogrel in the CREDO Trial (2008) (143)
Longitudinal Genome-Wide Association of Cardiovascular Disease Risk Factors in the Bogalusa Heart Study (2010) (143)
Telemedicine 2020 and the next decade (2020) (143)
Clinical benefit of glycoprotein IIb/IIIa blockade with Abciximab is independent of gender: pooled analysis from EPIC, EPILOG and EPISTENT trials. Evaluation of 7E3 for the Prevention of Ischemic Complications. Evaluation in Percutaneous Transluminal Coronary Angioplasty to Improve Long-Term Outcome (2000) (142)
Persistence of delays in presentation and treatment for patients with acute myocardial infarction: The GUSTO-I and GUSTO-III experience. (2002) (141)
Cost effectiveness of early discharge after uncomplicated acute myocardial infarction. (2000) (141)
High-Definition Medicine (2017) (141)
Strategies to achieve coronary arterial plaque stabilization. (1999) (141)
Increased Expression of Thrombospondin-1 in Vessel Wall of Diabetic Zucker Rat (2003) (140)
A new life-span approach to conscientiousness and health: combining the pieces of the causal puzzle. (2014) (140)
Mortality Within 24 Hours of Thrombolysis for Myocardial Infarction: The Importance of Early Reperfusion (1994) (139)
Reduction in the need for hospitalization for recurrent ischemic events and bleeding with clopidogrel instead of aspirin. CAPRIE investigators. (2000) (139)
Influence of genetic polymorphisms on the effect of high- and standard-dose clopidogrel after percutaneous coronary intervention: the GIFT (Genotype Information and Functional Testing) study. (2012) (139)
Hypertrophic obstructive cardiomyopathy: comparison of outcomes after myectomy or alcohol ablation adjusted by propensity score. (2005) (139)
Nonverbal Skill, Personal Charisma, and Initial Attraction (1988) (139)
Limitations of thrombolytic therapy for acute myocardial infarction complicated by congestive heart failure and cardiogenic shock. (1991) (138)
Artery size, neointima, and remodeling: time for some standards. (1998) (138)
Fate of patients with acute myocardial infarction with patency of the infarct-related vessel achieved with successful thrombolysis versus rescue angioplasty. (1990) (138)
Early discharge in the thrombolytic era: an analysis of criteria for uncomplicated infarction from the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) trial. (1996) (138)
Thrombocytopenia Caused by Abciximab or Tirofiban and Its Association With Clinical Outcome in Patients Undergoing Coronary Stenting (2004) (138)
The relative efficacy and safety of clopidogrel in women and men a sex-specific collaborative meta-analysis. (2009) (137)
A robust hybrid between genetic algorithm and support vector machine for extracting an optimal feature gene subset. (2005) (137)
Development of a blood-based gene expression algorithm for assessment of obstructive coronary artery disease in non-diabetic patients (2011) (136)
With an eye to AI and autonomous diagnosis (2018) (136)
Integrating complementary medicine into cardiovascular medicine. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (Writing Committee to Develop an Expert Consensus Document on Complementary and Integrative Medicine). (2005) (136)
Aspirin and clopidogrel resistance: an emerging clinical entity. (2006) (135)
The use of high-sensitivity assays for C-reactive protein in clinical practice (2008) (135)
Recurrent ischemia without warning. Analysis of risk factors for in-hospital ischemic events following successful thrombolysis with intravenous tissue plasminogen activator. (1989) (135)
Large scale association analysis for identification of genes underlying premature coronary heart disease: cumulative perspective from analysis of 111 candidate genes (2004) (135)
The multiple linkages of personality and disease (2008) (134)
Mortality at 1 year with combination platelet glycoprotein IIb/IIIa inhibition and reduced-dose fibrinolytic therapy vs conventional fibrinolytic therapy for acute myocardial infarction: GUSTO V randomized trial. (2002) (134)
Effects of antisense c-myb oligonucleotides on vascular smooth muscle cell proliferation and response to vessel wall injury. (1995) (134)
Extended Mortality Benefit of Early Postinfarction Reperfusion (1998) (133)
Meta-analysis of Dense Genecentric Association Studies Reveals Common and Uncommon Variants Associated with Height. (2011) (133)
Tissue factor, the emerging link between inflammation, thrombosis, and vascular remodeling. (2001) (133)
Economic evaluation of bivalirudin with provisional glycoprotein IIB/IIIA inhibition versus heparin with routine glycoprotein IIB/IIIA inhibition for percutaneous coronary intervention: results from the REPLACE-2 trial. (2004) (133)
Effect of clopidogrel pretreatment on inflammatory marker expression in patients undergoing percutaneous coronary intervention. (2004) (132)
Acute myocardial infarction and complete bundle branch block at hospital admission: clinical characteristics and outcome in the thrombolytic era. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA [tissue-type plasminogen activator] for Occluded Coronary Arteries. (1998) (132)
Standard versus low-dose weight-adjusted heparin in patients treated with the platelet glycoprotein IIb/IIIa receptor antibody fragment abciximab (c7E3 Fab) during percutaneous coronary revascularization. PROLOG Investigators. (1997) (131)
Intracoronary stenting compared with conventional therapy for abrupt vessel closure complicating coronary angioplasty: a matched case-control study. (1993) (131)
Characteristics of a contemporary population with angina pectoris. TIDES Investigators. (1994) (131)
Conscientiousness, Career Success, and Longevity: A Lifespan Analysis (2009) (131)
Long-term cost effectiveness of early and sustained dual oral antiplatelet therapy with clopidogrel given for up to one year after percutaneous coronary intervention results: from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial. (2005) (131)
Smoking, Clopidogrel, and Mortality in Patients With Established Cardiovascular Disease (2009) (131)
Platelet glycoprotein IIb/IIIa blockade and outcome of cardiogenic shock complicating acute coronary syndromes without persistent ST-segment elevation. (2000) (130)
Proteomic approach to coronary atherosclerosis shows ferritin light chain as a significant marker: evidence consistent with iron hypothesis in atherosclerosis. (2003) (130)
Impact of direct-to-consumer genomic testing at long term follow-up (2013) (129)
Left ventricular ejection fraction may not be useful as an end point of thrombolytic therapy comparative trials. (1990) (128)
Lack of evidence of a clopidogrel-statin interaction in the CHARISMA trial. (2006) (128)
Tolerance to organic nitrates (1986) (128)
Cardiogenic shock complicating acute myocardial infarction: the use of coronary angioplasty and the integration of the new support devices into patient management. (1992) (127)
Nonverbal Communication Between Patients and Medical Practitioners (1979) (126)
Digital medical tools and sensors. (2015) (126)
Nitroglycerin and long-acting nitrates. (1980) (125)
Rationale, design, implementation, and baseline characteristics of patients in the DIG trial: a large, simple, long-term trial to evaluate the effect of digitalis on mortality in heart failure. (1996) (125)
Attainment and maintenance of platelet inhibition through standard dosing of abciximab in diabetic and nondiabetic patients undergoing percutaneous coronary intervention. (1999) (124)
Heparin-induced thrombocytopenia. (1998) (124)
Prior aspirin use predicts worse outcomes in patients with non-ST-elevation acute coronary syndromes. PURSUIT Investigators. Platelet IIb/IIIa in Unstable angina: Receptor Suppression Using Integrilin Therapy. (1999) (124)
Comparing personality scales across time: an illustrative study of validity and consistency in life-span archival data. (2000) (124)
Cost-effectiveness of platelet glycoprotein IIb/IIIa inhibition with eptifibatide in patients with non-ST-elevation acute coronary syndromes. (2000) (123)
Randomised trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: results at six months. The EPIC Investigators. (1994) (123)
One-Year Results From the Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries (GUSTO-I) Trial (1996) (122)
Catastrophizing and Untimely Death (1998) (122)
Arthritis medicines and cardiovascular events--"house of coxibs". (2005) (122)
Stability of Physical Activity across the Lifespan (2008) (122)
Interpersonal issues in health care (1982) (122)
N-acetylcysteine reduces contrast-associated nephropathy but not clinical events during long-term follow-up. (2004) (121)
Consumer perceptions of direct-to-consumer personalized genomic risk assessments (2010) (121)
Role of platelets in restenosis after percutaneous coronary revascularization. (1996) (121)
Accurate detection and genotyping of SNPs utilizing population sequencing data. (2010) (120)
Long-term outcome and its predictors among patients with ST-segment elevation myocardial infarction complicated by shock: insights from the GUSTO-I trial. (2007) (120)
Beneficial actions of nitrates in cardiovascular disease. (1996) (120)
Facilitated percutaneous coronary intervention versus primary percutaneous coronary intervention: design and rationale of the Facilitated Intervention with Enhanced Reperfusion Speed to Stop Events (FINESSE) trial. (2004) (119)
Clinical outcomes of patients with diabetic nephropathy randomized to clopidogrel plus aspirin versus aspirin alone (a post hoc analysis of the clopidogrel for high atherothrombotic risk and ischemic stabilization, management, and avoidance [CHARISMA] trial). (2009) (119)
Pharmacodynamics of thrombolysis with recombinant tissue-type plasminogen activator. Correlation with characteristics of and clinical outcomes in patients with acute myocardial infarction. The TAMI Study Group. (1989) (119)
Combining thrombolysis with the platelet glycoprotein IIb/IIIa inhibitor lamifiban: results of the Platelet Aggregation Receptor Antagonist Dose Investigation and Reperfusion Gain in Myocardial Infarction (PARADIGM) trial. (1998) (119)
Systemic elevations of free radical oxidation products of arachidonic acid are associated with angiographic evidence of coronary artery disease. (2006) (119)
Unpatients—why patients should own their medical data (2015) (118)
Thrombospondin‐1 up‐regulates expression of cell adhesion molecules and promotes monocyte binding to endothelium (2005) (118)
Association between minor elevations of creatine kinase-MB level and mortality in patients with acute coronary syndromes without ST-segment elevation. PURSUIT Steering Committee. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy. (2000) (118)
Transcription factor MEF2A mutations in patients with coronary artery disease. (2004) (118)
Pulsed Doppler assessment of left ventricular diastolic filling in coronary artery disease before and immediately after coronary angioplasty. (1987) (117)
Effect of cigarette smoking on outcome after thrombolytic therapy for myocardial infarction. (1995) (117)
A common MECP2 haplotype associates with reduced cortical surface area in humans in two independent populations (2009) (117)
A randomized, placebo-controlled trial of intravenous recombinant tissue-type plasminogen activator and emergency coronary angioplasty in patients with acute myocardial infarction. (1987) (117)
Ticlopidine Pretreatment Before Coronary Stenting Is Associated With Sustained Decrease in Adverse Cardiac Events: Data From the Evaluation of Platelet IIb/IIIa Inhibitor for Stenting (EPISTENT) Trial (2001) (117)
Scorecard Cardiovascular Medicine: Its Impact and Future Directions (1994) (116)
Effect of platelet glycoprotein IIb/IIIa receptor inhibition on distal embolization during percutaneous revascularization of aortocoronary saphenous vein grafts. EPIC Investigators. Evaluation of IIb/IIIa platelet receptor antagonist 7E3 in Preventing Ischemic Complications. (1997) (116)
Peripheral vascular complications in the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT-I). (1995) (116)
The interrelationships of self-monitoring factors, personality traits, and nonverbal social skills (1982) (116)
The Extraction of Circulating Catecholamines by the Lungs in Normal Man and in Patients with Pulmonary Hypertension (1979) (116)
Frequency, patient characteristics, and outcomes of mild-to-moderate heart failure complicating ST-segment elevation acute myocardial infarction: lessons from 4 international fibrinolytic therapy trials. (2003) (116)
Enrichment of sequencing targets from the human genome by solution hybridization (2009) (115)
Clinical practice. Chronic stable angina. (2005) (115)
Neointimal Hyperplasia After Arterial Injury Is Increased in a Rat Model of Non–Insulin-Dependent Diabetes Mellitus (2001) (115)
Variations in patient management and outcomes for acute myocardial infarction in the United States and other countries. Results from the GUSTO trial. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. (1995) (115)
Native coronary disease progression exceeds failed revascularization as cause of angina after five years in the Bypass Angioplasty Revascularization Investigation (BARI). (2004) (115)
Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass grafts. (1995) (114)
Risk factors, time course and treatment effect for restenosis after successful percutaneous transluminal coronary angioplasty of chronic total occlusion. (1989) (114)
One-year follow-up in the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT I) (1995) (114)
Abciximab Suppresses the Rise in Levels of Circulating Inflammatory Markers After Percutaneous Coronary Revascularization (2001) (114)
In unstable angina or non-ST-segment acute coronary syndrome, should patients with multivessel coronary artery disease undergo multivessel or culprit-only stenting? (2007) (114)
Meta-analysis of randomized trials of percutaneous transluminal coronary angioplasty versus atherectomy, cutting balloon atherotomy, or laser angioplasty. (2004) (114)
Regional wall motion improvement after coronary thrombolysis with recombinant tissue plasminogen activator: importance of coronary angioplasty. (1985) (113)
Cardiac papillary fibroelastoma and stroke. Echocardiographic diagnosis and guide to excision. (1986) (113)
Aspirin resistance and a single gene. (2005) (113)
Effects of integrelin, a platelet glycoprotein IIb/IIIa receptor antagonist, in unstable angina. A randomized multicenter trial. (1996) (113)
Tirofiban as adjunctive therapy for acute coronary syndromes and percutaneous coronary intervention: a meta-analysis of randomized trials. (2010) (113)
Coronary Bypass Graft Patency in Patients With Diabetes in the Bypass Angioplasty Revascularization Investigation (BARI) (2002) (113)
Occurrence and clinical significance of pseudothrombocytopenia during abciximab therapy. (2000) (113)
Thrombolytic therapy for women with myocardial infarction: is there a gender gap? Thrombolysis and Angioplasty in Myocardial Infarction Study Group. (1993) (113)
Eptifibatide and low-dose tissue plasminogen activator in acute myocardial infarction: the integrilin and low-dose thrombolysis in acute myocardial infarction (INTRO AMI) trial. (2002) (113)
First chronic platelet glycoprotein IIb/IIIa integrin blockade. A randomized, placebo-controlled pilot study of xemilofiban in unstable angina with percutaneous coronary interventions. (1997) (113)
Impact of preprocedural white blood cell count on long term mortality after percutaneous coronary intervention: insights from the EPIC, EPILOG, and EPISTENT trials (2003) (113)
Alcohol septal ablation for the treatment of hypertrophic obstructive cardiomyopathy. A multicenter North American registry. (2011) (112)
Predictors and sequelae of distal embolization during saphenous vein graft intervention from the CAVEAT-II trial. Coronary Angioplasty Versus Excisional Atherectomy Trial. (1995) (112)
Randomized Trial of Late Elective Angioplasty Versus Conservative Management for Patients With Residual Stenoses After Thrombolytic Treatment of Myocardial Infarction (1992) (112)
Regionalization of care for acute ischemic heart disease: a call for specialized centers. (2003) (111)
A call for provisional stenting: the balloon is back! (1998) (111)
Gain‐of‐function ADCY5 mutations in familial dyskinesia with facial myokymia (2014) (110)
Decreased complication rates using the transradial compared to the transfemoral approach in percutaneous coronary intervention in the era of routine stenting and glycoprotein platelet IIb/IIIa inhibitor use: a large single-center experience. (2008) (110)
Present status of rescue coronary angioplasty: current polarization of opinion and randomized trials. (1992) (110)
Minimal myocardial damage during coronary intervention is associated with impaired outcome. (1999) (110)
Long-term mortality benefit with the combination of stents and abciximab for cardiogenic shock complicating acute myocardial infarction. (2002) (110)
Prognostic implications and predictors of enhanced regional wall motion of the noninfarct zone after thrombolysis and angioplasty therapy of acute myocardial infarction. The TAMI Study Groups. (1989) (110)
Percutaneous coronary intervention in diabetic patients with non-ST-segment elevation acute coronary syndromes. (2004) (110)
Coronary-artery stents--gauging, gorging, and gouging. (1998) (110)
Dual or Mono Antiplatelet Therapy for Patients With Acute Ischemic Stroke or Transient Ischemic Attack: Systematic Review and Meta-Analysis of Randomized Controlled Trials (2012) (109)
Manual of Cardiovascular Medicine (2000) (108)
Inducible carboxypeptidase activity. A role in clot lysis in vivo. (1996) (108)
Effect of clopidogrel pretreatment on periprocedural rise in C-reactive protein after percutaneous coronary intervention. (2004) (107)
Evidence for substantial effect modification by gender in a large-scale genetic association study of the metabolic syndrome among coronary heart disease patients (2003) (107)
The relationship between CYP2C19 polymorphisms and ischaemic and bleeding outcomes in stable outpatients: the CHARISMA genetics study. (2012) (107)
Diabetes mellitus, glycoprotein IIb/IIIa blockade, and heparin: evidence for a complex interaction in a multicenter trial. EPILOG Investigators. (1998) (107)
Dual antiplatelet therapy with clopidogrel and aspirin after carotid artery stenting. (2001) (107)
Incidence, predictors, and outcomes of high-degree atrioventricular block complicating acute myocardial infarction treated with thrombolytic therapy. (2005) (106)
Clinical characteristics and long-term outcome of patients in whom congestive heart failure develops after thrombolytic therapy for acute myocardial infarction: development of a predictive model. (1997) (106)
Triple antiplatelet therapy during percutaneous coronary intervention is associated withimproved outcomes including one-year survival (2003) (106)
Relation of Stenosis Morphology and Clinical Presentation to the Procedural Results of Directional Coronary Atherectomy (1991) (106)
Parental divorce: effects on individual behavior and longevity. (1997) (106)
Difference in countries' use of resources and clinical outcome for patients with cardiogenic shock after myocardial infarction: results from the GUSTO trial (1997) (106)
Racial Differences in Responses to Thrombolytic Therapy With Recombinant Tissue‐Type Plasminogen Activator: Increased Fibrin(ogen)olysis in Blacks (1991) (106)
Bleeding during thrombolytic therapy for acute myocardial infarction: mechanisms and management. (1989) (105)
Thrombospondin-4 and Its Variants: Expression and Differential Effects on Endothelial Cells (2003) (105)
Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease. (2000) (104)
Clinical outcomes of bivalirudin for ischemic heart disease. (1999) (104)
Ethnic variation in adverse cardiovascular outcomes and bleeding complications in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) study. (2009) (104)
Early percutaneous coronary intervention, platelet inhibition with eptifibatide, and clinical outcomes in patients with acute coronary syndromes. PURSUIT Investigators. (2000) (104)
A preferred reperfusion strategy for acute myocardial infarction. (2003) (103)
Pharmacological approaches for the prevention of restenosis after percutaneous coronary intervention. (1997) (103)
Impact of Different Platelet Glycoprotein IIb/IIIa Receptor Inhibitors Among Diabetic Patients Undergoing Percutaneous Coronary Intervention: Do Tirofiban and ReoPro Give Similar Efficacy Outcomes Trial (TARGET) 1-Year Follow-Up (2002) (103)
Pharmacogenomics in clinical practice and drug development (2012) (103)
One-year survival among patients with acute myocardial infarction complicated by cardiogenic shock, and its relation to early revascularization: results from the GUSTO-I trial. (1999) (103)
Relation between lesion characteristics and risk with percutaneous intervention in the stent and glycoprotein IIb/IIIa era: An analysis of results from 10,907 lesions and proposal for new classification scheme. (1999) (103)
Early educational milestones as predictors of lifelong academic achievement, midlife adjustment, and longevity. (2009) (102)
The Longevity Project: Surprising Discoveries for Health and Long Life from the Landmark Eight-Decade Study (2011) (102)
Thrombolysis-related intracranial hemorrhage: a radiographic analysis of 244 cases from the GUSTO-1 trial with clinical correlation. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. (1998) (101)
Variability of quantitative digital subtraction coronary angiography before and after percutaneous transluminal coronary angioplasty. (1987) (100)
Privacy and security in the era of digital health: what should translational researchers know and do about it? (2016) (100)
Recombinant human tissue-type plasminogen activator therapy in acute thromboembolic stroke. (1987) (100)
The arrhythmogenicity of theophylline. A multivariate analysis of clinical determinants. (1991) (100)
Complete atrioventricular block complicating inferior wall acute myocardial infarction treated with reperfusion therapy (1991) (100)
Combined tissue-type plasminogen activator and prostacyclin therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) 4 Study Group. (1989) (99)
Defining the appropriate threshold of creatine kinase elevation after percutaneous coronary interventions. (1996) (99)
Meta-analysis of survival with platelet glycoprotein IIb/IIIa antagonists for percutaneous coronary interventions. (2003) (99)
Safety of femoral closure devices after percutaneous coronary interventions in the era of glycoprotein IIb/IIIa platelet blockade. (2000) (99)
Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture (2021) (99)
Predictors and prognosis of suboptimal coronary blood flow after primary coronary angioplasty in patients with acute myocardial infarction. (2001) (98)
Benefit of facilitated percutaneous coronary intervention in high-risk ST-segment elevation myocardial infarction patients presenting to nonpercutaneous coronary intervention hospitals. (2009) (98)
Vascular access site complications after percutaneous coronary intervention with abciximab in the Evaluation of c7E3 for the Prevention of Ischemic Complications (EPIC) trial. (1998) (98)
Personality and Pathways of Influence on Physical Health (2011) (98)
Randomized comparison of direct thrombin inhibition versus heparin in conjunction with fibrinolytic therapy for acute myocardial infarction: results from the GUSTO-IIb Trial. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO-IIb) Investigators. (1998) (97)
A Covering Method for Detecting Genetic Associations between Rare Variants and Common Phenotypes (2010) (97)
Effect of Cigarette Smoking on Outcome After Thrombolytic Therapy for Myocardial Infarction (1991) (97)
Decreased perihematomal edema in thrombolysis-related intracerebral hemorrhage compared with spontaneous intracerebral hemorrhage. (2000) (97)
Nitrate tolerance and dependence. (1980) (97)
Late myocardial ischemic events after saphenous vein graft intervention--importance of initially "nonsignificant" vein graft lesions. (1997) (97)
Caveats about elective coronary stenting. (1994) (97)
Long COVID: major findings, mechanisms and recommendations (2023) (96)
Predictors of revascularization method and long-term outcome of percutaneous coronary intervention or repeat coronary bypass surgery in patients with multivessel coronary disease and previous coronary bypass surgery. (2006) (96)
Nesiritide - not verified. (2005) (96)
Value of percutaneous transluminal coronary angioplasty after unsuccessful intravenous streptokinase therapy in acute myocardial infarction. (1986) (96)
Incidence and clinical course of thrombotic thrombocytopenic purpura due to ticlopidine following coronary stenting. EPISTENT Investigators. Evaluation of Platelet IIb/IIIa Inhibitor for Stenting. (1999) (96)
A prospective randomized trial examining health care utilization in individuals using multiple smartphone-enabled biosensors (2015) (95)
The use of intraaortic balloon pumping as an adjunct to reperfusion therapy in acute myocardial infarction. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group. (1991) (95)
Community hospital administration of intravenous tissue plasminogen activator in acute myocardial infarction: improved timing, thrombolytic efficacy and ventricular function. (1987) (95)
Gene Variants of VAMP8 and HNRPUL1 Are Associated With Early-Onset Myocardial Infarction (2006) (94)
Troponin T and quantitative ST-segment depression offer complementary prognostic information in the risk stratification of acute coronary syndrome patients. (2003) (94)
Pharmacodynamic efficacy, clinical safety, and outcomes after prolonged platelet Glycoprotein IIb/IIIa receptor blockade with oral xemilofiban: results of a multicenter, placebo-controlled, randomized trial. (1998) (94)
Combination of platelet fibrinogen receptor antagonist and direct thrombin inhibitor at low doses markedly improves thrombolysis. (1994) (94)
Bivalirudin versus heparin and glycoprotein IIb/IIIa inhibition among patients with renal impairment undergoing percutaneous coronary intervention (a subanalysis of the REPLACE-2 trial). (2005) (93)
Effects of profound platelet inhibition with c7E3 before coronary angioplasty on complications of coronary bypass surgery. EPIC Investigators. Evaluation Prevention of Ischemic Complications. (1994) (93)
Significance of a coronary artery with thrombolysis in myocardial infarction grade 2 flow "patency" (outcome in the thrombolysis and angioplasty in myocardial infarction trials). Thrombolysis and Angioplasty in Myocardial Infarction Study Group. (1995) (93)
Diabetes mellitus and outcome after primary coronary angioplasty for acute myocardial infarction: Lessons from the GUSTO-IIb Angioplasty Substudy (2000) (92)
Protective alleles and modifier variants in human health and disease (2015) (92)
Efficacy and safety of esmolol vs propranolol in the treatment of supraventricular tachyarrhythmias: a multicenter double-blind clinical trial. (1985) (92)
Direct-to-consumer personalized genomic testing. (2011) (92)
A coxib a day won't keep the doctor away (2004) (92)
Incidence and predictors of bleeding after contemporary thrombolytic therapy for myocardial infarction. The Global Utilization of Streptokinase and Tissue Plasminogen activator for Occluded coronary arteries (GUSTO) I Investigators. (1997) (90)
Relation between estrogen replacement therapy and restenosis after percutaneous coronary interventions. (1996) (90)
34th Bethesda Conference: Can atherosclerosis imaging techniques improve the detection of patients at risk for ischemic heart disease? (2003) (90)
Dynamic QRS complex and ST segment vectorcardiographic monitoring can identify vessel patency in patients with acute myocardial infarction treated with reperfusion therapy. (1991) (90)
Outcomes at 6 months for the direct comparison of tirofiban and abciximab during percutaneous coronary revascularisation with stent placement: the TARGET follow-up study (2002) (90)
A randomized placebo-controlled trial of combined early intravenous captopril and recombinant tissue-type plasminogen activator therapy in acute myocardial infarction. (1991) (89)
Analysis and comparison of operator-specific outcomes in interventional cardiology. From a multicenter database of 4860 quality-controlled procedures. (1996) (89)
Long-Term Results After the Glycoprotein IIb/IIIa Inhibitor Abciximab in Unstable Angina: One-Year Survival in the GUSTO IV-ACS (Global Use of Strategies To Open Occluded Coronary Arteries IV—Acute Coronary Syndrome) Trial (2003) (89)
COVID-19 can affect the heart (2020) (89)
Identification of new genes differentially expressed in coronary artery disease by expression profiling. (2003) (88)
Prediction of Causal Candidate Genes in Coronary Artery Disease Loci (2015) (88)
Intravenous Fluosol in the Treatment of Acute Myocardial Infarction: Results of the Thrombolysis and Angioplasty in Myocardial Infarction 9 Trial (1994) (88)
Diabetic retinopathy should not be a contraindication to thrombolytic therapy for acute myocardial infarction: review of ocular hemorrhage incidence and location in the GUSTO-I trial. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries. (1997) (88)
Cardiovascular effects of alcohol. (1998) (88)
Atherosclerosis and coronary artery diseases (1996) (87)
An LRP8 variant is associated with familial and premature coronary artery disease and myocardial infarction. (2007) (87)
Granulocyte colony stimulating factor in patients with large acute myocardial infarction: results of a pilot dose-escalation randomized trial. (2006) (87)
Clinical trials--multiple treatments, multiple end points, and multiple lessons. (2003) (86)
Abciximab and bleeding during coronary surgery: results from the EPILOG and EPISTENT trials. Improve Long-term Outcome with abciximab GP IIb/IIIa blockade. Evaluation of Platelet IIb/IIIa Inhibition in STENTing. (2000) (86)
Abciximab therapy and unplanned coronary stent deployment: favorable effects on stent use, clinical outcomes, and bleeding complications. EPILOG Trial Investigators. (1998) (86)
Personalized medicine: risk prediction, targeted therapies and mobile health technology (2014) (86)
Thrombolytic therapy in patients requiring cardiopulmonary resuscitation. (1991) (85)
Coronary angioplasty for acute myocardial infarction. (1988) (85)
Characterization of Circulating Endothelial Cells in Acute Myocardial Infarction (2012) (85)
Cellular, but not direct, adenoviral delivery of vascular endothelial growth factor results in improved left ventricular function and neovascularization in dilated ischemic cardiomyopathy. (2004) (85)
Clinical correlates and course of thrombocytopenia during percutaneous coronary intervention in the era of abciximab platelet glycoprotein IIb/IIIa blockade. (2000) (85)
Coronary thrombolysis with recombinant tissue-type plasminogen activator. A hematologic and pharmacologic study. (1985) (84)
Bleeding risk associated with 1 year of dual antiplatelet therapy after percutaneous coronary intervention: Insights from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial. (2009) (83)
Impact of Clinical Syndrome Acuity on the Differential Response to 2 Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Coronary Stenting: The TARGET Trial* (2002) (83)
Validity of the type A construct: a reprise. (1988) (82)
Long-term survival in patients with resting obstructive hypertrophic cardiomyopathy comparison of conservative versus invasive treatment. (2011) (82)
Disagreements between central clinical events committee and site investigator assessments of myocardial infarction endpoints in an international clinical trial: review of the PURSUIT study (2001) (82)
Integrating prospective longitudinal data: modeling personality and health in the Terman Life Cycle and Hawaii Longitudinal Studies. (2014) (82)
Selection of thrombolytic therapy for individual patients: development of a clinical model. GUSTO-I Investigators. (1997) (82)
In-hospital cost of percutaneous coronary revascularization. Critical determinants and implications. (1995) (82)
Lifelong pathways to longevity: personality, relationships, flourishing, and health. (2014) (82)
Role of endothelial dysfunction in coronary artery disease. (1997) (81)
Age and outcome after acute coronary syndromes without persistent ST-segment elevation. (2000) (81)
Transforming Medicine via Digital Innovation (2010) (81)
Risk factors for in-hospital nonhemorrhagic stroke in patients with acute myocardial infarction treated with thrombolysis: results from GUSTO-I. (1998) (80)
The genomics gold rush. (2007) (80)
Effectiveness of early coronary angioplasty and abciximab for failed thrombolysis (reteplase or alteplase) during acute myocardial infarction (results from the GUSTO-III trial). Global Use of Strategies To Open occluded coronary arteries. (1999) (80)
Acute coronary syndromes in the GUSTO-IIb trial: prognostic insights and impact of recurrent ischemia. The GUSTO-IIb Investigators. (1998) (80)
Local drug delivery systems and prevention of restenosis. (1997) (80)
Unveiling the Role of the Most Impactful Cardiovascular Risk Locus through Haplotype Editing (2018) (80)
In-hospital initiation of lipid-lowering therapy after coronary intervention as a predictor of long-term utilization: a propensity analysis. (2003) (80)
Intramural methotrexate therapy for the prevention of neointimal thickening after balloon angioplasty. (1992) (80)
Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial (vol 292, pg 696, 2004) (2006) (80)
Clinical and electrocardiographic features of cardiac rupture following acute myocardial infarction. (1971) (79)
Platelet glycoprotein IIb/IIIa receptor antagonists in coronary artery disease. (1996) (79)
In-hospital costs associated with new percutaneous coronary devices. (1991) (79)
Stroke in patients with acute coronary syndromes: incidence and outcomes in the platelet glycoprotein IIb/IIIa in unstable angina. Receptor suppression using integrilin therapy (PURSUIT) trial. The PURSUIT Investigators. (1999) (79)
Extent of ST-segment depression and cardiac events in non-ST-segment elevation acute coronary syndromes. (2005) (79)
American College of Cardiology/Society for Cardiac Angiography and Interventions Clinical Expert Consensus Document on Cardiac Catheterization Laboratory Standards (2001) (79)
The duration of pretreatment with ticlopidine prior to stenting is associated with the risk of procedure-related non-Q-wave myocardial infarctions. (1998) (79)
Increased Hepatic Oxygenation following Ethanol Administration in the Baboon 1 (1977) (78)
Contemporary management of pregnancy-related coronary artery dissection: A single-centre experience and literature review. (2009) (78)
Accelerated plasminogen activator dose regimens for coronary thrombolysis. The TAMI-7 Study Group. (1992) (78)
An analysis of mortality rates with dual-antiplatelet therapy in the primary prevention population of the CHARISMA trial. (2007) (77)
Predicting outcome after thrombolysis in acute myocardial infarction according to ST-segment resolution at 90 minutes: a substudy of the GUSTO-III trial. Global Use of Strategies To Open occluded coronary arteries. (2002) (77)
Plasma dopamine responses to standing and exercise in man. (1979) (77)
Pronounced benefit of coronary stenting and adjunctive platelet glycoprotein IIb/IIIa inhibition in complex atherosclerotic lesions. (2000) (77)
Late assessment of thrombolytic efficacy (LATE) study: prognosis in patients with non-Q wave myocardial infarction. (LATE Study Investigators) (1996) (77)
Implications for patient triage from survival and left ventricular functional recovery analyses in 500 patients treated with coronary angioplasty for acute myocardial infarction. (1989) (76)
Intravenous recombinant tissue-type plasminogen activator in patients with unstable angina pectoris. Results of a placebo-controlled, randomized trial. (1990) (76)
Sudden paradoxic clinical deterioration during angioplasty of the occluded right coronary artery in acute myocardial infarction. (1989) (76)
Emerging concepts in the management of acute myocardial infarction in patients with diabetes mellitus. (2000) (76)
Management of Patients With Acute Coronary Syndromes in the United States by Platelet Glycoprotein IIb/IIIa Inhibition: Insights From the Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) Trial (2000) (76)
Peroxisome Proliferator-Activated Receptor γ Down-Regulates Receptor for Advanced Glycation End Products and Inhibits Smooth Muscle Cell Proliferation in a Diabetic and Nondiabetic Rat Carotid Artery Injury Model (2006) (76)
Prognostic significance of precordial ST segment depression during inferior myocardial infarction in the thrombolytic era: results in 16,521 patients. (1996) (76)
Safety and antiplatelet effect of murine monoclonal antibody 7E3 Fab directed against platelet glycoprotein llb/llla in patients undergoing elective coronary angioplasty (1993) (76)
Neuroticism and Health as Individuals Age (2019) (76)
Value of intraoperative left ventricular microbubbles detected by transesophageal two-dimensional echocardiography in predicting neurologic outcome after cardiac operations. (1985) (75)
Frequency and clinical outcome of cardiogenic shock during acute myocardial infarction among patients receiving reteplase or alteplase Results from GUSTO-III (1999) (75)
Atherectomy of right coronary ostial stenoses: initial and long-term results, technical features and histologic findings. (1991) (75)
Reduction in myocardial infarct size by basic fibroblast growth factor after temporary coronary occlusion in a canine model. (1996) (75)
Percutaneous coronary laser balloon angioplasty: initial results of a multicenter experience. (1990) (74)
International differences in evolution of early discharge after acute myocardial infarction (2004) (74)
A single center randomized trial assessing use of a vascular hemostasis device vs. conventional manual compression following PTCA: what are the potential resource savings? (1995) (73)
Modifiable Risk Factors for Vascular Access Site Complications in the IMPACT II Trial of Angioplasty With Versus Without Eptifibatide (1998) (73)
The role of nitrates in coronary heart disease. (1995) (73)
Thrombin generation, inhibition and clinical outcomes in patients with acute myocardial infarction treated with thrombolytic therapy and heparin: results from the GUSTO-I Trial. GUSTO-I Hemostasis Substudy Group. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries. (1998) (73)
Influence of diabetes mellitus on clinical outcomes across the spectrum of acute coronary syndromes. Findings from the GUSTO-IIb study. GUSTO IIb Investigators. (2000) (73)
Impact of female sex on death and bleeding after fibrinolytic treatment of myocardial infarction in GUSTO V. (2007) (73)
The V-stent: a novel technique for coronary bifurcation stenting. (1996) (73)
Future use of genomics in coronary artery disease. (2007) (73)
Long-term outcome of transient, uncomplicated in-laboratory coronary artery closure. (1995) (73)
Long-Term Mortality of Patients With Acute Myocardial Infarction in the United States and Canada: Comparison of Patients Enrolled in Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I (2004) (72)
The national cost of asthma among school-aged children in the United States. (2017) (72)
Nonverbal display of emotion in public and in private : self-monitoring, personality, and expressive cues (1991) (72)
Triple antiplatelet therapy during percutaneous coronary intervention is associated with improved outcomes including one-year survival: results from the Do Tirofiban and ReoProGive Similar Efficacy Outcome Trial (TARGET). (2003) (72)
Cocaine-induced aortic dissection. (1996) (72)
Design of the blockade of the glycoprotein IIb/IIIa receptor to avoid vascular occlusion (BRAVO) trial. (2000) (72)
Coronary angioplasty as primary therapy for acute myocardial infarction 6 to 48 hours after symptom onset: report of an initial experience. (1989) (72)
Potential impact of evidence-based medicine in acute coronary syndromes: insights from GUSTO-IIb. Global Use of Strategies to Open Occluded Arteries in Acute Coronary Syndromes trial. (1998) (72)
Inter- and intraindividual variability in daily resting heart rate and its associations with age, sex, sleep, BMI, and time of year: Retrospective, longitudinal cohort study of 92,457 adults (2020) (72)
Risk factors for premature coronary artery disease and determinants of adverse outcomes after revascularization in patients < or =40 years old. (2003) (72)
Integrin alphaIIbbeta3 and its antagonism. (2003) (72)
Comprehensive cardiovascular medicine (1998) (71)
Precordial ST segment depression predicts a worse prognosis in inferior infarction despite reperfusion therapy. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group. (1990) (71)
Longevity following the experience of parental divorce. (2005) (71)
Survival Outcomes 1 Year After Reperfusion Therapy With Either Alteplase or Reteplase for Acute Myocardial Infarction: Results From the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) III Trial (2000) (70)
Early personality traits as predictors of mortality risk following conjugal bereavement. (2009) (70)
Systematic adjudication of myocardial infarction end-points in an international clinical trial (2001) (70)
Factors influencing restenosis after coronary angioplasty. (1990) (70)
Acute coronary artery occlusion during percutaneous transluminal coronary angioplasty treated by redilation of the occluded segment. (1984) (70)
Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) trial. (1987) (70)
Deep Medicine: How Artificial Intelligence Can Make Healthcare Human Again (2019) (69)
Relation of temporal creatine kinase-MB release and outcome after thrombolytic therapy for acute myocardial infarction. TAMI Study Group. (2000) (69)
1-year survival in a randomized trial of facilitated reperfusion: results from the FINESSE (Facilitated Intervention with Enhanced Reperfusion Speed to Stop Events) trial. (2009) (69)
The brief saga of transdermal nitroglycerin discs: paradise lost? (1984) (69)
Effect of Clopidogrel plus ASA vs. ASA Early after TIA and Ischaemic Stroke: A Substudy of the CHARISMA Trial (2011) (69)
Coronary revascularization after intravenous tissue plasminogen activator for unstable angina pectoris: results of a randomized, double-blind, placebo-controlled trial. (1988) (68)
Colchicine and antineoplastic therapy for the prevention of restenosis after percutaneous coronary interventions. (1991) (67)
Determinants of 2‐Year Outcome After Coronary Angioplasty in Patients With Multivessel Disease on the Basis of Comprehensive Preprocedural Evaluation: Implications for Patient Selection (1991) (67)
Results of the BRAT study--a pilot study investigating the possible significance of ASA nonresponsiveness on the benefits and risks of ASA on thrombosis in patients undergoing coronary artery bypass surgery. (2000) (67)
Sustained ventricular arrhythmias and mortality among patients with acute myocardial infarction: results from the GUSTO-III trial. (2003) (67)
A study of the relationship between individual differences in nonverbal expressiveness and factors of personality and social interaction (1980) (67)
Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention. IMPACT-II Investigators. Integrilin (eptifibatide) to Minimize Platelet Aggregation and Coronary Thrombosis-II. (1999) (66)
C-reactive protein: a 'golden marker' for inflammation and coronary artery disease. (2001) (66)
Non-Q-wave versus Q-wave myocardial infarction after thrombolytic therapy: angiographic and prognostic insights from the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries-I angiographic substudy. GUSTO-I Angiographic Investigators. (1998) (66)
Support for the open-artery hypothesis in survivors of acute myocardial infarction: analysis of 11,228 patients treated with thrombolytic therapy. (1999) (66)
Randomized, double-blind, placebo-controlled trial of tissue plasminogen activator in unstable angina. (1989) (65)
Comparison of two dose regimens of intravenous tissue plasminogen activator for acute myocardial infarction. (1988) (65)
Is traditionally defined complete revascularization needed for patients with multivessel disease treated by elective coronary angioplasty? Multivessel Angioplasty Prognosis Study (MAPS) Group. (1993) (65)
Correlation between Baseline Plasminogen Activator Inhibitor Levels and Clinical Outcome during Therapy with Tissue Plasminogen Activator for Acute Myocardial Infarction (1991) (65)
The importance of proteinuria as a determinant of mortality following percutaneous coronary revascularization in diabetics. (1999) (65)
Evidence for the role of EPHX2 gene variants in anorexia nervosa (2013) (64)
Impact of Completeness of Revascularization on Long-Term Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus: Results from the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) (2012) (64)
Atrial Fibrillation in the Setting of Acute Myocardial Infarction: The GUSTO-I Experience fn1 (1997) (64)
Misreporting of myocardial infarction end points: results of adjudication by a central clinical events committee in the PARAGON-B trial. Second Platelet IIb/IIIa Antagonist for the Reduction of Acute Coronary Syndrome Events in a Global Organization Network Trial. (2002) (64)
Preprocedural white blood cell count and death after percutaneous coronary intervention. (2003) (64)
Causes and correlates of death after unsupported coronary angioplasty: implications for use of angioplasty and advanced support techniques in high-risk settings. (1991) (64)
Is a strategy of intended incomplete percutaneous transluminal coronary angioplasty revascularization acceptable in nondiabetic patients who are candidates for coronary artery bypass graft surgery? The Bypass Angioplasty Revascularization Investigation (BARI). (1999) (64)
Incidental Detection of Maternal Neoplasia in Noninvasive Prenatal Testing. (2018) (63)
Morbidity and mortality in mitral valve surgery. (1985) (63)
Early reinfarction after fibrinolysis: experience from the global utilization of streptokinase and tissue plasminogen activator (alteplase) for occluded coronary arteries (GUSTO I) and global use of strategies to open occluded coronary arteries (GUSTO III) trials. (2001) (63)
Enhanced Efficacy of Eptifibatide Administration in Patients With Acute Coronary Syndrome Requiring In-Hospital Coronary Artery Bypass Grafting (2000) (63)
Identification of Acute Myocardial Infarction Patients Suitable for Early Hospital Discharge After Aggressive Interventional Therapy: Results From the Thrombolysis and Angioplasty in Acute Myocardial Infarction Registry (1991) (63)
Age-related changes in the associations of social network ties with mortality risk. (1999) (63)
De novo refractory ventricular tachyarrhythmias after coronary revascularization. (1986) (62)
Replication of the association between the thrombospondin-4 A387P polymorphism and myocardial infarction. (2004) (62)
Autologous cell transplantation for the treatment of damaged myocardium. (2002) (62)
Selective inhibition of factor Xa during thrombolytic therapy markedly improves coronary artery patency in a canine model of coronary thrombosis (1996) (62)
Systolic Left Ventricular Function After Reperfusion Therapy for Acute Myocardial Infarction An Analysis of Determinants of Improvement (1993) (62)
Catecholamines in Coronary Sinus and Peripheral Plasma During Pacing-Induced Angina in Man (1979) (62)
Coronary 'Y' stenting: a technique for angioplasty of bifurcation stenoses. (1996) (61)
Childhood Psychosocial Predictors of Adulthood Smoking, Alcohol Consumption, and Physical Activity1 (1995) (61)
Increased risk of non-Q wave myocardial infarction after directional atherectomy is platelet dependent: evidence from the EPIC trial. Evaluation of c7E3 for the Prevention of Ischemic Complications. (1996) (61)
The Impact of Diabetic Status on Coronary Artery Bypass Graft Patency: Insights From the Radial Artery Patency Study (2008) (61)
Coronary angiography after thrombolytic therapy for acute myocardial infarction. (1991) (61)
Geographic variability in outcomes within an international trial of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes. Results from PURSUIT. (2000) (61)
A reappraisal of nitrate therapy. (1988) (60)
Thrombolytic therapy of acute myocardial infarction. Keeping the unfulfilled promises. (1992) (60)
An archival prospective study of mental health and longevity. (1995) (60)
Clinical importance of thrombocytopenia occurring in the hospital phase after administration of thrombolytic therapy for acute myocardial infarction. The Thrombolysis and Angioplasty in Myocardial Infarction Study Group. (1994) (60)
Prophylactic lidocaine use in acute myocardial infarction: incidence and outcomes from two international trials. The GUSTO-I and GUSTO-IIb Investigators. (1999) (60)
Meta-analysis: cardiovascular events associated with nonsteroidal anti-inflammatory drugs. (2006) (59)
Outcomes of Patients With Acute Coronary Syndromes and Prior Coronary Artery Bypass Grafting: Results From the Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) Trial (2002) (59)
Infarct vessel status after intravenous tissue plasminogen activator and acute coronary angioplasty: prediction of clinical outcome. (1988) (59)
Patterns of medication utilization and costs associated with the use of etanercept, adalimumab, and ustekinumab in the management of moderate-to-severe psoriasis. (2015) (59)
The prognostic value of creatine kinase elevations extends across the whole spectrum of acute coronary syndromes. (2002) (59)
Differences in the clinical features and outcomes in African Americans and whites with myocardial infarction. (2006) (59)
Spectrum of mutations in monogenic diabetes genes identified from high-throughput DNA sequencing of 6888 individuals (2017) (59)
Long‐Term Protection from Myocardial Ischemic Events in a Randomized Trial of Brief Integrin β3 Blockade with Percutaneous Coronary Intervention (1998) (58)
Association of genetic variants in the HDL receptor, SR-B1, with abnormal lipids in women with coronary artery disease (2003) (58)
Mechanisms of action of the organic nitrates in the treatment of myocardial ischemia. (1992) (58)
Prospects for the use of antagonists to the platelet glycoprotein IIb/IIIa receptor to prevent post-angioplasty restenosis and thrombosis. (1991) (58)
The long-term impact of diabetes on graft patency after coronary artery bypass grafting surgery: a substudy of the multicenter Radial Artery Patency Study. (2014) (58)
Type A behavior, nonverbal expressive style, and health. (1985) (58)
Safety of helicopter transport and out-of-hospital intravenous fibrinolytic therapy in patients with evolving myocardial infarction. (1986) (58)
Electrocardiographic subset analysis of diltiazem administration on long-term outcome after acute myocardial infarction. The Multicenter Diltiazem Post-Infarction Trial Research Group. (1991) (57)
Intracerebral hemorrhage complicating intravenous tissue plasminogen activator treatment. (1988) (57)
Role of stem cell homing in myocardial regeneration. (2004) (57)
Relationship between patient's risk profile and benefits in mortality from adjunctive abciximab to mechanical revascularization for ST-segment elevation myocardial infarction: a meta-regression analysis of randomized trials. (2006) (57)
Heterogeneity of platelet aggregation and major surface receptor expression in patients with acute myocardial infarction. (1998) (57)
Mortality benefit of beta blockade in patients with acute coronary syndromes undergoing coronary intervention: pooled results from the Epic, Epilog, Epistent, Capture and Rapport Trials. (2003) (57)
Thrombolytic therapy for elderly patients. (1992) (57)
Evaluation of the effects of aspirin combined with angiotensin-converting enzyme inhibitors in patients with coronary artery disease. (2000) (57)
Sensitivity to bodily nonverbal communication as a factor in practitioner-patient rapport (1979) (57)
The case for routine genotyping in dual-antiplatelet therapy. (2010) (57)
Hypertension associated with alcohol withdrawal: assessment of mechanisms and complications. (1985) (57)
Confronting the issues of patient safety and investigator conflict of interest in an international clinical trial of myocardial reperfusion. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO) Steering Committee. (1992) (57)
Prediction of 30-day mortality among patients with thrombolysis-related intracranial hemorrhage. (1998) (57)
Using C-reactive protein to assess cardiovascular disease risk. (2003) (56)
The role of antiplatelet agents in modifying the extent of restenosis following percutaneous transluminal coronary angioplasty. (1990) (56)
A decade of digital medicine innovation (2019) (56)
Risk of stroke associated with abciximab among patients undergoing percutaneous coronary intervention. (2001) (56)
Significance of atrial fibrillation during acute myocardial infarction, and its current management: insights from the GUSTO-3 trial. (2003) (55)
Risk of intracranial haemorrhage with combined fibrinolytic and glycoprotein IIb/IIIa inhibitor therapy in acute myocardial infarction. Dichotomous response as a function of age in the GUSTO V trial. (2003) (55)
Patients with acute coronary syndromes without persistent ST elevation undergoing percutaneous coronary intervention benefit most from early intervention with protection by a glycoprotein IIb/IIIa receptor blocker. (2002) (55)
Time-based risk assessment after myocardial infarction. Implications for timing of discharge and applications to medical decision-making. (2003) (55)
Association of diabetes mellitus and glycemic control strategies with clinical outcomes after acute coronary syndromes. (2004) (55)
Canadian-American Differences in the Management of Acute Coronary Syndromes in the GUSTO IIb Trial: One-Year Follow-Up of Patients Without ST-Segment Elevation (2000) (55)
The resequencing imperative (2007) (54)
Pharmacology of nitroglycerin and long-acting nitrates. (1985) (54)
Welcoming new guidelines for AI clinical research (2020) (54)
Effects of Thrombolytic Therapy Administered 6 to 24 Hours After Myocardial Infarction on the Signal‐Averaged ECG: Results of a Multicenter Randomized Trial (1994) (54)
State of Telehealth. (2016) (54)
Impact of blood transfusion on short- and long-term mortality in patients with ST-segment elevation myocardial infarction. (2009) (54)
Thrombospondins, their polymorphisms, and cardiovascular disease. (2007) (54)
Stroke complicating percutaneous coronary revascularization. (1993) (54)
Demonstration of dissimilar acute haemodynamic effects of ethanol and acetaldehyde. (1979) (54)
Prevention of intimal hyperplasia with recombinant soluble P-selectin glycoprotein ligand-immunoglobulin in the porcine coronary artery balloon injury model. (2001) (54)
Perspectives on large-scale cardiovascular clinical trials for the new millennium. The Virtual Coordinating Center for Global Collaborative Cardiovascular Research (VIGOUR) Group. (1997) (53)
Relation of Increased Arterial Blood Pressure to Mortality and Stroke in the Context of Contemporary Thrombolytic Therapy for Acute Myocardial Infarction (1996) (53)
Clinical Trials of Platelet Receptor Inhibitors (1993) (53)
Atherothrombosis and coronary artery disease (2005) (53)
Rationale and design of a home-based trial using wearable sensors to detect asymptomatic atrial fibrillation in a targeted population: The mHealth Screening To Prevent Strokes (mSToPS) trial. (2016) (53)
SYNTAX Score and Long-Term Outcomes: The BARI-2D Trial. (2017) (53)
Adjunctive selectin blockade successfully reduces infarct size beyond thrombolysis in the electrolytic canine coronary artery model. (1995) (53)
Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial. (2001) (53)
Mechanism and effect of thrombospondin-4 polymorphisms on neutrophil function. (2005) (53)
Pilot study of the antiplatelet effect of increased clopidogrel maintenance dosing and its relationship to CYP2C19 genotype in patients with high on-treatment reactivity. (2010) (52)
Blockade of the Platelet P2Y12 Receptor by AR-C69931MX Sustains Coronary Artery Recanalization and Improves the Myocardial Tissue Perfusion in a Canine Thrombosis Model (2003) (52)
Atypical presentation of papillary fibroelastoma mimicking multiple vegetations in suspected subacute bacterial endocarditis. (1993) (52)
Clinical, angiographic and procedural correlates of quantitative coronary dimensions after directional coronary atherectomy. (1991) (52)
Percutaneous support devices for high risk or complicated coronary angioplasty. (1991) (52)
Current Status and Future Prospects for Acute Myocardial Infarction Therapy (2003) (52)
Effect of revascularization on mortality associated with an elevated white blood cell count in acute coronary syndromes. (2003) (52)
The rise of open-source electronic health records (2011) (51)
iMedEd: The Role of Mobile Health Technologies in Medical Education (2014) (51)
Aspirin dose and six-month outcome after an acute coronary syndrome. (2004) (51)
Impact of Proton Pump Inhibitor Therapy on the Efficacy of Clopidogrel in the CAPRIE and CREDO Trials (2013) (51)
The Challenge of Sustainability at the Farm Level: Presidential Address (2008) (51)
Genomic information as a behavioral health intervention: can it work? (2011) (51)
Double jeopardy of renal insufficiency and anemia in patients undergoing percutaneous coronary interventions. (2004) (51)
The relation of renal function to ischemic and bleeding outcomes with 2 different glycoprotein IIb/IIIa inhibitors: the do Tirofiban and ReoPro Give Similar Efficacy Outcome (TARGET) trial. (2005) (51)
Colectomy and the Incidence of Postsurgical Complications Among Ulcerative Colitis Patients With Private Health Insurance in the United States (2008) (51)
Myocardial infarction with minimal coronary atherosclerosis in the era of thrombolytic reperfusion. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group. (1991) (51)
Predictors of success for coronary angioplasty performed for acute myocardial infarction. (1988) (51)
Stop the privatization of health data (2016) (50)
Comparison of stenting and balloon angioplasty for narrowings in aortocoronary saphenous vein conduits in place for more than five years. (1997) (50)
Novel antithrombotic approaches to coronary artery disease. (1995) (50)
Low-Dose Combined Therapy with Fluvastatin and Cholestyramine in Hyperlipidemic Patients (1994) (50)
Pan Vascular Medicine : integrated clinical management (2002) (50)
Moving From Digitalization to Digitization in Cardiovascular Care: Why Is it Important, and What Could it Mean for Patients and Providers? (2015) (50)
Efficacy and safety of clopidogrel pretreatment before percutaneous coronary intervention with and without glycoprotein IIb/IIIa inhibitor use. (2008) (49)
Assessment of Prolonged Physiological and Behavioral Changes Associated With COVID-19 Infection (2021) (49)
Impact of Diabetes Mellitus on Percutaneous Revascularization (CAVEAT-I) (1997) (49)
Platelet, Not Endothelial, P-Selectin Is Required for Neointimal Formation After Vascular Injury (2005) (49)
Gender-Related Individual Differences and Mortality in the Terman Longitudinal Study: Is Masculinity Hazardous to Your Health? (2000) (49)
Bleeding, mortality, and antiplatelet therapy: results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial. (2011) (49)
Health Care as an Interpersonal Process (1979) (49)
Nitroglycerin and long-acting nitrates in clinical practice. (1983) (49)
A Whole Blood Molecular Signature for Acute Myocardial Infarction (2016) (49)
Statin Use and Sex-Specific Stroke Outcomes in Patients With Vascular Disease (2006) (48)
COVID-19 vaccine breakthrough infections. (2021) (48)
Coronary artery disease and the thrombospondin single nucleotide polymorphisms. (2004) (48)
Impact of renal insufficiency on angiographic, procedural, and in-hospital outcomes following percutaneous coronary intervention. (2008) (48)
The influence of body mass index on mortality and bleeding among patients with or at high-risk of atherothrombotic disease. (2008) (48)
A Longitudinal Study of Religiosity and Mortality Risk (1999) (48)
Assessment of coronary reperfusion after thrombolysis with a model combining myoglobin, creatine kinase-MB, and clinical variables. TAMI-7 Study Group. Thrombolysis and Angioplasty in Myocardial Infarction-7. (1997) (48)
Lack of usefulness of prolonged bleeding times in predicting hemorrhagic events in patients receiving the 7E3 glycoprotein IIb/IIIa platelet antibody. The TAMI Study Group. (1993) (48)
Redefining medical treatment in the management of unstable angina. (2011) (48)
Promise of combined low-molecular-weight heparin and platelet glycoprotein IIb/IIIa inhibition: results from Platelet IIb/IIIa Antagonist for the Reduction of Acute coronary syndrome events in a Global Organization Network B (PARAGON B). (2002) (48)
The Genomic Basis of Myocardial Infarction (2005) (48)
Lessons we have learned from the GUSTO trial. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Arteries. (1995) (48)
Digital medicine, on its way to being just plain medicine (2018) (47)
Triple antiplatelet therapy does not increase femoral access bleeding with vascular closure devices. (2003) (47)
Timing of and risk factors for myocardial ischemic events after percutaneous coronary intervention (IMPACT-II). Integrilin to Minimize Platelet Aggregation and Coronary Thrombosis. (2000) (47)
Medical costs and resource utilization for hemophilia patients with and without HIV or HCV infection. (2015) (47)
The genetics of health (2006) (47)
Thrombolytic therapy for acute myocardial infarction. A review . (1992) (47)
Canada and COVID-19: learning from SARS (2020) (47)
Cardiovascular and nervous system changes during meditation (2015) (47)
Restenosis—an open file (1996) (47)
Does intracoronary thrombus influence the outcome of high risk percutaneous transluminal coronary angioplasty? Clinical and angiographic outcomes in a large multicenter trial. EPIC Investigators. Evaluation of IIb/IIIa Platelet Receptor Antagonist 7E3 in Preventing Ischemic Complications. (1998) (46)
Predictors of death and reinfarction at 30 days after primary angioplasty: the GUSTO IIb and RAPPORT trials. (2000) (46)
The impact of anthropomorphic indices on clinical outcomes in patients with acute ST-elevation myocardial infarction. (2007) (46)
Hostility, coping, & health. (1992) (46)
Atrial tachypacing in the treatment of a patient with primary orthostatic hypotension. (1980) (46)
Emergency coronary artery bypass surgery preserves global and regional left ventricular function after intravenous tissue plasminogen activator therapy for acute myocardial infarction. (1988) (46)
Atrioventricular and Intraventricular Conduction Disorders in Acute Myocardial Infarction: A Reappraisal in the Thrombolytic Era (1998) (46)
Usefulness of myocardial contrast echocardiographic quantification of risk area for predicting postprocedural complications in patients undergoing septal ethanol ablation for obstructive hypertrophic cardiomyopathy. (2004) (46)
Patterns and trends of contraceptive use among sexually active adolescents in Burkina Faso, Ethiopia, and Nigeria: evidence from cross-sectional studies (2015) (45)
Management and outcome of patients with atrial fibrillation during acute myocardial infarction: the GUSTO-III experience (2002) (45)
Outcome of acute ST-segment elevation myocardial infarction in patients with prior coronary artery bypass surgery receiving thrombolytic therapy. (2001) (45)
The role of maintenance of certification programs in governance and professionalism. (2015) (45)
Enoxaparin in primary and facilitated percutaneous coronary intervention A formal prospective nonrandomized substudy of the FINESSE trial (Facilitated INtervention with Enhanced Reperfusion Speed to Stop Events). (2010) (45)
Does devoutness delay death? Psychological investment in religion and its association with longevity in the Terman sample. (2009) (45)
Practice patterns and outcomes of percutaneous coronary interventions in the United States: 1995 to 1997. (2002) (44)
Long-term outcomes after percutaneous coronary intervention of bifurcation narrowings. (2008) (44)
Myocardial mechanics explains the time course of benefit for septal ethanol ablation for hypertrophic cardiomyopathy. (2008) (44)
Promises and pitfalls of new devices for coronary artery disease. (1991) (44)
Emerging strategies for failed percutaneous transluminal coronary angioplasty. (1989) (44)
Molecular and Functional Differences Induced in Thrombospondin-1 by the Single Nucleotide Polymorphism Associated with the Risk of Premature, Familial Myocardial Infarction* (2004) (44)
Hand Gesture and Mathematics Learning: Lessons From an Avatar (2017) (44)
The interactive effects of facial expressions of emotion and verbal messages on perceptions of affective meaning (1979) (44)
Emergency percutaneous transluminal coronary angioplasty during acute myocardial infarction for patients more than 70 years of age. (1989) (44)
Extended mortality benefit of early postinfarction reperfusion. GUSTO-I Angiographic Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries Trial. (1998) (44)
Mortality, kidney disease and cardiac procedures following acute coronary syndrome. (2007) (44)
Personality dimensions and measures potentially relevant to health: A focus on hostility (1995) (44)
Local delivery of nitric oxide from an eluting stent to inhibit neointimal thickening in a porcine coronary injury model. (2002) (44)
Comparison of long-term usefulness of clopidogrel therapy after the first percutaneous coronary intervention or coronary artery bypass grafting versus that after the second or repeat intervention. (2004) (43)
Outcomes of patients with acute coronary syndromes who are treated with bivalirudin during PCI: An analysis from the REPLACE-2 trial (2004) (43)
Adherence and asthma control with mometasone furoate versus fluticasone propionate in adolescents and young adults with mild asthma (2010) (43)
The Lifelong Mortality Risks of World War II Experiences (2009) (43)
Self-supervised learning in medicine and healthcare (2022) (43)
Polymorphisms A387P in thrombospondin‐4 and N700S in thrombospondin‐1 perturb calcium binding sites (2005) (43)
Clinical end point definitions after percutaneous coronary intervention and their relationship to late mortality: an assessment by attributable risk (2005) (43)
Cardiac angiography without cine film: erecting a "Tower of Babel" in the cardiac catheterization laboratory. American College of Cardiology Cardiac Catheterization Committee. (1994) (43)
International variation in the use of evidence-based medicines for acute coronary syndromes. (2003) (43)
Time for a prepublication culture in clinical research? (2015) (43)
Ischemic and bleeding outcomes in women treated with bivalirudin during percutaneous coronary intervention: a subgroup analysis of the Randomized Evaluation in PCI Linking Angiomax to Reduced Clinical Events (REPLACE)-2 trial. (2006) (42)
Early Reinfarction After Fibrinolysis: Experience From the Global Utilization of Streptokinase and Tissue Plasminogen Activator (Alteplase) for Occluded Coronary Arteries (GUSTO I) and Global Use of Strategies To Open Occluded Coronary Arteries (GUSTO III) Trials (2001) (42)
Impact of female sex on outcome after percutaneous coronary intervention. (2004) (42)
Direct-to-consumer pharmacogenomic testing is associated with increased physician utilisation (2013) (42)
The sad story of Vioxx, and what we should learn from it. (2004) (42)
The rudimentary phase of personalised medicine: coronary risk scores (2003) (42)
The national burden of poorly controlled asthma, school absence and parental work loss among school-aged children in the United States (2018) (42)
Personality and the enactment of emotion (1980) (42)
Use of bivalirudin during percutaneous coronary intervention in patients with diabetes mellitus: an analysis from the randomized evaluation in percutaneous coronary intervention linking angiomax to reduced clinical events (REPLACE)-2 trial. (2005) (41)
The Self-Healing Personality: Why Some People Achieve Health and Others Succumb to Illness (1991) (41)
Holding GUSTO Up to the Light (1994) (41)
lraq's health system yet to heal from ravages of war (2011) (41)
Population sequencing of two endocannabinoid metabolic genes identifies rare and common regulatory variants associated with extreme obesity and metabolite level (2010) (41)
Celecoxib, a Selective Cyclooxygenase-2 Inhibitor, Decreases Monocyte Chemoattractant Protein-1 Expression and Neointimal Hyperplasia in the Rabbit Atherosclerotic Balloon Injury Model (2005) (41)
Whole Blood Gene Expression Testing for Coronary Artery Disease in Nondiabetic Patients: Major Adverse Cardiovascular Events and Interventions in the PREDICT Trial (2012) (41)
Shock-wave thrombus ablation, a new method for noninvasive mechanical thrombolysis. (1992) (41)
Neurosurgical evacuation of intracranial hemorrhage after thrombolytic therapy for acute myocardial infarction: experience from the GUSTO-I trial. Global Utilization of Streptokinase and tissue-plasminogen activator (tPA) for Occluded Coronary Arteries. (1999) (41)
Cultivating healthy trajectories: An experimental study of community gardening and health (2018) (41)
Real‐world bare metal stenting: Identification of patients at low or very low risk of 9‐month coronary revascularization (2004) (41)
Trends in Prices of Popular Brand-Name Prescription Drugs in the United States (2019) (41)
Monitoring of Hemostasis Parameters During Coronary Thrombolysis with Recombinant Tissue-Type Plasminogen Activator (1988) (41)
Attenuation of Rebound Ischemia After Discontinuation of Heparin Therapy by Glycoprotein IIb/IIIa Inhibition With Eptifibatide in Patients With Acute Coronary Syndromes: Observations From the Platelet IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) Trial (2001) (40)
A global view of atherothrombosis: baseline characteristics in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial. (2005) (40)
Long-term follow-up of patients treated with coronary angioplasty for acute myocardial infarction. (1989) (40)
Atrial fibrillation and mortality among patients with acute coronary syndromes without ST-segment elevation: results from the PURSUIT trial. (2001) (40)
A gender-specific blood-based gene expression score for assessing obstructive coronary artery disease in nondiabetic patients: results of the Personalized Risk Evaluation and Diagnosis in the Coronary Tree (PREDICT) trial. (2012) (40)
Diabetes mellitus and outcome after primary coronary angioplasty for acute myocardial infarction: lessons from the GUSTO-IIb Angioplasty Substudy. Global Use of Strategies to Open Occluded Arteries in Acute Coronary Syndromes. (2000) (40)
Glycoprotein IIb/IIIa antagonists - from bench to practice (2002) (40)
Molecular Autopsy for Sudden Unexpected Death. (2016) (40)
Usefulness of a pericardial friction rub after thrombolytic therapy during acute myocardial infarction in predicting amount of myocardial damage. The TAMI Study Group. (1990) (40)
Comparison of outcomes of patients with myocardial infarction when living alone versus those not living alone. (2002) (40)
Variation in patient management and outcomes for acute coronary syndromes in Latin America and North America: results from the Platelet IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) trial. (2001) (40)
Local adenoviral-mediated inducible nitric oxide synthase gene transfer inhibits neointimal formation in the porcine coronary stented model. (2003) (40)
The Determinants of Activated Partial Thromboplastin Time, Relation of Activated Partial Thromboplastin Time to Clinical Outcomes, and Optimal Dosing Regimens for Heparin Treated Patients with Acute Coronary Syndromes: A Review of GUSTO-IIb (2002) (40)
Lack of progress in cardiogenic shock: lessons from the GUSTO trials (2000) (40)
Proteinuria is a key determinant of death in patients with diabetes after isolated coronary artery bypass grafting. (2000) (40)
Clinical and Therapeutic Profile of Patients Presenting With Acute Coronary Syndromes Who Do Not Have Significant Coronary Artery Disease (2000) (40)
Dose-finding, safety, and tolerability study of an oral platelet glycoprotein IIb/IIIa inhibitor, lotrafiban, in patients with coronary or cerebral atherosclerotic disease. (2000) (40)
Predictors of Physical Activity Patterns Across Adulthood: A Growth Curve Analysis (2010) (39)
Lack of clopidogrel pretreatment effect on the relative efficacy of bivalirudin with provisional glycoprotein IIb/IIIa blockade compared to heparin with routine glycoprotein IIb/IIIa blockade: a REPLACE-2 substudy. (2004) (39)
Antiplatelet and anticoagulant therapy in the secondary prevention of ischemic heart disease. (2001) (39)
Quantitative angiographic comparison of the immediate success of coronary angioplasty, coronary atherectomy and endoluminal stenting. (1990) (39)
Association of mortality with years of education in patients with ST-segment elevation myocardial infarction treated with fibrinolysis. (2011) (39)
Randomized trials of directional coronary atherectomy: implications for clinical practice and future investigation. (1994) (39)
Distinct effects of recombinant desulfatohirudin (Revasc) and heparin on plasma levels of fibrinopeptide A and prothrombin fragment F1.2 in unstable angina. A multicenter trial. (1996) (39)
Treatment of recurrent ischemia after thrombolysis and successful reperfusion for acute myocardial infarction: effect on in-hospital mortality and left ventricular function. (1991) (39)
Predictors of 90-day outcome in patients stabilized after acute coronary syndromes. (2003) (39)
Emerging genomic applications in coronary artery disease. (2011) (39)
Clot-selective coronary thrombolysis with pro-urokinase. (1989) (39)
Current Review of Interventional Cardiology (1997) (39)
Is There a Clinically Significant Interaction Between Calcium Channel Antagonists and Clopidogrel?: Results From the Clopidogrel for the Reduction of Events During Observation (CREDO) Trial (2012) (39)
How Consumers and Physicians View New Medical Technology: Comparative Survey (2015) (39)
Outcome of multivessel coronary intervention in the contemporary percutaneous revascularization era. (2006) (39)
Re-analysis of whole-exome sequencing data uncovers novel diagnostic variants and improves molecular diagnostic yields for sudden death and idiopathic diseases (2019) (39)
Clinical, biochemical, and genetic predictors of coronary artery bypass graft failure. (2014) (39)
Multimodal biomedical AI (2022) (39)
A direct comparison of tirofiban and abciximab during percutaneous coronary revascularization and stent placement: rationale and design of the TARGET study. (2000) (38)
The effects of erythromycin on the electrocardiogram. (1999) (38)
Prevention of cardiovascular ischemic complications with new platelet glycoprotein IIb/IIIa inhibitors. (1995) (38)
Abrupt vessel closure after directional coronary atherectomy (1992) (38)
National Prevalence of Poor Asthma Control and Associated Outcomes Among School-Aged Children in the United States. (2017) (38)
Quantitative analysis of factors influencing late lumen loss and restenosis after directional coronary atherectomy. (1993) (38)
Intracoronary stents: will they fulfill their promise as an adjunct to angioplasty? (1989) (38)
Recombinant Soluble P-Selectin Glycoprotein Ligand-Ig (rPSGL-Ig) Attenuates Infarct Size and Myeloperoxidase Activity in a Canine Model of Ischemia-Reperfusion (2002) (38)
Housing triggers health problems for Canada's First Nations (2015) (37)
Social psychology and medicine (1982) (37)
The Effects of Ethanol on Brain Blood Flow in Awake Dogs (1984) (37)
Virtual care for improved global health (2018) (37)
Frequency, significance, and cost of recurrent ischemia after thrombolytic therapy for acute myocardial infarction. TAMI Study Group. (1995) (37)
&bgr;-Blockers Before Percutaneous Coronary Intervention Do Not Attenuate Postprocedural Creatine Kinase Isoenzyme Rise (2001) (37)
Cardiovascular thrombosis : thrombocardiology and thromboneurology (1998) (37)
An analysis of the cause of early mortality after administration of thrombolytic therapy (1993) (37)
Integrative medicine: implementation and evaluation of a professional development program using experiential learning and conceptual change teaching approaches. (2006) (37)
Outcomes of patients with acute coronary syndromes who are treated with bivalirudin during percutaneous coronary intervention: an analysis from the Randomized Evaluation in PCI Linking Angiomax to Reduced Clinical Events (REPLACE-2) trial. (2006) (37)
Peripheral vascular disease and one-year mortality following percutaneous coronary revascularization. (2003) (37)
The Relative Strength of Verbal versus Nonverbal Cues (1978) (37)
Differential Influence of Diabetes Mellitus on Increased Jeopardized Myocardium After Initial Angioplasty or Bypass Surgery: Bypass Angioplasty Revascularization Investigation (2002) (37)
Genetic determinants of phenotypic diversity in humans (2008) (37)
Frequency of stent thrombosis after acute coronary syndromes (from the SYMPHONY and 2nd SYMPHONY trials). (2003) (36)
The Pathway to Patient Data Ownership and Better Health. (2017) (36)
Outcome of acute ST-segment elevation myocardial infarction in diabetics treated with fibrinolytic or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: lessons from the GUSTO V trial. (2004) (36)
Immediate enhancement of left ventricular relaxation by coronary artery bypass grafting: intraoperative assessment. (1988) (36)
Importance of microembolization and inflammation in atherosclerotic heart disease. (2000) (36)
Therapeutic value of eptifibatide at community hospitals transferring patients to tertiary referral centers early after admission for acute coronary syndromes. PURSUIT Investigators. (2001) (36)
Interactions between organic nitrates and thiol groups. (1991) (36)
Adjuncts to thrombolysis for myocardial reperfusion. (1991) (36)
School absence and productivity outcomes associated with childhood asthma in the USA (2018) (36)
Results of percutaneous transluminal coronary angioplasty of high-risk angulated stenoses. (1990) (36)
Prognostic importance of concomitant heparin with eptifibatide in acute coronary syndromes. PURSUIT Investigators. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy. (2001) (36)
A comparison of debulking versus dilatation of bifurcation coronary arterial narrowings (from the CAVEAT I Trial). Coronary Angioplasty Versus Excisional Atherectomy Trial-I. (1996) (35)
Platelet glycoprotein IIb/IIIa receptor blockade with abciximab reduces ischemic complications in patients undergoing directional coronary atherectomy. EPILOG Investigators. Evaluation of PTCA to Improve Long-term Outcome by c7E3 GP IIb/IIIa Receptor Blockade. (1998) (35)
Conjunctive Use of Platelet Glycoprotein IIb/IIIa Antagonists and Thrombolytic Therapy for Acute Myocardial Infarction (1997) (35)
Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Stroke in Patients with a History of Atrial Fibrillation: Subgroup Analysis of the CHARISMA Randomized Trial (2008) (35)
Peroxisome proliferator-activated receptor gamma agonists for the Prevention of Adverse events following percutaneous coronary Revascularization--results of the PPAR study. (2007) (35)
Effect of maximal medical therapy on refractoriness of unstable angina pectoris. (1992) (35)
Evidence that angiotensin-converting enzyme inhibitor use diminishes the need for coronary revascularization after stenting. (2002) (35)
Are we promoting true informed consent in cardiovascular clinical trials? (1995) (35)
Angiographic adverse events, creatine kinase-MB elevation, and ischemic end points complicating percutaneous coronary intervention (a REPLACE-2 substudy). (2006) (35)
Prospective case-control comparison of percutaneous transluminal coronary revascularization in patients with multivessel disease treated in 1986-1987 versus 1991: improved in-hospital and 12-month results. Multivessel Angioplasty Prognosis Study (MAPS) Group. (1995) (35)
Erythromycin-induced digoxin toxicity. (1982) (34)
Benefit of early sustained reperfusion in patients with prior myocardial infarction (the GUSTO-I trial). Global Utilization of Streptokinase and TPA for occluded arteries. (1998) (34)
Reduction in myocardial infarct size by basic fibroblast growth factor following coronary occlusion in a canine model. (1999) (34)
Towards a smart medical home (2017) (34)
Smoking status and outcome after primary coronary angioplasty for acute myocardial infarction. (1999) (34)
Insights into the pathophysiology of atherosclerosis and prognosis of black Americans with acute coronary syndromes. (1999) (34)
Cost-effectiveness of clopidogrel plus aspirin versus aspirin alone for secondary prevention of cardiovascular events: results from the CHARISMA trial. (2009) (34)
Effect of abciximab on angiographic complications during percutaneous coronary stenting in the Evaluation of Platelet IIb/IIIa Inhibition in Stenting Trial (EPISTENT). (2002) (34)
Cardiovascular effects of alcohol with particular reference to the heart. (1984) (34)
Comparison of histopathologic coronary lesions obtained from directional atherectomy in stable angina versus acute coronary syndromes. (1994) (34)
The influence of body mass index on outcomes and the benefit of antiplatelet therapy following percutaneous coronary intervention. (2006) (34)
Redefining risk in acute coronary syndromes using molecular medicine. (2007) (34)
Technical feasibility , safety , and clinical outcome of stenting of unprotected left main coronary artery bifurcation narrowing (34)
Continuous electrocardiographic monitoring in patients with sickle‐cell anemia during pain crisis (1983) (34)
Messenger RNA vaccines against SARS-CoV-2 (2021) (34)
A standardized procedure for serum protein electrophoresis on cellulose acetate membrane strips. (1961) (33)
Acute myocardial infarction: thrombolysis (2000) (33)
Effects of magnesium chloride on cardiovascular hemodynamics in the neurally intact dog. (1987) (33)
Clinical outcomes according to permanent discontinuation of clopidogrel or placebo in the CHARISMA trial. (2009) (33)
Ancient DNA Reveals Key Stages in the Formation of Central European Mitochondrial Genetic Diversity (2013) (33)
Variant-proof vaccines — invest now for the next pandemic (2021) (33)
The stentor and the sea change. (1995) (33)
Catapulting clopidogrel pharmacogenomics forward (2011) (33)
Elevated creatine kinase-MB with normal creatine kinase predicts worse outcomes in patients with acute coronary syndromes: results from 4 large clinical trials. (2006) (32)
An overview of the results of the EPIC trial. (1995) (32)
Intracoronary stenting to prevent restenosis: Preliminary results of a multicenter study using the palmaz-schatz stent suggest benefit in selected high risk patients (1990) (32)
Complications associated with the guide wire in percutaneous transluminal coronary angioplasty. (1987) (32)
Treating menstruating women with thrombolytic therapy: insights from the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (GUSTO-I) trial. (1995) (32)
A Longitudinal Investigation of Associations Between Boys’ Pubertal Timing and Adult Behavioral Health and Well-Being (2006) (32)
Comparison of benefits and complications of hirudin versus heparin for patients with acute coronary syndromes undergoing early percutaneous coronary intervention. (2001) (32)
Oral glycoprotein IIb/IIIa inhibitors: why don't they work? (2001) (32)
Deficiency of LRP8 in mice is associated with altered platelet function and prolonged time for in vivo thrombosis. (2009) (32)
Is breast-feeding in infancy associated with adult longevity? (1994) (32)
The REPLACE 1 trial: a pilot study of bivalirudin versus heparin during percutaneous coronary intervention with stenting and GP IIb/IIIa blockade (2002) (32)
A Genome Sequencing Program for Novel Undiagnosed Diseases (2015) (32)
Early angioplasty in acute coronary syndromes without persistent ST-segment elevation improves outcome but increases the need for six-month repeat revascularization: an analysis of the PURSUIT Trial. Platelet glycoprotein IIB/IIIA in Unstable angina: Receptor Suppression Using Integrilin Therapy. (2002) (32)
Frequency and clinical outcome of cardiogenic shock during acute myocardial infarction among patients receiving reteplase or alteplase. Results from GUSTO-III. Global Use of Strategies to Open Occluded Coronary Arteries. (1999) (32)
Can hospital rounds with pocket ultrasound by cardiologists reduce standard echocardiography? (2014) (32)
Digital medicine: empowering both patients and clinicians (2016) (32)
COVID-19 highlights Canada's care home crisis (2021) (32)
Long-Term Follow-Up of Gender-Specific Outcomes After Thrombolytic Therapy for Acute Myocardial Infarction from the GUSTO-I Trial (1997) (32)
Significance of a Negative Exercise Thallium Test in the Presence of a Critical Residual Stenosis After Thrombolysis for Acute Myocardial Infarction (1991) (32)
Economic Assessment of Platelet Glycoprotein IIb/IIIa Receptor Blockade With Abciximab and Low-Dose Heparin During Percutaneous Coronary Revascularization: Results From the EPILOG Randomized Trial (2000) (32)
Effect of Clopidogrel on the Rate and Functional Severity of Stroke Among High Vascular Risk Patients: A Prespecified Substudy of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA) Trial (2010) (32)
Cox-2: where are we in 2003? - Cardiovascular risk and Cox-2 inhibitors (2002) (31)
Bivalirudin vs Heparin in Percutaneous Coronary Intervention: A Pooled Analysis (2005) (31)
Interval therapy to avoid nitrate tolerance: paradise regained? (1989) (31)
Heart failure disease management in an indigent population. (2001) (31)
Passive detection of COVID-19 with wearable sensors and explainable machine learning algorithms (2021) (31)
Self-Monitoring Utilization Patterns Among Individuals in an Incentivized Program for Healthy Behaviors (2016) (31)
Results of directional coronary atherectomy during multicenter preapproval testing. The US Directional Coronary Atherectomy Investigator Group. (1993) (31)
Aspirin with bypass surgery--from taboo to new standard of care. (2002) (31)
Assessment of atrioventricular conduction in aortic valve disease. (1978) (31)
Evaluation of patients with chest pain and normal coronary angiograms. (2001) (31)
Mortality related to diagnostic cardiac catherization (1997) (31)
Definition and measurement of restenosis after successful coronary angioplasty: implications for clinical trials. (1993) (31)
Clinical Implications of Human Population Differences in Genome-Wide Rates of Functional Genotypes (2012) (31)
Recurrent ischemia after thrombolysis: importance of associated clinical findings. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA [tissue-plasminogen activator] for Occluded Coronary Arteries. (1998) (31)
Challenges in the phenotypic characterisation of patients in genetic studies of coronary artery disease (2006) (31)
Increased baseline levels of platelet P‐selectin, and platelet‐endothelial cell adhesion molecule‐1 in patients with acute myocardial infarction as predictors of unsuccessful thrombolysis (1998) (31)
Selective inhibition of factor Xa is more efficient than factor VIIa-tissue factor complex blockade at facilitating coronary thrombolysis in the canine model. (1996) (31)
Augmenting diagnostic vision with AI (2017) (30)
The benefit of abciximab in percutaneous coronary revascularization is not device-specific. (2000) (30)
Reperfusion revisited: Beyond TIMI3 flow (1999) (30)
Effects of alcohol on experimental atrial fibrillation. (1987) (30)
Acute myocardial infarction: early diagnosis and management (1998) (30)
Effects of stroke on medical resource use and costs in acute myocardial infarction. GUSTO I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries Study. (1999) (30)
Exercise testing three days after onset of acute myocardial infarction. (1987) (30)
Safety of abciximab during percutaneous coronary intervention in patients with chronic renal insufficiency. (2002) (30)
Effect of anti-tumor necrosis factor-alpha polyclonal antibody on restenosis after balloon angioplasty in a rabbit atherosclerotic model. (2002) (30)
Comparison of peak serum C-reactive protein and hydroxybutyrate dehydrogenase levels in patients with acute myocardial infarction treated with alteplase and streptokinase. (1997) (30)
Angiographic variables predict increased risk for adverse ischemic events after coronary stenting with glycoprotein IIb/IIIa inhibition: results from the TARGET trial. (2003) (30)
Impact of peer review in reduction of permanent pacemaker implantations. (1981) (30)
Lack of progress in cardiogenic shock: lessons from the GUSTO trials. (2000) (30)
Long-term angiographic and clinical outcome after implantation of a balloon-expandable stent in the native coronary circulation. Palmaz-Schatz Stent Study Group. (1994) (30)
Therapy of stable angina pectoris: the uncomplicated patient. (2005) (30)
Thrombolysis with recombinant tissue plasminogen activator in atherosclerotic thrombotic occlusion. (1985) (29)
Long-term follow-up of gender-specific outcomes after thrombolytic therapy for acute myocardial infarction from the GUSTO-I trial. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. (1997) (29)
Influence of pre-PTCA strategy and initial PTCA result in patients with multivessel disease: the Bypass Angioplasty Revascularization Investigation (BARI). (1999) (29)
Operation Nasal Vaccine—Lightning speed to counter COVID-19 (2022) (29)
TIMI grade 3 flow and reocclusion after intravenous thrombolytic therapy: a pooled analysis. (1997) (29)
Impact of sex, metabolic syndrome, and diabetes mellitus on cardiovascular events. (2007) (29)
The unmet need of education in genomic medicine. (2012) (29)
Glyceryl trinitrate (nitroglycerin) and the organic nitrates. Choosing the method of administration. (1987) (29)
Acute effects of ethanol on myocardial blood flow in the nonischemic and ischemic heart. (1981) (29)
Health in Colombia: a system in crisis (2012) (28)
Reconstruction efforts in Iraq failing health care (2009) (28)
Long-term Efficacy of Bivalirudin and Provisional Glycoprotein IIb/IIIa Blockade vs Heparin and Planned Glycoprotein IIb/IIIa Blockade During Percutaneous Coronary Revascularization (2004) (28)
The big medical data miss: challenges in establishing an open medical resource (2015) (28)
Mortality benefit of beta-blockade after successful elective percutaneous coronary intervention. (2002) (28)
Cost and procedure implications of thrombolytic therapy for acute myocardial infarction. (1988) (28)
One-year outcome after therapy with tissue plasminogen activator: report from the Thrombolysis and Angioplasty in Myocardial Infarction trial. (1990) (28)
Relationship Between Baseline Inflammatory Markers, Antiplatelet Therapy, and Adverse Cardiac Events After Percutaneous Coronary Intervention: An Analysis From the Clopidogrel for the Reduction of Events During Observation Trial (2009) (28)
More on the GUSTO Trial (1994) (28)
Polygenic Risk Scores Expand to Obesity (2019) (28)
Cystic fibrosis in an era of genomically guided therapy. (2012) (28)
To ablate or operate? that is the question! (2001) (28)
Ethnic Differences in Health Behaviors Among College Students (2007) (28)
Minimizing the risk of inappropriately administering thrombolytic therapy (Thrombolysis and Angioplasty in Myocardial Infarction [TAMI] study group). (1993) (28)
Nonverbal Communication on Television News (1980) (28)
The Healthy Pregnancy Research Program: transforming pregnancy research through a ResearchKit app (2018) (28)
Prognostic Value of Estimated Functional Capacity Incremental to Cardiac Biomarkers in Stable Cardiac Patients (2014) (28)
Clinical Trials to Prevent Restenosis after Percutaneous Coronary Revascularization (1997) (28)
Administration of Recombinant P-Selectin Glycoprotein Ligand Fc Fusion Protein Suppresses Inflammation and Neointimal Formation in Zucker Diabetic Rat Model (2002) (28)
Coronary artery spasm and cardiac arrest in carcinoid heart disease. (1984) (27)
Colectomy subtypes, follow‐up surgical procedures, postsurgical complications, and medical charges among ulcerative colitis patients with private health insurance in the United States (2009) (27)
The relationship between periprocedural myocardial infarction and subsequent target vessel revascularization following percutaneous coronary revascularization: insights from the EPIC trial. Evaluation of IIb/IIIa platelet receptor antagonist 7E3 in Preventing Ischemic Complications. (1999) (27)
Characteristics of Genomic Test Consumers Who Spontaneously Share Results With Their Health Care Provider (2014) (27)
Association between admission white blood cell count and one-year mortality in patients with acute coronary syndromes. (2003) (27)
Prognostic value of congestive heart failure history in patients undergoing percutaneous coronary interventions. (1998) (27)
Negative T waves shortly after ST-elevation acute myocardial infarction are a powerful marker for improved survival rate. (2000) (27)
Fluid phase biopsy for detection and characterization of circulating endothelial cells in myocardial infarction (2014) (27)
Modifiable risk factors for vascular access site complications in the IMPACT II Trial of angioplasty with versus without eptifibatide. Integrilin to Minimize Platelet Aggregation and Coronary Thrombosis. (1998) (26)
Pharmacogenomics in cardiovascular diseases. (2003) (26)
Incidence and predictors of early recurrent ischemia after successful percutaneous transluminal coronary angioplasty for acute myocardial infarction. (1989) (26)
Angiographic and echocardiographic correlates of suitable septal perforators for alcohol septal ablation in hypertrophic obstructive cardiomyopathy. (2014) (26)
Is birth order associated with adult mortality? (1996) (26)
Reactivation of ischemic events in acute coronary syndromes: results from GUSTO-IIb. Gobal Use of Strategies To Open occluded arteries in acute coronary syndromes. (2001) (26)
Resource utilization in asthma:combined fluticasone propionate/salmeterol compared with inhaled corticosteroids (2007) (26)
Depressed platelet status in an elderly patient with hemorrhagic stroke after thrombolysis for acute myocardial infarction. GUSTO-III Investigators. (1998) (26)
A Novel Molecular Diagnostic Marker for Familial and Early-Onset Coronary Artery Disease and Myocardial Infarction in the LRP8 Gene (2014) (26)
Risk factors for intracranial hemorrhage and nonhemorrhagic stroke after fibrinolytic therapy (from the GUSTO-i trial). (2004) (26)
Digital health care for older adults (2019) (26)
Lipids, nutrition, and coronary heart disease. (1996) (26)
Atlas of Interventional Cardiology (1994) (26)
Perceived Bias in the Facial Expressions of Television News Broadcasters. (1980) (26)
Actual and perceived emotional sending and personality correlates (1985) (26)
An analysis of Wenckebach periodicity. (1975) (26)
Clinical angiographic and histologic correlates of ectasia after directional coronary atherectomy. (1992) (26)
Thrombolysis and angioplasty in acute myocardial infarction. (1988) (26)
Comparison of the safety and efficacy of emboli prevention devices versus platelet glycoprotein IIb/IIIa inhibition during carotid stenting. (2005) (25)
Retrospective claims study of fluticasone propionate/salmeterol fixed-dose combination use as initial asthma controller therapy in children despite guideline recommendations. (2009) (25)
Stenting for acute myocardial infarction (1997) (25)
Genetic structure of community acquired methicillin-resistant Staphylococcus aureus USA300 (2012) (25)
Comparison of left ventricular function and contractile reserve after successful recanalization by thrombolysis versus rescue percutaneous transluminal coronary angioplasty for acute myocardial infarction. (1988) (25)
Mortality at 1 year for the direct comparison of tirofiban and abciximab during percutaneous coronary revascularization: do tirofiban and ReoPro give similar efficacy outcomes at trial 1-year follow-up. (2005) (25)
Can the results of contemporary aortic valve replacement be improved? (1986) (25)
Convergence of atherosclerosis and alzheimer's disease: Cholesterol, inflammation, and misfolded proteins. (2004) (25)
Baseline coronary angiographic findings in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial (BARI 2D). (2009) (25)
FIRST PHARMACOGENOMIC ANALYSIS USING WHOLE EXOME SEQUENCING TO IDENTIFY NOVEL GENETIC DETERMINANTS OF CLOPIDOGREL RESPONSE VARIABILITY: RESULTS OF THE GENOTYPE INFORMATION AND FUNCTIONAL TESTING (GIFT) EXOME STUDY (2012) (25)
Molecular Autopsy for Sudden Death in the Young: Is Data Aggregation the Key? (2017) (25)
Homocysteine: A new cardiac risk factor? (2001) (25)
Abciximab survival advantage following percutaneous coronary intervention is predicted by clinical risk profile. (2002) (25)
Life-threatening ventricular tachyarrhythmias in delirium tremens. (1977) (25)
Molecular mechanisms of myocardial infarction. (2005) (25)
Stenting for ischemic heart disease. (1997) (25)
Which thrombolytic agent should one choose? (1991) (24)
Determinants of the need for early acute intervention in patients treated conservatively after thrombolytic therapy for acute myocardial infarction. TAMI-5 Study Group. (1991) (24)
Determination of the natural history of aspirin resistance among stable patients with cardiovascular disease: Reply (2003) (24)
Antiplatelet and anticoagulant use after myocardial infarction (1996) (24)
Higher T-wave amplitude associated with better prognosis in patients receiving thrombolytic therapy for acute myocardial infarction (a GUSTO-I substudy). Global Utilization of Streptokinase and Tissue plasminogen Activator for Occluded Coronary Arteries. (1998) (24)
Thyrotoxicosis and the cardiovascular system: subtle but serious effects. (2003) (24)
Tolerance: An Historical Overview (1998) (24)
Use of carbon-11 acetate and dynamic positron emission tomography to assess regional myocardial oxygen consumption in patients with acute myocardial infarction receiving thrombolysis or coronary angioplasty. (1993) (24)
The case for investing in the male condom (2017) (24)
UNAIDS survey aligns with so-called fourth 90 for HIV/AIDS (2019) (24)
New nitrate delivery systems: buccal nitroglycerin. (1983) (24)
Evolution of improved antithrombotic and antiplatelet agents: genesis of the Comparison of Abciximab Complications with Hirulog [and back-Up Abciximab] Events Trial (CACHET). (1998) (24)
Pan Vascular Medicine (2002) (24)
Relation of an elevated white blood cell count after percutaneous coronary intervention to long-term mortality. (2004) (24)
ST-segment resolution 60 minutes after combination treatment of abciximab with reteplase or reteplase alone for acute myocardial infarction (30-day mortality results from the resolution of ST-segment after reperfusion therapy substudy). (2004) (24)
Frequency of high-risk patients not receiving high-potency statin (from a large managed care database). (2015) (24)
Cardiac function in alcohol-associated systemic hypertension. (1986) (24)
In Vitro Efficacy of Platelet Glycoprotein IIb/IIIa Antagonist in Blocking Platelet Function in Plasma of Patients with Heparin-induced Thrombocytopenia (1998) (24)
A guide to therapeutic decision-making in patients with non-ST-segment elevation acute coronary syndromes. (2003) (24)
Information and Artificial Intelligence. (2018) (24)
Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes. (2004) (24)
Coronary collaterals revisited. Accessory pathway to myocardial preservation during infarction. (1991) (24)
Abrupt closure: The CAVEAT I experience (1995) (24)
Gender Disparities in Lipid-Lowering Therapy in Cardiovascular Disease: Insights from a Managed Care Population. (2016) (24)
The digitised clinical trial (2017) (23)
Genotype-Based Risk and Pharmacogenetic Sampling in Clinical Trials (2010) (23)
C-reactive protein, inflammation, and coronary risk: an update. (2003) (23)
Patient outcomes after fibrinolytic therapy for acute myocardial infarction at hospitals with and without coronary revascularization capability. (2002) (23)
Arterial Remodeling: A Critical Factor in Restenosis (1997) (23)
Direct thrombin inhibitors in acute coronary syndromes: effect in patients undergoing early percutaneous coronary intervention. (2005) (23)
Combination therapy with ezetimibe/simvastatin versus statin monotherapy for low-density lipoprotein cholesterol reduction and goal attainment in a real-world clinical setting. (2011) (23)
Effects of Indomethacin on Acute Insulin Release in Man (1980) (23)
Cardiac troponin T and cardiac troponin I: relative values in short-term risk stratification of patients with acute coronary syndromes. GUSTO-IIa Investigators. (1998) (23)
Heart rate variability in atrial fibrillation related to left atrial size. (2004) (23)
The lost decade of nesiritide. (2011) (23)
Understanding hostility, coping, and health. (1992) (23)
Playing with pets and longevity among older people. (1995) (23)
The Future of Antiplatelet Therapy: Optimizing Management in Patients with Acute Coronary Syndrome (2000) (23)
Some Effects of Gaze on Subjects Motivated to Seek or to Avoid Social Comparison. (1978) (23)
Comparison of Radial Artery and Saphenous Vein Graft Stenosis More Than 5 Years After Coronary Artery Bypass Grafting. (2016) (23)
Clinical aspects of nitrate tolerance. (1991) (23)
Randomized evaluation of coronary angioplasty for early TIMI 2 flow after thrombolytic therapy for the treatment of acute myocardial infarction: a new look at an old study (1994) (23)
Causal Inference and the Millennium Development Goals (MDGs): Assessing Whether There Was an Acceleration in MDG Development Indicators Following the MDG Declaration (2013) (23)
Comparison of three coronary stents: clinical and angiographic outcome after elective placement in 134 consecutive patients. (1994) (23)
Nitrate delivery systems in perspective. A decade of progress. (1984) (23)
Alteration of digoxin pharmacokinetics by a single dose of quinidine. (1980) (23)
Effect of autonomic blockade on the hemodynamic findings in acute cardiac tamponade. (1977) (23)
Validation of a genetic risk score for atrial fibrillation: A prospective multicenter cohort study (2018) (23)
Cost-efficacy modeling of catheter reuse for percutaneous transluminal coronary angioplasty. (1996) (23)
Comparison of incidence of bleeding and mortality of men versus women with ST-elevation myocardial infarction treated with fibrinolysis. (2012) (23)
Cigarette smoking status and outcome among patients with acute coronary syndromes without persistent ST-segment elevation: effect of inhibition of platelet glycoprotein IIb/IIIa with eptifibatide. The PURSUIT trial investigators. (2000) (23)
Outcomes in African Americans and whites after percutaneous coronary intervention. (2005) (23)
Evaluation of Left Ventricular Relaxation and Filling Pressures in Obstructive Hypertrophic Cardiomyopathy: Comparison between Invasive Hemodynamics and Two‐Dimensional Speckle Tracking (2012) (23)
Personality, Disease, and Self-healing (2011) (23)
Tissue plasminogen activator for acute ischemic stroke. (1996) (22)
Favorable early and long-term prognosis following coronary bypass surgery therapy for myocardial infarction: results of a multicenter trial. TAMI Study Group. (1989) (22)
Emotion, Personality, and Health (1996) (22)
711-3-A Multicenter, Randomized, Double-Blind Pilot Trial of Standard Versus Low Dose Weight-Adjusted Heparin in Patients Treated with the Platelet GP IIb/IIIa Receptor Antibody c7E3 During Percutaneous Coronary Revascularization (1995) (22)
Essentials of Cardiac Physical Diagnosis (1987) (22)
Comparative gene expression analysis between coronary arteries and internal mammary arteries identifies a role for the TES gene in endothelial cell functions relevant to coronary artery disease. (2012) (22)
711-3-A Multicenter, Randomized, Double-Blind Pilot Trial of Standard Versus Low Dose Weight-Adjusted Heparin in Patients Treated with the Platelet GP IIb/IIIa Receptor Antibody c7E3 During Percutaneous Coronary Revascularization (1995) (22)
Management and outcome of patients with atrial fibrillation during acute myocardial infarction: the GUSTO-III experience. Global use of strategies to open occluded coronary arteries. (2002) (22)
Correlates of in-hospital cost among patients undergoing abdominal aortic aneurysm repair. (1998) (22)
Absence of increased in-hospital complications with reused balloon catheters. (1996) (22)
Abnormalities of the cardiovascular response to cold pressor test in type 1 diabetes. Correlation with blood glucose control. (1984) (22)
Effectiveness and safety of bivalirudin during percutaneous coronary intervention in a single medical center. (2005) (22)
Assessing the human immune response to SARS-CoV-2 variants (2021) (22)
Association of Sleep Duration and Variability With Body Mass Index: Sleep Measurements in a Large US Population of Wearable Sensor Users. (2020) (22)
Use of evidence-based medical therapy in patients undergoing percutaneous coronary revascularization in the United States, Europe, and Canada. Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT-I) and Canadian Coronary Atherectomy Trial (CCAT) investigators. (1997) (22)
Current management of depression in cancer patients. (2002) (22)
Significance of prolonged electrocardiographic pauses in sinoatrial disease: sick sinus syndrome. (1983) (22)
Septal ethanol ablation for hypertrophic obstructive cardiomyopathy: early and intermediate results of a Canadian referral centre. (2003) (22)
Massive hemorrhagic myocardial infarction after coronary thrombolysis. (1986) (22)
How to Use Nitrates (2002) (22)
Why do some people thrive while others succumb to disease and stagnation?: Personality, social relations, and resilience (2010) (21)
Echocardiographic detection of fungal vegetations in Candida parasilopsis endocarditis. (1976) (21)
Miscues on the "lack of MEF2A mutations" in coronary artery disease. (2005) (21)
Digital recruitment and enrollment in a remote nationwide trial of screening for undiagnosed atrial fibrillation: Lessons from the randomized, controlled mSToPS trial (2019) (21)
Ascites as a marker for the hyperdynamic heart of Laennec's cirrhosis. (1992) (21)
Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass grafts following percutaneous transluminal coronary angioplasty. (1992) (21)
Mechanical activation of noncoding-RNA-mediated regulation of disease-associated phenotypes in human cardiomyocytes (2019) (21)
Diagnosing and Managing Unstable Angina, Quick Reference Guide for Clinicians (1994) (21)
Comparison of major complication rates with new atherectomy devices for percutaneous coronary intervention in women versus men. (1993) (21)
Percutaneous transluminal angioplasty of an anomalous left circumflex coronary artery arising from the right sinus of Valsalva. (1982) (21)
Use of bedside activated partial thromboplastin time monitor to adjust heparin dosing after thrombolysis for acute myocardial infarction: results of GUSTO-I. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries. (1998) (21)
Association of direct‐to‐consumer genome‐wide disease risk estimates and self‐reported disease (2012) (20)
Clinical significance of the magnesium: calcium ratio; technic for the determination of magnesium and calcium in biologic fluids. (1955) (20)
Medicine unplugged: the future of laboratory medicine. (2012) (20)
Prolonged dual antiplatelet therapy after percutaneous coronary intervention reduces ischemic events without affecting the need for repeat revascularization: insights from the CREDO trial. (2007) (20)
A randomized pilot trial of brief versus prolonged heparin after successful reperfusion in acute myocardial infarction. (1990) (20)
Annotating individual human genomes. (2011) (20)
Selection of dilatation hardware for PTCA--1985. (1985) (20)
Clinical risk factors for ischemic complications after percutaneous coronary interventions: Results from the EPIC trial (1999) (20)
The relationship of obesity to ischemic outcomes following coronary stent placement in contemporary practice (2006) (20)
Fibrinolytic treatment for elderly patients with acute myocardial infarction (2002) (20)
A retrospective study of the use of fluticasone propionate/salmeterol combination as initial asthma controller therapy in a commercially insured population. (2008) (20)
Answers to complex questions cannot be derived from “simple” trials (1992) (20)
An invasive strategy is associated with decreased mortality in patients with unstable angina and non-ST-elevation myocardial infarction: GUSTO IIb trial. (2003) (20)
Predictors of left ventricular function after acute myocardial infarction: effects of time to treatment, patency, and body mass index: the GUSTO-I angiographic experience. (2001) (20)
How is biomedical research funding faring during the COVID-19 lockdown? (2020) (20)
Sex differences in nonverbal expressiveness: Emotional expression, personality, and impressions (1993) (20)
Platelet glycoprotein IIb/IIIa receptor inhibitors in ischemic heart disease. (1995) (20)
Outcomes of patients with acute coronary syndromes and prior percutaneous coronary intervention: a pooled analysis of three randomized clinical trials. (2005) (20)
Creatine kinase-MB elevation after coronary artery bypass grafting surgery in patients with non-ST-segment elevation acute coronary syndromes predict worse outcomes: results from four large clinical trials. (2007) (19)
Oral Glycoprotein IIb/IIIa Inhibitors (2001) (19)
The KIF6 collapse. (2010) (19)
Heparin monitoring during coronary intervention: activated clotting time versus activated partial thromboplastin time. (1993) (19)
Profound inhibition of platelet aggregation with monoclonal antibody 7E3 Fab thrombolytic therapy (1993) (19)
A Systematic Global Review of Condom Availability Programs in High Schools. (2019) (19)
The effects of atrial fibrillation on regional blood flow in the awake dog. (1987) (19)
Real World Home Blood Pressure Variability in Over 56,000 Individuals With Nearly 17 Million Measurements (2018) (19)
Influence of a randomized clinical trial on practice by participating investigators: lessons from the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT). CAVEAT I and II Investigators. (1998) (19)
A framework for smartphone-enabled, patient-generated health data analysis (2016) (19)
Survival benefit of Abciximab administration during early rescue angioplasty: analysis of 387 patients from the GUSTO-III trial (1998) (19)
High-sensitivity C-reactive protein and clopidogrel treatment in patients at high risk of cardiovascular events: a substudy from the CHARISMA trial (2011) (19)
AI-facilitated health care requires education of clinicians (2021) (19)
Medical faculties decimated by violence in Iraq (2009) (19)
Sweden’s health data goldmine (2014) (19)
Zones of atrial vulnerability. Relationships to basic cycle length. (1996) (19)
Multi-allelic haplotype association identifies novel information different from single-SNP analysis: a new protective haplotype in the LRP8 gene is against familial and early-onset CAD and MI. (2013) (19)
Reperfusion therapy of acute myocardial infarction. (1988) (19)
Coronary risk factors and their modification: lipids, smoking, hypertension, estrogen, and the elderly. (1995) (19)
Pacemaker Guidelines) Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 American College of Cardiology/American Heart Association Task Force on Pacemakers and Antiarrhythmia Devices: Summary Article : A Report of the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac (2006) (19)
Diagnostic considerations in electromechanical dissociation (1976) (19)
Risk stratification for patients undergoing nonurgent percutaneous coronary intervention using N-terminal pro-B-type natriuretic peptide: a Clopidogrel for the Reduction of Events During Observation (CREDO) substudy. (2007) (19)
Giant left atrial V-waves in post-myocardial infarction ventricular septal defect. (1979) (19)
Pharmacogenomics in cardiovascular diseases. (2002) (19)
Outcome of Hispanic patients treated with thrombolytic therapy for acute myocardial infarction: results from the GUSTO-I and III trials. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries. (1999) (18)
Direct-to-consumer genetic testing: reliable or risky? (2011) (18)
Lesotho's controversial public–private partnership project (2015) (18)
Extracardiac vascular disease and effectiveness of sustained clopidogrel treatment (2005) (18)
Mitral valve prolapse: A plea for unanimity (1976) (18)
Reperfusion momentum: lessons from the randomized trials of immediate coronary angioplasty for myocardial infarction. (1989) (18)
Comparison of ST-segment resolution with combined fibrinolytic and glycoprotein IIb/IIIa inhibitor therapy versus fibrinolytic alone (data from four clinical trials). (2005) (18)
The History and Background of Health Psychology. (2007) (18)
Association of persistent and transient worsening renal function with mortality risk, readmissions risk, length of stay, and costs in patients hospitalized with acute heart failure (2015) (18)
Poultry, politics, and antibiotic resistance (2009) (18)
Should Farmers Invest in Financial Assets as a Risk Management Strategy? Some Evidence from New Zealand (2008) (18)
Thrombolytic Therapy for Acute Myocardial Infarction (1992) (18)
Patterns and trends of contraceptive use among sexually active adolescents in Burkina Faso, Ethiopia, and Nigeria: evidence from cross-sectional studies (2015) (18)
Long-term angiographic assessment of the influence of coronary risk factors on native coronary circulation and saphenous vein aortocoronary grafts. (1977) (18)
Reduction in vascular access site bleeding in sequential abciximab coronary intervention trials (2002) (18)
Current concepts of the genesis of heart sounds. II. Third and fourth sounds. (1978) (18)
Coronary angioplasty as therapy for acute myocardial infarction: University of Michigan experience. (1987) (18)
Serum homocysteine and stroke in atrial fibrillation. (2001) (18)
Pimavanserin evaluated by the FDA (2018) (17)
Applicability of percutaneous transluminal coronary angioplasty to patients with recombinant tissue plasminogen activator mediated thrombolysis. (1985) (17)
Bridging Antiplatelet Therapy With Cangrelor in Patients Undergoing Cardiac Surgery: A Randomized Controlled Trial (2012) (17)
Nonverbal Greetings (1981) (17)
Pathobiology of atherosclerosis: are there racial and ethnic differences? (2004) (17)
Late cardiac tamponade following open-heart surgery: detection by echocardiography. (1977) (17)
Determinants of the total cosine of the spatial angle between the QRS complex and the T wave (TCRT): implications for distinguishing primary from secondary T-wave abnormalities. (2007) (17)
Sustained-release local hirulog therapy decreases early thrombosis but not neointimal thickening after arterial stenting. (1996) (17)
Acute intervention during myocardial infarction in patients with prior coronary bypass surgery. (1990) (17)
Does Intracoronary Thrombus Influence the Outcome of High Risk Percutaneous Transluminal Coronary Angioplasty? Clinical and Angiographic Outcomes in a Large Multicenter Trial fn1fn1This study was suppported by a grant from Centocor, Inc. (1998) (17)
Transdermal nitroglycerin and nitrate tolerance. (1986) (17)
Troponin, embolization and restoration of microvascular integrity. (2000) (17)
Hemodynamic changes during hemodialysis: role of dialyzate. (1983) (17)
Recommendations for development and maintenance of competence in coronary interventional procedures. American College of Cardiology Cardiac Catheterization Committee. (1993) (17)
Readiness for the scorecard era in cardiovascular medicine. (1995) (17)
Has SARS-CoV-2 reached peak fitness? (2021) (17)
Optimizing percutaneous coronary revascularization in diabetic women: analysis from the EPISTENT trial. (2000) (17)
Revisiting optimal anticoagulation with unfractionated heparin during coronary stent implantation. (2003) (17)
Inferior infarction following alcohol septal ablation: A consequence of “collateral damage”? (2007) (17)
Evaluating the Employment Benefits of Education and Targeted Interventions to Reduce Child Marriage. (2019) (17)
Atherectomy of the left main coronary artery with percutaneous cardiopulmonary bypass support. (1989) (17)
Individual differences in ability to encode complex affects. (1999) (17)
Rational medical therapy for stable angina pectoris. (1984) (17)
Provisional glycoprotein IIb/IIIa blockade in a randomized investigation of bivalirudin versus heparin plus planned glycoprotein IIb/IIIa inhibition during percutaneous coronary intervention: predictors and outcome in the Randomized Evaluation in Percutaneous coronary intervention Linking Angiomax t (2006) (17)
Appearance of atrial rhythm with absent P wave in longstanding atrial fibrillation. (1974) (17)
Synthesis of 1-arsanaphthalene (1980) (17)
The Oxford Handbook of the Five Factor Model of Personality (2016) (17)
Guiding ultrasound image capture with artificial intelligence (2020) (17)
Abciximab-facilitated percutaneous coronary intervention and long-term survival--a prospective single-center registry. (2003) (17)
Integrelin for emergency coronary artery stenting (1996) (17)
Coronary artery stenting: indications and cost implications. (1996) (17)
The draw-back stent deployment technique: a strategy for the treatment of coronary branch ostial lesions. (2002) (17)
Sex, clinical symptoms, and angiographic findings in patients with diabetes mellitus and coronary artery disease (from the Bypass Angioplasty Revascularization Investigation [BARI] 2 Diabetes trial). (2011) (16)
Use of radiographic devices by cardiologists (1995) (16)
Prior aspirin use predicts worse outcomes in patients with non–ST-elevation acute coronary syndromes11This study was sponsored by COR Therapeutics Inc., South San Francisco, California; and Schering-Plough Research Institute, Kenilworth, New Jersey. (1999) (16)
Sexual activity as a predictor of life-span mortality risk (2002) (16)
Is my cough COVID-19? (2020) (16)
Contraceptive use and distribution of high-risk births in Nigeria: a sub-national analysis (2015) (16)
Physicians and the Investment Industry (2005) (16)
Reuse of coronary angioplasty equipment: technical and clinical issues. (1996) (16)
Cost of cardiac care in the three years after coronary catheterization in a contained care system: critical determinants and implications. (1998) (16)
Risk for cardiovascular outcomes among subjects with atherosclerotic cardiovascular disease and greater-than-normal estimated glomerular filtration rate. (2007) (16)
A profile of candidates for repeat myocardial revascularization: implications for selection of treatment. (1997) (16)
Health Disparities Among Children with Asthma in the United States by Place of Residence. (2019) (16)
Mortality related to diagnostic cardiac catheterization. The importance of left main coronary disease and catheter induced trauma. (1997) (16)
Advances in Thrombolytic Therapy for Acute Myocardial Infarction (1987) (16)
Physicians and the investment industry. (2005) (16)
Relationship Between Baseline Inflammatory Markers, Antiplate let Therapy, and Adverse Cardiac Events After Percutaneous Coronary Intervention (2009) (16)
The genetics of heart attack (2005) (16)
Clinical ResearchCardiac Genetic: Editorial CommentThe KIF6Collapse⁎ (2010) (16)
Verapamil prolongs atrial fibrillation by evoking an intense sympathetic neurohumoral effect. (1999) (16)
Tissue plasminogen activator: why the backlash? (1989) (16)
Current concepts of the genesis of heart sounds. I. First and second sounds. (1978) (16)
A genome-wide linkage scan identifies multiple quantitative trait loci for HDL-cholesterol levels in families with premature CAD and MI (2010) (16)
Cardiovascular Effects of Ethanol (1992) (16)
Clot-selective coronary thrombolysis with lowdose synergistic combinations of single-chain urokinase-type plasminogen activator and recombinant tissue-type plasminogen activator☆ (1991) (16)
Impact of diabetes mellitus on percutaneous revascularization (CAVEAT-I). CAVEAT-I Investigators. Coronary Angioplasty Versus Excisional Atherectomy Trial. (1997) (15)
The perils of poultry (2009) (15)
Can skin cancer diagnosis be transformed by AI? (2019) (15)
Spin delocalization in 7-norbornenyl-type radicals. 2. The effect of 7-substitution on stereochemistry (1977) (15)
Comparative Assessment of Medical Resource Use and Costs Associated with Patients with Symptomatic Peripheral Artery Disease in the United States. (2016) (15)
Trickle down thrombolysis. (1993) (15)
Priority Areas for Adolescent Health Measurement (2021) (15)
Does Tolerance Develop During Long-Acting Nitrate Therapy? A Critical Review (1983) (15)
Interventions to prevent skin cancer: Experimental evaluation of informational and fear appeals (1995) (15)
Post-intervention cardiac enzyme elevations: Prognostic significance in IMPACT II (1996) (15)
Coronary revascularization surgery after myocardial infarction: impact of bypass surgery on survival after thrombolysis. GUSTO Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. (1997) (15)
Molecular genetics of atrial fibrillation (2009) (15)
Predictors of adverse psychological experiences surrounding genome-wide profiling for disease risk (2018) (15)
Measurement of left anterior descending coronary arterial blood flow. Technique, methods of blood flow analysis and correlation with angiography. (1973) (15)
Sarcoidosis with incomplete bilateral bundle branch block pattern disappearing following steroid therapy: an electrophysiological study. (1976) (15)
Off the cuff: rebooting blood pressure treatment (2016) (15)
A call for standardised age-disaggregated health data (2021) (15)
Prognostic implication of activated partial thromboplastin time after reteplase or half-dose reteplase plus abciximab: results from the GUSTO-V trial. (2005) (15)
Simon Dack Lecture. The genomic basis of myocardial infarction. (2005) (15)
Thrombolytic therapy: adjuvant mechanical intervention for acute myocardial infarction. (1992) (15)
Moxifloxacin versus levofloxacin for treatment of acute rhinosinusitis: a retrospective database analysis of treatment duration, outcomes, and charges (2006) (15)
Pharmacy Benefit Managers, Pharmacies, and Pharmacogenomic Testing: Prescription for Progress? (2010) (15)
The fibrillin-1 gene: unlocking new therapeutic pathways in cardiovascular disease (2012) (15)
Roots of Iraq's maternal and child health crisis run deep (2013) (15)
The use of dextran-40 during percutaneous transluminal coronary angioplasty: a report of three cases of anaphylactoid reactions--one near fatal. (1985) (15)
Evidence for an Adverse Interaction Between ACE Inhibitors and Aspirin Following Myocardial Infarction: The GUSTO-I Trial (1998) (14)
Long-Term Mortality of Patients With Acute Myocardial Infarction in the United States and Canada (2004) (14)
Update on Clinical Trials of Antiplatelet Therapy for Cerebrovascular Diseases (2000) (14)
Effect of abciximab versus tirofiban on activated clotting time during percutaneous intervention and its relation to clinical outcomes--observations from the TARGET trial. (2003) (14)
Effect of smoking status and abciximab use on outcome after percutaneous coronary revascularization: Pooled analysis from EPIC, EPILOG, and EPISTENT. (2001) (14)
Cox-2 inhibitors and cardiovascular risk: we defend our data and suggest caution. (2001) (14)
Percutaneous coronary laser balloon angioplasty preliminary results of a multicenter trial (1989) (14)
Effect of hirudin vs heparin on haemostatic activity in patients with acute coronary syndromes; the GUSTO-IIb haemostasis substudy. (2002) (14)
Childhood sleep duration and lifelong mortality risk. (2014) (14)
Medically induced opioid addiction reaching alarming levels (2012) (14)
Metabolic imaging by positron emission tomography early after myocardial infarction as a predictor of recovery of myocardial function after reperfusion (1994) (14)
Direct angioplasty in acute myocardial infarction. State of the art and current controversies. (1995) (14)
Three Decades Later: The Life Experiences and Mid-Life Functioning of 1980s Heavy Metal Groupies, Musicians, and Fans (2015) (14)
Trends and patterns of modern contraceptive use and relationships with high-risk births and child mortality in Burkina Faso (2015) (14)
Identification of paroxysmal atrial fibrillation subtypes in over 13,000 individuals. (2019) (14)
Evidence for a pivotal role of platelets in vascular reocclusion and restenosis. (1996) (14)
Prognostic significance of creatine kinase-MB elevation after percutaneous coronary intervention in patients with chronic renal dysfunction. (2002) (14)
Quantitative evaluation of local drug delivery using the InfusaSleeve catheter. (1997) (14)
Treatment with inhaled mometasone furoate reduces short-acting β(2) agonist claims and increases adherence compared to fluticasone propionate in asthma patients. (2011) (14)
Creatine kinase MM and MB isoforms in patients receiving thrombolytic therapy and acute angiography. TAMI Study Group. (1995) (14)
Rebooting cancer tissue handling in the sequencing era: toward routine use of frozen tumor tissue. (2013) (14)
Contraceptive use and distribution of high-risk births in Nigeria: a sub-national analysis (2015) (14)
Diabetes mellitus: biological determinants of atherosclerosis and restenosis. (1999) (14)
Coronary artery imaging with multidetector computed tomography: a call for an evidence-based, multidisciplinary approach. (2006) (14)
Adding artificial intelligence to gastrointestinal endoscopy (2020) (14)
Lack of adverse clopidogrel-atorvastatin clinical interaction. (2004) (14)
Intramuscular Bumetanide and Furosemide in Congestive Heart Failure (1981) (14)
Preparedness of the CTSA's Structural and Scientific Assets to Support the Mission of the National Center for Advancing Translational Sciences (NCATS) (2012) (14)
Bridging the chasm between AI and clinical implementation (2022) (14)
Percutaneous transluminal angioplasty of coronary saphenous vein bypass grafts. (1985) (13)
Hemodynamic changes during dialysis. (1979) (13)
An LRP 8 Variant Is Associated with Familial and Premature Coronary Artery Disease and Myocardial Infarction (2007) (13)
Coronary bypass surgery improves global and regional left ventricular function following thrombolytic therapy for acute myocardial infarction (1991) (13)
Inhibition of Platelet Aggregation with a Glycoprotein IIb-IIIa Antagonist Does Not Prevent Thrombin Generation in Patients Undergoing Thrombolysis for Acute Myocardial Infarction (2004) (13)
Personality, Health, and Longevity (1994) (13)
Indonesia makes maternal health a national priority (2012) (13)
One-year results from the Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries (GUSTO-I) trial. GUSTO-I Investigators. (1996) (13)
Artificial intelligence, bias, and patients' perspectives (2021) (13)
Recent advances in anticoagulant therapy for acute coronary syndromes. (2001) (13)
Hypertensive Hypertrophic Cardiomyopathy (1985) (13)
Intracoronary-stent placement for coronary artery disease (1997) (13)
A comparison of ionic versus nonionic contrast medium during primary percutaneous transluminal coronary angioplasty for acute myocardial infarction (GUSTO IIb). Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes. (2000) (13)
Preeminence Toward a New Frontier in Myocardial Reperfusion Therapy : Emerging Platelet (1998) (13)
Demonstration of a depressor reflex in acute cardiac tamponade. (1977) (13)
Vasodilatory state of decompensated cirrhosis: relation to hepatic dysfunction, ascites, and vasoactive substances. (1995) (13)
Superior Yield of the New strategy of Enoxaparin, Revascularization and GlYcoprotein IIb/IIIa inhibitors (SYNERGY) Trial (2004) (13)
The role of low-molecular-weight heparin in cardiovascular diseases. (2002) (13)
Effect of a single bolus of intracoronary basic fibroblast growth factor on perfusion in an ischemic porcine model. (1999) (13)
Percutaneous revascularization of ostial saphenous vein graft stenoses. (1995) (13)
Money back guarantees for non-reproducible results? (2016) (13)
Clinical study of the cardiac findings in patients on chronic maintenance hemodialysis: the relationship to coronary risk factors. (1981) (13)
Impact of on-site cardiac interventional facilities on management and outcome of patients with acute coronary syndromes. (2003) (13)
Use of Intraaortic Balloon Counterpulsation in Patients Presenting With Cardiogenic Shock: Observations From the GUSTO-I Study fn1fn1This study was funded by grants from Bayer, New York, New York; CIBA-Corning, Medfield, Massachusetts; Genentech, South San Francisco, California; ICI Pharmaceuticals, (1997) (13)
Glyceryl Trinitrate (Nitroglycerin) and the Organic Nitrates (1987) (13)
Inter-individual variation in objective measure of reactogenicity following COVID-19 vaccination via smartwatches and fitness bands (2022) (13)
CYP2C19 genotype and cardiovascular events. (2012) (13)
Optimal Activated Clotting Time During Percutaneous Coronary Intervention (2001) (13)
Association between cardiac, renal, and hepatic biomarkers and outcomes in patients with acute heart failure (2016) (13)
Urinary digoxin-like immunoreactive substance in pregnancy. Relation to urinary electrolytes. (1987) (13)
The next phase in human genetics (2011) (13)
Delaying and Preventing Ischemic Events in Patients with Acute Coronary Syndromes Using the Platelet Glycoprotein IIb/IIIa Inhibitor Lamifiban (1997) (13)
Genome-Wide Linkage Analysis of Large Multiple Multigenerational Families Identifies Novel Genetic Loci for Coronary Artery Disease (2017) (13)
Histopathologic correlates of coronary lesion angiographic morphology: lessons from a directional atherectomy experience (1992) (13)
Disruptive Innovation in Laboratory Medicine. (2015) (13)
Coronary Artery Calcium Scoring by Computed Tomography in Global Cardiovascular Risk Assessment and in Evaluation of Patients With Chest Pain (2007) (13)
First experience with chronic platelet GPIIb/IIIa receptor blockade: A pilot study of xemlofiban an orally active antagonist in unstable angina patients eligible for PTCA (1996) (13)
Clinical trials of recombinant hirudin in acute coronary syndromes. (1996) (13)
Real world usage characteristics of a novel mobile health self-monitoring device: Results from the Scanadu Consumer Health Outcomes (SCOUT) Study (2019) (12)
The pathogenesis and spectrum of acute coronary syndromes: from plaque formation to thrombosis. (1999) (12)
Observational studies and randomized trials. (2000) (12)
Dramatic budget increase for hepatitis treatment in federal prisons (2017) (12)
Quantitative determination of total lipids in serum. (1968) (12)
Relation between aspirin dose, all-cause mortality, and bleeding in patients with recent cerebrovascular or coronary ischemic events (from the BRAVO Trial). (2008) (12)
The ECG in acute coronary syndromes: new tricks from an old dog (2005) (12)
Iraq's growing health crisis (2014) (12)
A retrospective analysis of clinical characteristics, hospitalization, and functional outcomes in residents with and without Clostridium difficile infection in US long-term care facilities (2014) (12)
Inflammation and embolization in ischemic heart disease. (2000) (12)
Cardiogenic shock: current understandings and future research directions. (1994) (12)
Effect of subintimal resection on initial outcome and restenosis for native coronary lesions and saphenous vein graft disease treated by directional coronary atherectomy. A report from the CAVEAT I and II investigators. Coronary Angioplasty Versus Excisional Atherectomy Trial. (1996) (12)
Aboriginal health programming under siege, critics charge (2012) (12)
(Committee on the Management of Patients With Chronic Stable Angina) Cardiology/American Heart Association Task Force on Practice Guidelines Stable Angina—Summary Article: A Report of the American College of ACC/AHA 2002 Guideline Update for the Management of Patients With Chronic (2008) (12)
Now we're talking: bringing a voice to digital medicine (2018) (12)
Monitoring Jet Engines and the Health of People (2018) (12)
US big businesses struggle to cope with health-care costs (2006) (12)
Diagnosing and managing unstable angina (1994) (12)
Advanced and Accurate Mobile Health Tracking Devices Record New Cardiac Vital Signs (2018) (12)
The cost:benefit ratio of acute intervention for myocardial infarction: results of a prospective, matched pair analysis. (1989) (12)
Attention shifts to the white clot (1997) (12)
Wanted: Dead or Alive Assessment of Myocardial Viability After Thrombolysis (1993) (12)
Toward superhuman SARS-CoV-2 immunity? (2020) (12)
The mystery of nitrate resistance. (1991) (12)
Changes in lipid values and lipoprotein patterns of serum samples contaminated with bacteria. (1973) (12)
Clinical results of pericardial xenograft valves: the Ionescu-Shiley and Hancock valves. (1988) (12)
Relation of insurance status to performance of coronary angiography in patients with unstable angina pectoris or acute myocardial infarction. (2003) (12)
The Promise of Digital Health: Then, Now, and the Future. (2022) (12)
Laser balloon angioplasty: Coronary angiografhic follow-up of a multicenter trial (1990) (12)
Coronary-stent placement compared with balloon angioplasty. (1995) (12)
Combination thrombolytic therapy: a comparison of simultaneous and sequential regimens of tissue plasminogen activator and urokinase. (1991) (12)
Digitising the mind (2017) (12)
Inhibitors of platelet glycoprotein IIb/IIIa as augmenters of thrombolysis. (1995) (12)
Canadian Aboriginal people's health and the Kelowna deal (2006) (11)
737–5 Risk Stratification in Acute Ischemic Syndromes Using Serum Tropenin T (1995) (11)
The relationship between baseline risk and mortality in ST-elevation acute myocardial infarction treated with pharmacological reperfusion: insights from the Global Utilization of Strategies To open Occluded arteries (GUSTO) V trial. (2005) (11)
Impact of polygenic risk communication: an observational mobile application-based coronary artery disease study (2022) (11)
Warfarin Pharmacogenomics: A big step forward for individualized medicine: enlightened dosing of warfarin (2008) (11)
Pyrolysis of 1-arsabicyclo[2.2.2]triene derivatives (1977) (11)
Deep Learning Under Scrutiny: Performance Against Health Care Professionals in Detecting Diseases from Medical Imaging - Systematic Review and Meta-Analysis (2019) (11)
To truly look inside (2016) (11)
Nitrate tolerance and dependence. A critical assessment. (1980) (11)
National standards for electronic health records remain remote (2010) (11)
Health in the Arctic Circle (2005) (11)
A call to action: lowering the cost of health care. (2013) (11)
Percutaneous coronary intervention for patients with prior bypass surgery: therapy in evolution. (2000) (11)
Reactions to the National Academies/Royal Society Report on Heritable Human Genome Editing. (2020) (11)
Effects of thrombolytic regimen, early catheterization, and predischarge angiographic variables on six-week left ventricular function. The TAMI Investigators. Thrombolysis and Angioplasty in Acute Myocardial Infarction. (1997) (11)
Hormone replacement therapy among postmenopausal women presenting with acute myocardial infarction: insights from the GUSTO-III trial. (2010) (11)
Death and nonfatal reinfarction within the first 24 hours after presentation with an acute coronary syndrome: experience from GUSTO-IIb. Global Utilization of Strategies for Total Occlusion. (1999) (11)
Convergence of atherosclerosis and Alzheimer's disease (2004) (11)
Mitral regurgitation measured by continuous infusion of 133 xenon. An evaluation of the method in 91 patients. (1972) (11)
Genome-Wide Association of Implantable Cardioverter-Defibrillator Activation With Life-Threatening Arrhythmias (2012) (11)
Risk reduction with long-term clopidogrel following percutaneous coronary intervention. (2004) (11)
An Automated Strategy for Bedside aPTT Determination and Unfractionated Heparin Infusion Adjustment in Acute Coronary Syndromes: Insights from PARAGON A (2002) (11)
Stenting for acute myocardial infarction: The early United States multicenter experience (1996) (11)
Determinants of high cost in multiple sclerosis patients: a claims and chart review study (2016) (11)
Assessment of reperfusion after thrombolytic therapy for myocardial infarction. (1992) (11)
Comparative analysis of length of stay, total costs, and treatment success between intravenous moxifloxacin 400 mg and levofloxacin 750 mg among hospitalized patients with community-acquired pneumonia. (2009) (11)
Persistency, medication prescribing patterns, and medical resource use associated with multiple sclerosis patients receiving oral disease-modifying therapies: a retrospective medical record review (2016) (11)
Assessment and therapy (2001) (11)
A laboratory in your pocket (2016) (10)
Thrombosis of a prosthetic valve managed by thrombolysis: a case report. (1985) (10)
Prevention of acute complications after percutaneous transluminal coronary angioplasty. (1990) (10)
HIV/AIDS explosion in Russia triggers research boom (2003) (10)
Possible survival benefit from concomitant beta-but not calcium-antagonist therapy during reperfusion for acute myocardial infarction. (1990) (10)
Trends in Asthma Control, Treatment, Health Care Utilization, and Expenditures Among Children in the United States by Place of Residence: 2003-2014. (2019) (10)
Inflammation in acute coronary syndromes. (2002) (10)
Conquering Atherosclerotic Cardiovascular Disease - 50 Years of Progress. (2021) (10)
Exploring factors associated with health disparities in asthma and poorly controlled asthma among school-aged children in the U.S. (2020) (10)
Individual differences in expressive style as a mediator of expectancy communication (1985) (10)
Plasma cortisol changes following a mile run in conditioned subjects. (1970) (10)
Recurrent ischemia after thrombolysis for acute myocardial infarction. (2001) (10)
Centralized, nationwide electronic health records schemes under assault (2011) (10)
Trends in contraceptive use and distribution of births with demographic risk factors in Ethiopia: a sub-national analysis (2015) (10)
Anticoagulation and enoxaparin use in patients with prosthetic heart valves and/or pregnancy. Report and Recommendations of the Anticoagulation in Prosthetic Valves and Pregnancy Consensus Report (APPCR) Panel and Scientific Roundtable (2002) (10)
Disease-prone and self-healing personalities. (1992) (10)
Electrocardiographic features of experimental cardiac tamponade in closed-chest dogs. (1977) (10)
Home Monitoring of Blood Pressure: Short–Term Changes During Serial Measurements for 56398 Subjects (2018) (10)
On shutting one's eyes to face validity. (1983) (10)
Clopidogrel is associated with better in-hospital and 30-day outcomes than ticlopidine after coronary stenting. (2003) (10)
The clinical role of platelet glycoprotein IIb/IIIa receptor inhibitors in ischemic heart disease. (1996) (10)
Use of nitrates in ischemic heart disease. (1992) (10)
Clopidogrel with Aspirin Is the Optimal Antiplatelet Regimen for Intracoronary Stenting (1999) (10)
Association of genetic variants in the HDL receptor , SRB 1 , with abnormal lipids in women with coronary artery disease (2003) (10)
Language barriers restricting access to health care for Indigenous populations (2018) (10)
Induction of angiogenesis in a canine model of chronic myocardial ischemia with intravenous infusion of Vascular Endothelial Growth Factor (VEGF) combined with ultrasound energy and echo contrast agent (2002) (10)
Study Finds Heavy Contamination Across Vast Russian Arctic (2004) (10)
Validation of the early open infarct vessel hypothesis. (1993) (10)
AlzEye: longitudinal record-level linkage of ophthalmic imaging and hospital admissions of 353 157 patients in London, UK (2022) (10)
Smartphone Medicine (2016) (10)
Indigenous Canadians confront prescription opioid misuse (2013) (10)
Outcome of acute myocardial infarction in patients with prior coronary artery bypass grafting treated with combination reduced fibrinolytic therapy and abciximab. (2002) (10)
Canada's Indigenous suicide crisis (2016) (10)
Cholesterol, racial variation and targeted medicines (2005) (10)
Holding GUSTO up to the light. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. (1994) (10)
Transcutaneous nitroglycerin--ointment or disc? (1984) (9)
Exposure to Flame Retardants On the Rise (2004) (9)
Past the wall in cardiovascular R&D (2009) (9)
Does creatinine kinase-MB elevation after percutaneous coronary intervention predict outcomes in 2005? Authors' reply (2005) (9)
Characteristics, Treatment and Outcome of Patients with Non-ST-Elevation Acute Coronary Syndromes and Multivessel Coronary Artery Disease: Observations from PURSUIT (Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrelin Therapy) (2002) (9)
ACCF/AHA/CDC conference report on emerging infectious diseases and biological terrorism threats: the clinical and public health implications for the prevention and control of cardiovascular diseases. (2007) (9)
Selective use of embolic protection devices during saphenous vein grafts interventions: A single‐center experience (2009) (9)
Medical therapy of unstable angina and non-Q-wave myocardial infarction. (2000) (9)
Canada curbs Aboriginal health leadership (2012) (9)
Maximal benefit of integrelin platelet IIB/IIIa blockade 6–24 hours after therapy: Results of the IMPACT-II trial (1996) (9)
Clinical outcomes of patients more than one year following randomization in the Canadian Coronary Atherectomy Trial (CCAT). (1997) (9)
901-14 Impact of Ionic and Non-ionic Contrast Media on Post-PTCA Ischemic Complications: Results from the EPIC Trial (1995) (9)
Submaximal exercise thallium-201 SPECT for assessment of interventional therapy in patients with acute myocardial infarction. (1991) (9)
Medical data debates: Big is better? Small is beautiful? (2011) (9)
Environmental Cross Compliance - Panacea or Placebo? (2002) (9)
Early reperfusion therapy improves left ventricular function after acute inferior myocardial infarction associated with right coronary artery disease. (1987) (9)
An overview of the thrombolysis and angioplasty in acute myocardial infarction (TAMI) trials. (1988) (9)
Temporal evolution in the management of acute ST elevation myocardial infarction: the seven-year GUSTO experience from canada and the united states. The North American GUSTO-I and GUSTO-III investigators. (2000) (9)
Glycoprotein IIb/IIIa inhibitors: current indications and future prospects. (2000) (9)
Interobserver Reproducibility and Biological Variability of the Surgicutt II Bleeding Time (1998) (9)
Usefulness of long-acting nitrates in cardiovascular disease. (1978) (9)
CHAPTER 62 – αIIbβ3 (GPIIb-IIIa) Antagonists (2007) (9)
Moving Beyond Clinical Risk Scores with a Mobile App for the Genomic Risk of Coronary Artery Disease (2017) (9)
A Health System-Based Investment Case for Adolescent Health. (2019) (9)
Prison puzzle: treating hepatitis C (2012) (9)
A rapid screening test for abnormal hemoglobins. The detection of hemoglobin-A2. (1962) (9)
CIHR cutting MD/PhD training program (2015) (9)
Role of leukocytes in neointimal formation after balloon angioplasty in the rabbit atherosclerotic model (1995) (9)
Coronary angioplasty versus excisional atherectomy trial: CAVEAT. (1992) (9)
Digitising the way to better sleep health (2019) (9)
Predictive value of high sensitivity C-reactive protein in the diagnosis and outcomes of acute aortic syndromes (2010) (9)
Myocardial necrosis is halved in patients undergoing elective percutaneous coronary intervention who are pretreated with lipid-lowering therapy (2002) (9)
Procainamide-induced sinus node dysfunction in patients with chronic renal failure. (1979) (9)
Personality : classic theories and modern (2014) (9)
Effects of atrial fibrillation on myocardial blood flow in the ischemic heart of the dog. (1984) (9)
Relation of platelet inactivation with intravenous glycoprotein IIb/IIIa antagonists to major bleeding (from the GOLD study). (2002) (9)
Mometasone furoate versus beclomethasone dipropionate: effectiveness in patients with mild asthma. (2010) (9)
World Bank approves loan to help Russia tackle HIV/AIDS and tuberculosis (2003) (9)
Acute myocardial infarction after aortic valve endocarditis. (2001) (9)
One year followup from the GUSTO I trial (1994) (9)
Influence of local delivery of the protein tyrosine kinase receptor inhibitor tyrphostin-47 on smooth-muscle cell proliferation in a rat carotid balloon-injury model. (1997) (9)
Indonesia: The midwife and maternal mortality miasma (2013) (9)
Is all unstable angina the same? insights from the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT-I). The CAVEAT-Investigators. (1999) (9)
Simultaneous platelet glycoprotein IIb/IIIa integrin blockade and front-loaded tissue plasminogen activator in acute myocardial infarction: Results from a randomized trial (1996) (8)
Petain's Crime: The Full Story of French Collaboration in the Holocaust (1990) (8)
Direct thrombin inhibition appears to be a safe and effective anticoagulant for percutaneous bypass graft interventions (2006) (8)
Lack of clean water exacerbates cholera outbreak in Haiti (2011) (8)
Canada’s electronic health records initiative stalled by federal funding freeze (2010) (8)
Patient stratification and its predictive value for cardiac events. (1998) (8)
Role of percutaneous transluminal coronary angioplasty in acute myocardial infarction. (1987) (8)
Synopsis of Cardiac Physical Diagnosis (1989) (8)
Economic and cost-effectiveness in evaluating the value of cardiovascular therapies. The impact of the cost-effectiveness study of GUSTO-1 on decision making with regard to fibrinolytic therapy. (1999) (8)
Global action urged in response to new breed of drug-resistant bacteria (2010) (8)
The prognostic value of the admission and predischarge electrocardiogram in acute coronary syndromes: the GUSTO-IIb ECG Core Laboratory experience. (2006) (8)
Use of tissue plasminogen (1987) (8)
901-3 The Potential for Unexpected Hazard of Intravenous Beta-Blockade for Acute Myocardial Infarction: Results from the GUSTO Trial (1995) (8)
Potential value of platelet GPIIb/IIIa antagonist for treating heparin-induced thrombocytopenia (HIT) (1996) (8)
Indonesia: Islam and health (2013) (8)
The restenosis "antitheory". (1993) (8)
Restenosis after excellent angiographic angioplasty result for chronic total coronary artery occlusion--implications for newer percutaneous revascularization devices. (1989) (8)
Trends in contraceptive use and distribution of births with demographic risk factors in Ethiopia: a sub-national analysis (2015) (8)
Debate: PCI or CABG for multivessel disease? Viewpoint: No clear winner in an unfair fight (2001) (8)
Unexpected mortality reduction with abciximab for in-stent restenosis. (2000) (8)
Mechanisms of spin delocalization. .gamma. and .delta. Proton contact shifts (1974) (8)
Pacifying the infarct vessel. (1997) (8)
The rise of the virtualist (2019) (8)
Textbook of Interventional Cardiology, 6th Edition (2011) (8)
Genetic testing for coronary heart disease: the approaching frontier (2002) (8)
Two-year outcome after angiographically documented myocardial reperfusion for acute coronary occlusion. Thrombolysis and Angioplasty Study Group. (1990) (8)
Indicators of poorly controlled asthma and health-related quality of life among school-age children in the United States. (2017) (8)
Pathology of unstable angina: Analysis of biopsies obtained by directional coronary atherectomy (2005) (8)
1100-59 High-dose clopidogrel loading rapidly reduces both platelet inflammatory marker expression and aggregation (2004) (8)
Coronary stenting and use of abciximab (1998) (8)
Strategies for Treating Arterial Restenosis Using Polymeric Controlled Release Implants (1994) (8)
Digital orthodoxy of human data collection (2019) (8)
Disagreement between site investigators and clinical event committees is common and can affect trial results (1998) (8)
Short‐ and long‐term outcome of balloon angioplasty for compromised side branches after intracoronary stent deployment (1999) (8)
Smartphone apps in the COVID-19 pandemic (2022) (8)
Lack of cardioprotective effect of naproxen. (2002) (8)
Time to significant gradient reduction following septal balloon occlusion predicts the magnitude of final gradient response during alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy. (2011) (8)
Oxycodone class action lawsuit filed (2012) (8)
Creation of a large-scale genetic data bank for cardiovascular association studies. (2005) (8)
Vasodilator therapy for chronic congestive heart failure. (1985) (7)
Electronic health records a “strong priority” for US government (2010) (7)
Adjunctive therapy for percutaneous revascularization in acute myocardial infarction. (2004) (7)
Pharmacogenetics: Point-of-care genetic testing—a new frontier explored (2012) (7)
Blood, sweat and tears in biotech — the Theranos story (2018) (7)
Emerging clinical applications in cardiovascular pharmacogenomics (2011) (7)
Questions raised over Iraq congenital birth defects study (2013) (7)
Safe and efficacious use of bivalirudin for percutaneous coronary intervention with adjunctive platelet glycoprotein IIb/IIIa receptor inhibition. (2003) (7)
Genome-Wide Linkage Scan Identifies Two Novel Genetic Loci for Coronary Artery Disease: In GeneQuest Families (2014) (7)
Trends and patterns of modern contraceptive use and relationships with high-risk births and child mortality in Burkina Faso (2015) (7)
Sex and Gender in the 1980s Heavy Metal Scene: Groupies, Musicians, and Fans Recall Their Experiences (2014) (7)
Dexamethasone-nanoparticles for intra-arterial localization in restenosis in rats (1995) (7)
A matter of life and death? The Heart Protection Study and protection of clinical trial participants. (2003) (7)
Clinical Outcomes, Health Resource Use, and Cost in Patients with Early versus Late Dual or Triple Anti-Platelet Treatment for Acute Coronary Syndrome (2013) (7)
North America's medical isotope crisis (2009) (7)
The combination of enoxaparin, glycoprotein IIb/IIIa inhibitors and an early invasive approach among acute coronary syndrome patients. (2004) (7)
New Frontiers in Resilient Aging: Why do some people thrive while others succumb to disease and stagnation? (2010) (7)
A skin patch for sensing blood pressures (2018) (7)
Increased risk for abrupt closure during elective PTCA in the post-myocardial infarction period (1991) (7)
Adjunctive abciximab to reperfusion therapy in patients with acute st-segment elevation myocardial infarction: A meta-analysis of randomized trials (2005) (7)
Spin delocalization in 7-norbornenyl-type radicals (1974) (7)
Pulmonary hemorrhage after intracoronary stent placement. (1994) (7)
Multivariate sib-pair linkage analysis of longitudinal phenotypes by three step-wise analysis approaches (2003) (7)
Conflict-of-interest policies. (2001) (7)
Medicine and meteorology: Cloud, connectivity, and care (2020) (7)
Clopidogrel pretreatment prior to percutaneous coronary intervention attenuates periprocedural rise of C-reactive protein (2003) (7)
In-hospital clinical outcomes in the TAMI 5 study (1990) (7)
Genetic linkage analysis of longitudinal hypertension phenotypes using three summary measures (2003) (7)
A polio-free world? (2005) (7)
Relationship of Outcomes to Treatment with Lamifiban in Patients Undergoing PTCA: Analysis of PARAGON A (1997) (7)
Rethinking the medical record (2018) (7)
Canada’s ehealth software “Tower of Babel” (2010) (7)
Prescription drug abuse rising among Aboriginal youths (2012) (7)
Directional atherectomy for total coronary occlusions (1991) (7)
Directional variability in the R wave response during serial exercise testing in patients with coronary artery disease. (1984) (7)
It takes a planet (2019) (7)
Abstract 4403: Significant Single Nucleotide Polymorphism Associated with Atrial Fibrillation Located on Chromosome 4q25 in a Whole Genome Association Study and Association with Left Atrial Gene Expression (2008) (7)
Dispense With Supplements for Improving Heart Outcomes (2019) (7)
Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into the complex genetic architecture (2020) (7)
Thrombolytic therapy for acute myocardial infarction: GUSTO criticized. (1994) (7)
Debate over recreational cannabis use legalisation in Canada (2018) (7)
What role for catheter laboratories in unstable angina? (1998) (7)
Text book of interventional cardiology (2013) (7)
The long-term investment of coronary angioplasty for acute myocardial infarction. (1988) (7)
Long-Term Results After the Glycoprotein IIb/IIIa Inhibitor Abciximab in Unstable Angina (2003) (7)
Aspirin resistance and its implications in clinical practice. (2005) (7)
Early myocardial reperfusion: an assessment of current strategies in acute myocardial infarction. (1996) (7)
Effect of institutional volume and academic status on outcomes of coronary interventions: the IMPACT-II experience. (1999) (7)
Pharmaceutical advertising versus research spending: are profits more important than patients? (2003) (7)
Reduction in the need for unplanned stenting with the use of platelet glycoprotein IIb/IIIa blockade in percutaneous coronary intervention. (1998) (7)
Familial dilated cardiomyopathy with troponin T K210del mutation. (2006) (6)
ACE inhibitors still the drug of choice for heart failure—and more (1999) (6)
Early, Complete Infarct Vessel Patency: Arriving at a Gold Standard for Future Clinical Investigation in Myocardial Reperfusion (2004) (6)
Analysis of the 9p21.3 sequence associated with coronary artery disease reveals a tendency for duplication in a CAD patient (2018) (6)
Health in Colombia: the chronic disease burden (2012) (6)
Current concepts of the genesis of heart sounds. II. Third and fourth sounds. (1978) (6)
Deep learning detects impending organ injury in the clinic (2019) (6)
Coronary angioplasty in myocardial infarction. (1990) (6)
National electronic health records initiative remains muddled, auditors say (2010) (6)
Clinical risk factors for ischemic complications after percutaneous coronary interventions: results from the EPIC trial. The EPIC Investigators. (1999) (6)
Over-the-counter statins: a new controversy (2005) (6)
Therapy of angina pectoris with long-acting nitrates: which agent and when? (1996) (6)
Nitrate Tolerance in Angina Pectoris (1985) (6)
Prospective use of glycoprotein IIb/IIIa receptor blockers in the emergency department setting. (1998) (6)
Personality and Health (2001) (6)
A digital toolkit for improved maternal health (2018) (6)
Direct to Consumer Fitness DNA Testing. (2019) (6)
Uncoupling clinical outcomes and coronary angiography: a review and perspective of recent trials in coronary artery disease. (1996) (6)
Antibiotic overprescribing a growing problem (2017) (6)
Aortic valve replacement with fascia lata. An encouraging late study. (1974) (6)
Suicide rates in Russia on the increase (2003) (6)
Scaling up family planning in Sierra Leone: A prospective cost–benefit analysis (2017) (6)
Preprocedure inflammatory state predicts periprocedural myocardial infarction after elective percutaneous coronary intervention: An EPIC substudy (2003) (6)
A Major Dichotomy in Unstable Angina Outcome : ST Depression Versus T-Wave Inversion : GUSTO-II Results (1996) (6)
Management of myocardial ischemia: role of intermittent nitrate therapy. (1990) (6)
Drug shops as primary point of care—the case of Nigeria (2017) (6)
Risk assessment of post-discharge mortality among recently hospitalized Medicare heart failure patients with reduced or preserved ejection fraction (2020) (6)
Passive Monitoring of Physiological Data and Self-reported Symptoms to Detect Clusters of People with COVID-19 (2020) (6)
Canada's updated food guide promotes mindful eating (2019) (6)
Analysis of causal effect of APOA5 variants on premature coronary artery disease (2018) (6)
Transdermal nitroglycerin in angina pectoris. (1989) (6)
The clinical impact of platelet glycoprotein IIb/IIIa receptor blockade in cardiovascular medicine. (1998) (6)
The consumer movement in health care. (2010) (6)
Reduction in percutaneous coronary intervention-related bleeding with bivalirudin is particularly striking in women (2002) (6)
Five‐Year Follow‐up of Hancock Pericardial Valves: Management of Premature Failure (1988) (6)
701-6 Dissociation Between Minimal Luminal Diameter and Clinical Outcome at 6 Month Follow-up in Randomized Trials of Percutaneous Revascularization (1995) (6)
Exercise capacity in patients 3 days after acute, uncomplicated myocardial infarction. (1989) (6)
Patient Data Ownership-Reply. (2018) (6)
Progress culminating from ten years of clinical trials on thrombolysis for acute myocardial infarction. GUSTO-I Steering Committee. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. (1995) (6)
Current Status of Nitroglycerin Ointment in Angina Pectoris: a New Look At an Old Drug (1977) (6)
Overview of the Glycoprotein IIb/IIIa Inhibitor Interventional Trials (1999) (6)
Canada strengthens pandemic plan in wake of SARS (2004) (6)
Conflict-of-interest policies. (2001) (6)
Failure of antiplatelet agents to reduce restenosis after ptca in a double blind placebo controlled trial (1988) (6)
Effects of cardiac glycosides on atrial contractile dysfunction after short-term atrial fibrillation. (2000) (6)
Intracoronary myocardial contrast echocardiography in a patient with drug refractory hypertrophic obstructive cardiomyopathy revealing extensive myocardium at risk for infarction with alcohol septal ablation. (2004) (6)
Platelet glycoprotein IIb/IIIa inhibition during percutaneous coronary revascularization: what more needs to be proven? (2000) (6)
Drafter and draftees (1998) (6)
Integration of anticoagulation, thrombolysis and coronary angioplasty for unstable angina pectoris. (1991) (6)
Nitrates, package inserts, and the Food and Drug Administration. A clinical paradox. (1981) (6)
Introduction to the Special Issue on Theory in Nonverbal Communication (2019) (6)
An ensemble method for gene discovery based on DNA microarray data (2004) (6)
Cardiology and emergency medicine: united we stand, divided we fall. (2002) (6)
Towards a tricorder for diagnosing paediatric conditions (2019) (6)
Atherosclerosis and coronary artery disease: Volume 1 and Volume 2. (1996) (6)
Rotablator to the rescue. (1993) (6)
Late diverging event curves for survival following IIb/IIIa antagonism in patients with unstable angina: PARAGON study 1-year follow-up (1998) (6)
Federal inmates treated for hep C drop 29% (2015) (6)
Ambulatory electrocardiographic monitoring at high altitude (1992) (6)
Atlas of atherothrombosis (2006) (6)
Association of pre-intervention activated clotting times (ACT) and clinical outcomes following percutaneous coronary revascularization: Results from the IMPACT-II trial (1996) (6)
Brachial approach to emergency cardiac catheterization during thrombolytic therapy for acute myocardial infarction. TAMI Study Group. (1990) (6)
Characteristics of the modern-day physician house call (2019) (6)
Secrecy on cost of publicly funded hep C treatment (2017) (6)
Implantable devices in the coronary artery from metal to genes. (1991) (6)
The Intellectual Roots of Health Psychology (2011) (6)
The deadly effects of violence against medical workers in war zones (2011) (6)
Genome scanning and cardiovascular disease (2008) (6)
Puerperal symphysis fundus distance: normal values (2010) (6)
The arterial inflammation hypothesis. (2002) (6)
Thrombolytic therapy for patients with prior percutaneous transluminal coronary angioplasty and subsequent acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries. (1996) (6)
Computer-assisted reporting system for the follow-up of patients with prosthetic heart valves. (1978) (6)
What's lurking in your electrocardiogram? (2021) (5)
Canada moves to protect babies from chemical (2008) (5)
Can Canada reckon with its health costs? (2012) (5)
Canada proposes new legal hurdles for supervised injection (2013) (5)
Richard Reznick: leading innovator of surgical education (2011) (5)
CMAJ editors dismissed amid calls for more editorial freedom (2006) (5)
Many refugees still denied care despite ruling (2015) (5)
Ontario issues final SARS Commission report (2007) (5)
The pocketbook impact of electronic health records: Part 1 (2010) (5)
Digital health technologies and health-care privatisation (2019) (5)
Canadian researchers respond to CMAJ crisis (2006) (5)
Patient data in the cloud (2019) (5)
United States to compel physicians to make “meaningful use” of electronic health records (2010) (5)
Experts call for health infoway “watchdog” (2011) (5)
For Precarious Populations, Pollutants Present New Perils (2003) (5)
Federal policies fuel spread of swine flu, experts say (2009) (5)
Evaluation of the Patient with Heart Disease: Integrating the Physical Exam and Echocardiography (2002) (5)
Successful treatment of a monoamine oxidase inhibitor-tyramine hypertensive emergency with intravenous labetalol. (1985) (5)
The aortic valve by Mano Thubrikar Crc Press, Inc., Boca Raton (1990) 221 pages, illustrated, $97.50 ISBN: 0–8493–4771–8 (1991) (5)
Time course of the interaction between tadalafil and nitrates. (2004) (5)
Reporting of coronary risk factors. (1995) (5)
Digoxin-like immunoreactivity. (1988) (5)
Lifetime Biopsychosocial Trajectories of the Terman Gifted Children: Health, Well‐Being, and Longevity (2014) (5)
Use of control steady-state serum digoxin levels for predicting serum digoxin concentration after quinidine administration. (1982) (5)
Measuring the Cost–Effectiveness of Midwife-Led versus Physician-Led Intrapartum Teams in Developing Countries (2015) (5)
A Scoping Review of Adolescent Health Indicators (2021) (5)
Comparative effectiveness of budesonide inhalation suspension and montelukast in children with mild asthma in Korea (2020) (5)
Mometasone furoate vs fluticasone propionate with salmeterol: multivariate analysis of resource use and asthma-related charges (2009) (5)
Resource use and costs in high-risk symptomatic peripheral artery disease patients with diabetes and prior acute coronary syndrome: a retrospective analysis (2016) (5)
Clinical performance of Bjork-Shiley mechanical heart valves: a perspective on outlet strut fractures in the 60 degrees and 70 degrees convexo-concave disc models. (1988) (5)
Antithrombotic and thrombolytic therapy in patients undergoing coronary artery interventions: a review. (1995) (5)
Amelioration of microvascular angina with arginine supplementation. (2003) (5)
Plasma concentration of lamifiban and glycoprotein IIb-IIIa receptor occupancy best predict clinical outcome in patients with unstable angina: results from PARAGON A (1998) (5)
Thrombocytopenia in a large, international trial of the GP IIb/IIIa inhibitor eptitibatide in patients with acute coronary syndromes (1998) (5)
Angioplasty versus thrombolytics for patients presenting with congestive heart failure; GUSTO IIb substudy findings (1998) (5)
Complementarity of stenting and abciximab for percutaneous coronary intervention (1998) (5)
Abrupt closure: the CAVEAT I experience. Coronary Angioplasty Versus Excisional Atherectomy Trial. (1995) (5)
Coronary stenting for abrupt closure vs elective stenting for refractory restenosis: Clinical and quantitative angiographic outcomes (1991) (5)
Glycoprotein IIb-IIIa inhibition with abciximab and postprocedural risk assessment: lessons from the evaluation of platelet IIb/IIIa inhibitor for stenting trial and implication for ad hoc use of glycoprotein IIb-IIIa antagonists. (2002) (5)
Recurrent Ischemia After Thrombolysis: Importance of Associated Clinical Findings fn1fn1This study was supported by grants from Bayer, New York, New York; CIBA-Corning, Medfield, Massachusetts; Genentech, South San Francisco, California; ICI Pharmaceuticals, Wilmington, Delaware; and Sanofi Pharmace (1998) (5)
Economic evaluation of clopidogrel plus aspirin for secondary prevention of cardiovascular events in Canada for patients with established cardiovascular disease: Results from the CHARISMA trial. (2011) (5)
Relation between previous lipid-lowering therapy and infarct size (creatine kinase-MB level) in patients presenting with acute myocardial infarction. (2008) (5)
Primary percutaneous coronary intervention vs. fibrinolytic therapy for acute ST-elevation myocardial infarction in the elderly. (2006) (5)
Low Molecular Weight Heparin in Prevention of Restenosis After Angioplasty (2005) (5)
Use of tissue plasminogen activator in the emergency department for acute myocardial infarction. (1987) (5)
A contemporary assessment of low-molecular-weight heparin for the treatment of acute coronary syndromes: factoring in new trials and meta-analysis data. (2005) (5)
Identification of atherosclerosis-modifying genes: pathogenic insights and therapeutic potential (2006) (5)
28th Bethesda Conference. Task Force 5: Assessment, approval, and regulation of new technology. (1997) (5)
Timing and correlates of very early major adverse clinical events following percutaneous coronary intervention. (2008) (5)
Practice guidelines and physician scorecards: grading the graders. (1996) (5)
Three year clinical outcomes in a nationwide, observational, siteless clinical trial of atrial fibrillation screening—mHealth Screening to Prevent Strokes (mSToPS) (2021) (5)
The Challenge for Stem Cell Therapy (2007) (5)
1018-46 Influence of Randomized Trials on Clinical Practice: A Comparison of Directional Atherectomy and New Device Use Before and After the CAVEAT Trial at CAVEAT Sites (1995) (5)
Risk Factors for In-hospital Nonhemorrhagic Stroke in Patients With Acute Myocardial Infarction Treated With Thrombolysis: Results from GUSTO-I : Results From Gusto-I (1998) (5)
A highly significant 40% reduction in ischemic complications of percutaneous coronary intervention in 1995: Beginning of a new era? (1996) (5)
Your digital nutritionist (2019) (5)
Should Older Patients with Acute Myocardial Infarction Receive Thrombolytic Therapy? (1992) (5)
Thrombin Generation, Inhibition and Clinical Outcomes in Patients With Acute Myocardial Infarction Treated With Thrombolytic Therapy and Heparin: Results From the GUSTO-I Trial fn1fn1This study was supported by Genentech, Inc., South San Francisco, California; Bayer Corporation, New York, New York; (1998) (5)
Implications for Patient Selection (2005) (5)
Acute coronary intervention (1988) (5)
Dramatic increase in 30-day mortality in diabetic patients with non-ST segment elevation acute coronary syndromes (2002) (5)
Future directions in thrombolysis for myocardial infarction: what are the unanswered questions? (1994) (5)
Association of race with complications and prognosis following acute coronary syndromes. (2004) (5)
Cardiac rehabilitation in the digital era (2021) (5)
Atheromatous showers, periprocedural myocardial infarction, and fatality. (2003) (5)
Hierarchy of risk based on history and location of prior myocardial infarction in the thrombolytic era. GUSTO-I Investigators. (2000) (5)
Genomic integrity of human induced pluripotent stem cells across nine studies in the NHLBI NextGen program (2020) (5)
Analysis of the occurrence and clinical significance of thrombocytopenis with c7E3 (abciximab) in the EPIC trial (1996) (5)
The TARGET trial: hit or miss? (2002) (5)
Acute myocardial infarction: treatment with thrombolytic therapy. (1989) (5)
Patients on lipid-lowering therapy at the time of a myocardial infarction have smaller infarcts: further evidence to suggest a salutary effect in acute coronary syndromes (2002) (5)
Foundation models for generalist medical artificial intelligence (2023) (5)
PEPFAR at 15 years (2018) (4)
Characterization of myocardial infarction as an end point in two large trials of acute coronary syndromes. (2005) (4)
790-4 The Prognostic Importance of Anterior ST-Segment Depression in Inferior Myocardial Infarctions: Results in 16,185 Patients (1995) (4)
Relation Between Late Patency of the Infarct-Related Artery, Left Ventricular Function, and Clinical Outcomes After Primary Percutaneous Intervention for Acute Myocardial Infarction (CADILLAC Trial) (2004) (4)
Audit concludes Infoway missed program targets (2011) (4)
Uganda registers successes with child-health volunteers (2009) (4)
Coronary angioplasty of a posterolateral branch with severe proximal vessel tortuosity. (1997) (4)
Potential for a new coronary thrombolytic plateau (2004) (4)
Antioxidant vitamins for prevention of cardiovascular disease (2003) (4)
1017-68 Influence of Platelet GP IIb/IIIa Receptor Inhibition with c7E3 on the Sequelae of Dissection During Percutaneous Coronary Revascularization (1995) (4)
Infant mortality is falling in Russia, latest figures suggest (2003) (4)
Percutaneous transluminal angioplasty of stenotic saphenous vein right coronary bypass grafts utilizing a peripheral balloon dilatation catheter without a guiding catheter. (1989) (4)
THE GENETICS OF HEART ATTACK Eric J Topol (2006) (4)
Indonesia: The tobacco industry’s “Disneyland” (2013) (4)
The Proportion of SARS-CoV-2 Infections That Are Asymptomatic (2021) (4)
An Investment Case to Guarantee the Rights of Adolescents. (2019) (4)
The Physiologic Response to COVID-19 Vaccination (2021) (4)
If I were a rich man. (2002) (4)
Industry-led committee urges delay in closing loophole allowing import of unapproved antibiotics for animals (2009) (4)
Accelerated, combined, and adjunctive thrombolytic strategies for acute myocardial infarction (1990) (4)
From Dissecting Cadavers to Dissecting Genomes (2013) (4)
Animation Stimuli System for Research on Instructor Gestures in Education (2017) (4)
Readiness for mammography and artificial intelligence (2021) (4)
Gamma Globulin in Serum (1958) (4)
Eric Jeffrey Topol: a conversation with the editor. (1996) (4)
Local control over Aboriginal health care improves outcome, study indicates (2009) (4)
The Abciximab ST-Recovery on AMI (ASTRONAMI) GUSTO V substudy: enhanced early speed, stability, and quality of reperfusion with anti-pletelet augmented thrombolytic therapy for ST-elevation AMI (2002) (4)
An outpatient “evolution” in orthopedic surgery (2017) (4)
Percutaneous atherectomy catheters. (1988) (4)
Cardiogenic shock: 'going to the mat'--is it needed and does it work? (1997) (4)
Russia Can Save Kyoto, If It Can Do the Math (2002) (4)
The Short- and Long-Term Outcome of Left Internal Mammary Artery Angioplasty (1997) (4)
Integrating prison health care into public health care: the global view (2013) (4)
Classification and regression trees (CART) models to delineate use of angiography and revascularization after thrombolysis for acute myocardial infarction (1996) (4)
Contemporary clinical trials of restenosis. (1994) (4)
Clinicopathological correlations in patients who received an isolated model 104 Beall mitral valve. (1980) (4)
Randomized, placebo-controlled study of Lamifiban with thrombolytic therapy for the treatment of acute myocardial infarction: Rationale and design for the Platelet Aggregation Receptor Antagonist Dose Investigation and Reperfusion Gain in Myocardial Infarction (PARADIGM) study (1995) (4)
Digital Medicine and the Scripps Translational Science Institute (2011) (4)
The Modification of Word Meaning by Nonverbal Cues (1982) (4)
Haunted by Red October (2003) (4)
Paths to Longevity in the Highly Intelligent Terman Cohort (2003) (4)
The pocketbook impact of electronic health records: Part 2 (2010) (4)
Theophylline produces an adverse effect on myocardial lactate metabolism at a therapeutic serum concentration: an effect blocked by verapamil. (1991) (4)
Minority health care remains a problem for Canada's leaders (2005) (4)
Optimal treatment and current situation in reperfusion after thrombolysis for acute myocardial infarction (2002) (4)
TARGET: Do Tirofiban And ReoPro Give Similar Efficacy Trial? (2000) (4)
Intravenous glycoprotein IIb/IIIa inhibition in non-ST segment elevation acute coronary syndromes. (2001) (4)
Anticoagulation with prosthetic cardiac valves. (2003) (4)
Facility attacks in Syria contravene Geneva Convention (2016) (4)
Thrombolytic therapy for acute myocardial infarction. (1989) (4)
Denver votes to decriminalise psilocybin mushrooms (2019) (4)
Another step toward resolving the contrast controversy. (1996) (4)
Clinical outcome of “high-risk” vs “elective” patients undergoing percutaneous coronary intervention: Results from IMPACT-II (1996) (4)
Personality and Differences in Health and Longevity (2013) (4)
Not all that glitters: mercury poisoning in Colombia (2012) (4)
“Under severe duress”: health care in Iraq (2016) (4)
Planned versus provisional use of glycoprotein IIb/IIIa inhibitors in smokers undergoing percutaneous coronary intervention. (2006) (4)
Comparative effectiveness research stalls in the USA (2010) (4)
Demonstration of a relation between urinary digoxin-like immunoreactive substance and cardiac performance. (1993) (4)
Discordance in results of right coronary intervention. (1991) (4)
What next for MDGs? (2012) (4)
The cult of St Thomas Becket in the Plantagenet world, c.1170-c.1220 (2016) (4)
Russia underestimates HIV/AIDS incidence (2005) (4)
Strategies for administration of tissue plasminogen activator. (1991) (4)
Total Proteins in Cerebrospinal Fluid (Colorimetric) (1965) (4)
Is there sex bias in the management of coronary artery disease? (1992) (4)
35th Bethesda Conference. Cardiology's Workforce Crisis: a pragmatic approach. Bethesda, Maryland, 17-18 October 2003. (2004) (4)
Effects of self-esteem and expected duration of interaction on liking for a highly rewarding partner. (1976) (4)
Reinventing the eye exam (2019) (4)
Does late reperfusion therapy for myocardial infarction improve left ventricular function? preliminary results of the TAMI-6 randomized, controlled trial (1991) (3)
THROMBOLYTIC THERAPY FOR ACUTE MYOCARDIAL INFARCTION : GUSTO CRITICIZED. AUTHORS REPLY (1994) (3)
984-30 Use of Electroporated Platelets as a Novel Drug Delivery System in Preventing Complications of Coronary Angioplasty (1995) (3)
Cocaine use is associated with a number of life-threatening cardiovascular complications that require careful treatment (2010) (3)
Heparin as an adjuvant to thrombolytic therapy in acute myocardial infarction. (1996) (3)
CIHR modifies virtual peer review amidst complaints (2015) (3)
Elevated Baseline CRP Levels Predict Death or MI in Diabetic Patients Undergoing Percutaneous Coronary Intervention (2001) (3)
901-7 The Survival Advantage of Early Grade 3 Patency After Thrombolysis for Infarction Increases Over Time (1995) (3)
Hirudin Significantly Reduces Ischemic Events Following Coronary Intervention for Acute Coronary Syndromes (2000) (3)
Hormones and the cardiologist (1998) (3)
Health in Colombia: treating the displaced (2012) (3)
Termination of the CRESCENDO trial – Authors' reply (2010) (3)
Canadian hospitals call for restrictions on single-use devices (2004) (3)
Lateral flow test engineering and lessons learned from COVID-19 (2023) (3)
The fourth heart sound—A normal finding? (1975) (3)
Healthy Life‐Style Across the Life‐Span: The Heck with the Surgeon General! (2009) (3)
Court halts closure of Canada's safe-injection site (2008) (3)
When genomics goes digital (2018) (3)
Early hospital discharge in the myocardial reperfusion era. (1989) (3)
The paradoxical benefit of sulfonylurea agents in diabetics undergoing coronary revascularization. (1998) (3)
Time to evaluate why high-volume hospitals have better surgical outcomes (2005) (3)
From second to hundredth opinion in medicine: A global consultation platform for physicians (2018) (3)
The Role of Tissue Plasminogen Activator in Myocardial Infarction (1987) (3)
Canadian soldiers and doctors face torture allegations (2007) (3)
Alarm grows over management of antibiotic resistance file (2010) (3)
Hundreds of scientists sign letter arguing that regulation is stifling cannabis research. (2021) (3)
Combining IIb/IIIa Inhibition and Heparin for Acute Coronary Syndromes: Evidence of a Gradient for Bleeding Hazard from the PARAGON Randomized Factorially Designed Trial (1997) (3)
More than meets the AI: refining image acquisition and resolution (2020) (3)
Russia hunts for funds for ailing health service (2003) (3)
The extinction of an e-health strategy (2012) (3)
Thrombolytic or Angioplasty Therapy of Evolving Myocardial Infarction? (1998) (3)
Overview of the Glycoprotein IIb/IIIa Interventional Trials (2003) (3)
Second thoughts semantic ambiguity, the “non-” nosology and myocardial infarction (1994) (3)
New insights into the management of myocardial ischemia. Overview. (1990) (3)
An overview of the thrombolysis and angioplasty in acute myocardial infarction (TAMI) trials. (1988) (3)
Mortality reduction with accelerated tissue plasminogen activator is explained by early coronary patency (1993) (3)
King John and Religion (2015) (3)
935-34 Special Considerations for Diabetics Receiving Platelet IIb/IIIa Antagonists During Coronary Interventions: Results from the EPIC Trialart (1995) (3)
Association of Worsening Renal Function with Length of Stay and Costs in Patients Hospitalized with Acute Heart Failure (2014) (3)
Author Response to Comment on “Characterization of Circulating Endothelial Cells in Acute Myocardial Infarction” (2012) (3)
On the Effectiveness of Deep Representation Learning: The Atrial Fibrillation Case (2019) (3)
Recombinant tissue plasminogen activator: implications in therapy. (1989) (3)
Crown versus Church after Becket: King John, St Thomas and the Interdict (2016) (3)
Monday, 27 August 2012 (2012) (3)
Response to Polygenic Risk: Results of the MyGeneRank Mobile Application-Based Coronary Artery Disease Study (2021) (3)
Is there a genetic basis for acute coronary syndrome? (2007) (3)
Gaining insights in coronary disease genomics. (2008) (3)
Northwest Territories leads Canada in electronic medical record coverage (2017) (3)
Perioperative creatine kinase elevation is a strong predictor of early and late mortality after coronary bypass grafting (2002) (3)
Comparison of long-term survival following non-Q-wave creatine kinase elevation after percutaneous coronary intervention in patients discharged on a beta blocker versus those not so treated. (2002) (3)
ACCF COMPLEMENTARY MEDICINE EXPERT CONSENSUS DOCUMENT (2018) (3)
Mobile-izing healthcare. Wireless technologies will continue to revolutionize the industry. (2011) (3)
Influence of a Randomized Clinical Trial on Practice by Participating Investigators: Lessons From the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT) fn1fn1To discuss this article on-line, visit the ACC Home Page at www.acc.org/membersand click on the JACC Forum (1998) (3)
No can-do? (2006) (3)
Abrupt closure following directional coronary atherectomy: Clinical, anglographic and procedural outcome (1991) (3)
UN summit urges more accountability within food and beverage industry (2011) (3)
Online ratings for doctors are flawed, but “not going anywhere” (2018) (3)
A critical analytic literature review of virtue ethics for social work : beyond codified conduct towards virtuous social work (2011) (3)
Nothing cutting edge about Canadian ehealth strategy, critics say (2012) (3)
Surgical cover for angioplasty (1994) (3)
Minatom: the Grab for Trash (2002) (3)
The redlining of harm reduction programs (2012) (3)
A model course in social psychology and health. (1982) (3)
Variations in Sampling Cam Specifications for Continuous-Flow Automated Systems (1970) (3)
Epicardial versus microcirculatory dissociation. (2002) (3)
Pretreatment with ticlopidine reduces non-Q-wave myocardial infarctions following intracoronary stenting (1998) (3)
No beneficial effect of 24-48 hours abciximab infusion in aspirin and heparin treated acute coronary syndrome patients with elevated troponin without early revascularisation procedures A GUSTO-IV ACS Substudy (2001) (3)
Warfarin alone or with aspirin was superior to aspirin alone after acute myocardial infarction but increased bleeding (2003) (3)
Computer vision's potential to improve health care (2020) (3)
Consensus mounts for national drug formulary (2016) (3)
Amplification of clinical benefit at six months with the glycoprotein IIb/IIIa inhibitor lamifiban in patients with non ST segment elevation in acute coronary syndromes (1997) (3)
Persistent repetitive supraventricular tachycardia. (1977) (3)
The Last Word on GUSTO, for Now (1994) (3)
E-health progress still poor $2 billion and 14 years later (2015) (3)
Contributions of Personality to Health Psychology (2011) (3)
Effect of Myocardial Ischemia on Cardiac Troponin I and T (2002) (3)
From mRNA sensing to vaccines (2021) (3)
Figure Correction: How Consumers and Physicians View New Medical Technology: Comparative Survey (2015) (3)
[Heart failure due to a postlaminectomy arteriovenous fistula]. (1995) (3)
Left ventricular function assessment and acute myocardial infarction (1992) (3)
The role of bivalirudin in percutaneous coronary intervention. (2000) (3)
Thrombolytic therapy for myocardial infarction. (1998) (3)
Myocardial Release of Lactate , Inosine and Hypoxanthine During Atrial Pacing and Exercise-Induced Angina (3)
Growing use of integrated e-health systems (2017) (3)
Comment on “The Predictive Capacity of Personal Genome Sequencing” (2012) (3)
Comparison of stroke rates in patients with acute coronary syndromes and patients with acute myocardial infarction (1998) (3)
THROMBOLYTIC THERAPY FOR ACUTE MYOCARDIAL INFARCTION : GUSTO CRITICIZED. AUTHORS REPLY (1994) (3)
Electronic health records: an asset or a whole lot of hype? (2010) (3)
Cost avoidance through early discharge of the uncomplicated acute myocardial infarction patient (1996) (3)
Personality and Longevity: Paradoxes (1999) (3)
Carotid-artery stenting versus endarterectomy. (2005) (3)
Regulation of genetic tests unnecessary, government says (2010) (3)
Trials in myocardial infarction. (1997) (3)
Economics and quality of care for patients with acute coronary syndromes: The impending crisis (2002) (3)
Medical appropriateness of coronary angiograms. (1991) (3)
Albertans to gain electronic access to personal health files (2010) (3)
Inappropriate Therapy From a Defibrillator Complicating Transcoronary Ablation of Septal Hypertrophy in a Patient with Hypertrophic Obstructive Cardiomyopathy (2004) (3)
Relation of temporal creatine kinase-MB release and outcome after thrombolytic therapy for acute myocardial infarction∗∗A complete list of the TAMI Study Group appears in J Am Coll Cardiol 1992;19:482–489. (2000) (3)
Therapeutic options in coronary artery disease: focusing on the guidelines. (2009) (3)
Pharm-econogenomics: a new appraisal. (2013) (3)
Symptoms of patients with silent ischemia as detected by thallium stress testing. (1994) (3)
Nitrate tolerance: Past, present, and future - Discussion sessions (1998) (3)
Aminophylline for angina pectoris. Boon or bust? (1990) (3)
Does the presence or absence of chest pain at initiation of thrombolysis in acute myocardial infarction affect outcome (1996) (3)
Lack of impact of early catheterization and fibrin specificity on bleeding complications after thrombolytic therapy: Results of a randomized trial (1990) (2)
Cyclooxygenase-2 : where are we in 2003 ? Cardiovascular risk and COX-2 inhibitors (2015) (2)
Potentially adverse effects of sublingual nitroglycerin during consumption of alcohol (1990) (2)
Nitrates and nitrate tolerance in congestive heart failure. (1993) (2)
Early Structural Deterioration of a Sutureless Bioprosthetic Aortic Valve (2020) (2)
Introduction: First North American nitroglycerin symposium (1983) (2)
Working group 1: How to increase the output of cardiologists. (2004) (2)
Abrupt vessel closure after directional coronary atherectomy. The U.S. Directional Atherectomy Investigator Group. (1992) (2)
Healthcare resource utilization following ECG sensor patch screening for atrial fibrillation (2020) (2)
Application of a continuous regression model of restenosis to saphenous vein grafts after successful percutaneous transluminal coronary angioplasty or directional coronary atherectomy. (2000) (2)
New nitroglycerin formulations: transdermal and transmucosal nitroglycerin. (1985) (2)
Benefit of Facilitated PCI in High Risk ST Elevation MI Patients Presenting to Non-PCI Hospitals (2008) (2)
Thrombolysis: go with the flow. (1991) (2)
Use of radiographic devices by cardiologists. American College of Cardiology Cardiac Catheterization Committee. (1995) (2)
Effectiveness of right heart catheterization: time for a randomized trial. (1997) (2)
How should intravenous thrombolytic agents for acute myocardial infarction be selected? (1990) (2)
A comparison of clinical and quantitative angiographic outcomes of coronary stenting in elective and emergency settings: A single center experience (1991) (2)
Abstract 3071: Meta-Analysis of High-Dose Single-Bolus Tirofiban versus Abciximab in Patients Undergoing Percutaneous Coronary Interventions (2006) (2)
Defining social psychology. (1977) (2)
Better results with HIV clubs in South Africa (2015) (2)
Association of height with outcomes in patients with acute myocardial infarction receiving reperfusion therapy. (2005) (2)
Atherectomy or angioplasty for coronary artery disease (1994) (2)
Abstract 13757: A Nationwide Trial of Screening for Undiagnosed Atrial Fibrillation in an At-Risk Population Using a Self-Applied ECG Recording Patch Sensor: Results of the Randomized Component of the mHealth Screening to Prevent Strokes (mSToPS) Trial (2017) (2)
Unresolved issues: late reperfusion, lytic failure, and reocclusion (1990) (2)
Curricula reform needed to develop more tech-savvy physicians (2011) (2)
Seeing is Belizing (2011) (2)
Readings in personality : classic theories and modern research (2001) (2)
Turmoil Threatens to Sink Canadian Journal (2006) (2)
Comparison of immediate and long term outcome of patients having emergent or deferred coronary bypass surgery following intravenous thrombolytic therapy for acute myocardial infarction (1991) (2)
Models of Physical Health and Personality (2020) (2)
National wait time standards remain elusive (2005) (2)
National electronic health information strategy needs to be refocused, critics say (2011) (2)
Safety of adjunctive glycoprotein IIb/IIIa blockade during rescue/early percutaneous coronary intervention following full-dose fibrinolytic therapy for acute myocardial infarction (2003) (2)
Hepatitis C-infected organ transplants offer hope (2018) (2)
Analytics-driven health care growing in Ontario (2014) (2)
Tobacco control measures under industry assault (2011) (2)
A new paradigm for health research funding (2014) (2)
Global Fund approves grants to fight HIV/AIDS in Russia (2003) (2)
Infoway calls for e-prescribing proposals (2016) (2)
Setting the Forest Alight (2007) (2)
Nigeria’s polio endgame impeded by Boko Haram (2017) (2)
Crown, cathedral and conflict: King John and Canterbury (2011) (2)
Canada's G8 health plan receives praise and criticism (2010) (2)
Digitising the prediction and management of sepsis (2022) (2)
908-108 Outcome of Patients with Acute Myocardial Infarction and Bundle Branch Block in the Thrombolytic Era: Observations from GUSTO (1995) (2)
Ontario health records proposal would breach privacy, experts say (2011) (2)
Ultimate Price (2020) (2)
Federal Wi-Fi safety report is deeply flawed, say experts (2014) (2)
Prestigious Plant Institute in Jeopardy (2003) (2)
Acute Coronary Syndromes, Third Edition (1998) (2)
Revolutionary health psychology versus scientific health psychology – commentary on Murray (2012) (2014) (2)
Canada to widen its newly opened retail cannabis market (2019) (2)
Using military resources to fight disease (2014) (2)
FDA chief attacks Canada's drug price controls (2003) (2)
Quebec’s new e-health records may spur change (2016) (2)
Temporary coronary “splinting” for abrupt closure post-PTCA: Initial in vivo studies (1991) (2)
LEFT VENTRICULAR RELAXATION IS ENHANCED IMMEDIATELY FOLLOWING CORONARY ARTERY BYPASS SURGERY (1986) (2)
Variations between countries in invasive cardiac procedures (1998) (2)
Optimal dosing of a glycoprotein IIb/IIIa antagonist with simplified renal-based algorithm: pharmacodynamic and clinical findings from PARAGON B (2001) (2)
The application of micro-computer technology to international agricultural research and development (1984) (2)
Population attributable fraction: its implications for genetic epidemiology and illness prevention. (2007) (2)
Prisons face hep C–treatment funding crisis (2016) (2)
Platelets in Thrombotic and Non-thrombotic Disorders: Antiplatelet therapy in cardiology (2002) (2)
CHAPTER 65 – Experimental Antiplatelet Therapy (2007) (2)
Observational versus randomized medical device testing before and after market approval--the atherectomy-versus-angioplasty controversy. (1995) (2)
Psychological Predictors of Heart Disease (2012) (2)
Progress towards the UN Commission on Life Saving Commodities recommendations after five years: a longitudinal assessment (2020) (2)
Clinical efficacy of integrilin in unstable angina is accompanied by a modest increase in hemorrhagic risk: the PURSUIT trial (1998) (2)
[Contribution of Holter monitoring in the diagnosis of a case of Prinzmetal's angina]. (1993) (2)
Comparison of Treatment Outcomes in Patients >80 Years Undergoing Transradial Versus Transfemoral Coronary Intervention (2004) (2)
The scientific error of sexist research: A case study (1980) (2)
US drug strategy runs counter to Canada’s (2013) (2)
Diabetes doubles the risk of death among patients presenting with acute coronary syndromes: insights from SYMPHONY, a large international trial (2001) (2)
Clot-selective coronary thrombolysis with low-dose synergistic combinations of single-chain urokinase-type plasminogen activator and recombinant tissue-type plasminogen activator. The Pro-Urokinase for Myocardial Infarction Study Group. (1991) (2)
Antoine de Saint-Exupéry : the life and death of The Little Prince (1993) (2)
Patients want access to digital health information (2013) (2)
Urgent need for federal investment in research on cannabis health impacts, say researchers (2018) (2)
Proceedings of the 2nd Conference on Wireless Health (2011) (2)
First human randomized trial of G-CSF stem cell mobilization to treat large acute myocardial infarction—preliminary results of a pilot study (2004) (2)
Physicians pressed to play nice (2010) (2)
Beta carotene increases all-cause mortality and cardiovascular death: A pooled analysis of randomized trials (2003) (2)
LONG-TERM PROTECTION FROM MYOCARDIAL ISCHEMIC EVENTS IN A RANDOMIZED TRIALOF BRIEF INTEGRIN BETA 3 BLOCKADE WITH PERCUTANEOUS CORONARY INTERVENTION. COMMENTARY (1997) (2)
Aboriginal groups seek representation on Pan-Canadian Public Health Network (2009) (2)
725-1 Long-term Impact of a Patent Infarct-related Artery: 1-Year Survival In the GUSTO Trial (1995) (2)
Introduction. The cult of St Thomas Becket: An historiographical pilgrimage (2016) (2)
Improved flu screening needed at airports (2009) (2)
The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Trials: A Decade of Reperfusion Strategies (1996) (2)
Annals Q&A with Dr. Eric Topol. Interview by Truman J Milling Jr. (2012) (2)
Re-analysis of whole-exome sequencing data uncovers novel diagnostic variants and improves molecular diagnostic yields for sudden death and idiopathic diseases (2019) (2)
Point of care testing for aPTT improves cost outcomes following coronary intervention (1998) (2)
Agreement Unlocks Loan for TB and AIDS Treatment in Russia (2002) (2)
Observations on the determination of serum protein-bound iodine. (1962) (2)
Russian COVID-19 vaccine in jeopardy after Ukraine invasion. (2022) (2)
Considering transparency and value for fairer drug prices (2018) (2)
On the Significance of Linkage Studies of Complex Traits: Reply to Newton-Cheh et al. (2004) (2)
Natural history and patterns of treatment change in Parkinson’s disease: A retrospective chart review (2021) (2)
A brighter future for kidney disease? (2020) (2)
The Measurement and Health Outcomes of Social Support: (582032007-001) (2006) (2)
Contemporary clinical trials of restenosis. (1994) (2)
U.N. Joins Russia's Fight to Save Western Pacific Salmon (2003) (2)
Canada Launches Massive Study of Adult Cancer Precursors (2008) (2)
A discussion with digital health pioneer Dr. Eric Topol. Interview by Paul Webster. (2013) (2)
Insufficient efforts to boost maternal health (2014) (2)
Simultaneous and completely automated methods for serum iron and iron-binding capacity determinations. (1971) (2)
Long data from the electrocardiogram (2019) (2)
Fluoroquinolone Therapy for Uncomplicated Skin and Skin Structure Infections (2005) (2)
Canada reveals needle exchange programme in prisons (2018) (2)
Experts split on adequacy of surveillance since SARS. (2013) (2)
Accountability in Canada's Muskoka Initiative questioned (2014) (2)
Higher aPTTs associated with worse outcomes after thrombolytic therapy with reduced-dose heparin: results from Assent-2 (2000) (2)
Acute intervention for myocardial infarction. (1987) (2)
Infoway to become more responsive to needs, CEO vows (2012) (2)
Different Outcome of Patients With Sustained Monomorphic Ventricular Tachycardia Requiring Cardioversion During Acute Myocardial Infarction: Analysis in the GUSTO I Study (1998) (2)
Worries grow about medically assisted dying in Canada (2022) (2)
Platelet glycoprotein IIb/IIIa antagonists are beneficial in patients with acute coronary syndromes who undergo in-hospital coronary artery bypass surgery (2003) (2)
Hirudin Reduces Death and Myocardial (Re)infarction at 6 Months: Follow-up Results of the GUSTO IIb Trial (1998) (2)
Corrigendum: Pharmacogenomics in clinical practice and drug development (2012) (2)
New platelet glycoprotein IIb/IIIa inhibitor trials in percutaneous coronary intervention. (1999) (2)
Crackdown on factory farm drug use urged (2012) (2)
Cardiovascular events and COX-2 inhibitors. Authors' reply (2001) (2)
Validation for coronary stenting: a permanent implant for interventional cardiology. (1997) (2)
Nuclear Power: No can-do? (2006) (2)
Noninvasive testing is done only in low risk patients with unstable angina and non-Q-wave Myocardial Infarction (MI): Results from GUSTO-IIa (1996) (2)
The future of antithrombotic and antiplatelet therapy for ischemic heart disease. (1998) (2)
National electronic disease surveillance: a dream delayed (2013) (2)
Treatment of acute myocardial infarction: in which patients should primary percutaneous transluminal coronary angioplasty be preferred to thrombolysis? (1996) (2)
A distinction between process and outcome of lumen renarrowing after coronary angioplasty. (1994) (2)
Usefulness of Hyperglycemia in Predicting Renal and Myocardial Injury in Patients With Diabetes Mellitus Undergoing Percutaneous Coronary Intervention (2004) (2)
Determinants of the key decision for prior CABG patients facing need for repeat revascularization: PTCA or CABG? (1996) (2)
Arthritis Medications and Cardiovascular Events—Reply (2005) (1)
Doctors renew calls for nuclear disarmament (2022) (1)
The irony of biased editors who write editorials (1993) (1)
INFLUENCE OF SMOKING ON THE ANTIPLATELET EFFECT OF CLOPIDOGREL DIFFERS ACCORDING TO DOSING STRATEGY: INSIGHTS FROM THE GRAVITAS TRIAL (2013) (1)
Administrator urges penalties for doctors who don’t use electronic medical records (2011) (1)
Nunavut government assailed over outbreak (2011) (1)
Renal insufficiency and anemia in patients undergoing percutaneous coronary interventions: A double jeopardy (2003) (1)
Case 1-1982: Atrioventricular heart block. (1982) (1)
Reforms mean 25 million Russians lose free health care (2004) (1)
1060-80 Female sex: A more important prognostic marker than treatment assignment or comorbid conditions among patients with acute myocardial infarction in the GUSTO V trial (2004) (1)
Intramuscular iron therapy. (1958) (1)
G8 Summit: sorting out the supplicants (2010) (1)
Convergence of atherosclerosis and Alzheimer's disease. Authors' reply (2004) (1)
GAMA Adolescent Health Indicator Mapping (2020) (1)
Low inflammatory activity evidenced by hsCRP predicts a benefit from clopidogrel treatment in patients with high risk for cardiovascular events. A substudy from the CHARISMA trial (2007) (1)
Improving outcome in treatment of diabetics with ST elevation myocardial infarction: insights from the GUSTO trials (2002) (1)
1116-6 Long-term clopidogrel therapy following percutaneous coronary intervention improves clinical outcome but is not associated with increased bleeding: New insights from the CREDO trial (2004) (1)
Wherefore health psychology (2003) (1)
Morris, King John: Treachery, Tyranny and the Road to Magna Carta (Hutchinson, 2015) (2016) (1)
Canada criticised over refugee health-care restrictions (2015) (1)
Word attack : a way to better reading (1956) (1)
Risk factors and outcomes in patients with ventricular septal defects (VSD) complicating acute MI (1996) (1)
Atlas of Handheld Ultrasound (2018) (1)
Study design and the drug development process. (2014) (1)
6 month serologic response to the Pfizer-BioNTech COVID-19 vaccine among healthcare workers (2022) (1)
Abstract 1876: Development and Multi-Center Validation of a Blood-based Gene Expression Test for Diagnosis of Obstructive CAD in Non-Diabetic Patients (2009) (1)
Abstract 261: Predicting Inpatient Hospital Length of Stay for Acute Health Failure Patients (2013) (1)
Physical Examination of the Heart and Circulation (2005) (1)
CMA takes on electronic medical records (2015) (1)
Comparative Assessment of Asthma Control Outcomes Among Pediatric Asthma Patients: Learnings From Database Studies in The U.S and South Korea (2018) (1)
Indigenous leaders call for control of health care (2016) (1)
Better home care and better pay for doctors urged at CMA town hall (2011) (1)
Pivotal role of early and sustained infarct vessel patency in patients with acute myocardial infarction. (1990) (1)
Understanding drivers of domestic public expenditure on reproductive, maternal, neonatal and child health in Peru at district level: an ecological study (2018) (1)
Prospective use of platelet glycoprotein IIb/IIIa receptor blockers in the emergency department setting. (1998) (1)
Canada wins legal battle to set patent rules. (2017) (1)
New electronic health record blueprint to call for increased patient participation (2010) (1)
[Changes in coronary angiography in young patients with myocardial infarction]. (1991) (1)
Badiou and social work: a commentary on Reactivating the ‘communist hypothesis’: Alain Badiou and social work (2013) (1)
Just like old times (2003) (1)
It’s not too late (2022) (1)
Acute coronary artery occlusion likely due to thrombus occurring during coronary angiography: report of a case. (1998) (1)
Canada on Kyoto: What a Gas (2006) (1)
Courage in a climate of fear (2020) (1)
Semantic ambiguity, the "non-" nosology and myocardial infarction. (1994) (1)
Canadian infection-control experts push for health reform (2003) (1)
Acute myocardial infarction in young patients: The significance of smoking. Results from the GUSTO-1 trial (1996) (1)
Concern raised over control of cost-benefit research in United States (2010) (1)
Atlas and Manual of Cardiovascular Multidetector Computed Tomography (2005) (1)
Digitising heart transplant rejection (2022) (1)
Colectomy for Ulcerative Colitis in a Large Private Insurance Claims Database: Types of Surgical and Medical Complications Occurring within 180 Days (2006) (1)
Canada's municipalities push for health-based climate action (2021) (1)
Determinants of Left Ventricular Functional Recovery After Thrombolytic Therapy and/or Immediate Coronary Angioplasty in Acute Myocardial Infarction (1988) (1)
Canada to legalise physician-assisted dying (2015) (1)
A prospective, blinded determination of the natural history of aspirin resistance among stable cardiac patients (2002) (1)
Four powerful reasons for increasing investment in adolescents and their wellbeing (2022) (1)
BC reinstates one of seven fired PharmaNet employees (2014) (1)
Effect of uncoated stenting versus balloon angioplasty alone of long coronary (>20 mm) versus shorter narrowings on one-year event-free survival. (2003) (1)
Peer review conflicts of interest surface at CIHR (2015) (1)
Affan Hamakhan Jafar: treating trauma in northern Iraq (2009) (1)
The symptomatic status of patients one year following revascularization by either coronary surgery or angioplasty. (1987) (1)
Abstracts - posterEvidence for on adverse interaction between ACE inhibitors and aspirin following myocardial infarction: the GUSTO-I trial (1998) (1)
Go local, European review of electronic health records advises (2011) (1)
Angioplasty of isolated acute marginal coronary artery disease. (1996) (1)
Hepatitis C treatment in Guatemala: the struggle for access (2018) (1)
PRISMA AI reporting guidelines for systematic reviews and meta-analyses on AI in healthcare (2023) (1)
Ottawa erases legal basis for refugee care (2015) (1)
Health psychology at the crossroads. (1983) (1)
715-1 Predictors of Mortality in Cardiogenic Shock: The GUSTO Experience (1995) (1)
The importance of intravenous antiplatelet therapy with abciximab during percutaneous coronary intervention in diabetic patients (2001) (1)
ACCF Complementary Medicine Expert Consensus Document — Online Appendices Integrating Complementary Medicine Into Cardiovascular Medicine (2005) (1)
COMPARATIVE EFFECTIVENESS OF MOMETASONE FUROATE INHALATION POWDER VERSUS BECLOMETHASONE DIPROPIONATE HYDROFLUOROALKANE AEROSOL IN THE TREATMENT OF CONTROLLER-NAIVE PATIENTS WITH MILD, PERSISTENT ASTHMA (2009) (1)
Meta‐Analysis of the Efficacy of Pharmacotherapies and Allergen Immunotherapy for Adult Perennial Allergic Rhinitis: L25 (2019) (1)
Vascular access site complications during angioplasty with glycoprotein IIbIIIa receptor inhibition in the IMPACT II trial (1996) (1)
International experts laud Canadian child and maternal health plan (2010) (1)
Effects of acetyl strophanthidin on duration of atrial fibrillation in the neurally-intact and blockaded dog (1988) (1)
A VALIDATED, PERIPHERAL BLOOD GENE EXPRESSION PATTERN CORRELATES WITH CORONARY ARTERIAL PLAQUE BURDEN BY QUANTITATIVE CORONARY ANGIOGRAPHY AND CORONARY ARTERY CALCIUM SCORING (2011) (1)
Pure Genius, the TV Series: Is There an ICD-10 Code for Hyperbole? (2017) (1)
The winners of the 2010 Gairdner Awards (2010) (1)
“Irresponsible” not to adopt national hepatitis plan (2016) (1)
Cardiology in the 21st century (2000) (1)
Crosby, The King’s Bishops: The Politics of Patronage in England and Normandy, 1066-1216 (Palgrave Macmillan, 2013) (2015) (1)
Erratum: Meta-analysis of dense genecentric association studies reveals common and uncommon variants associated with height ((The American Journal of Human Genetics (2010) 88 (6-18)) (2012) (1)
Tracking opioid use vital to avoiding scourge (2012) (1)
Clinical use of streptokinase and urokinase therapy for acute myocardial infarction. (1987) (1)
715-4 Thrombolytic Therapy During the “Golden Rrst Hour” in GUSTO (1995) (1)
Heparin-induced Thrombocytopenia Syndrome Complicating Percutaneous Coronary Intervention (1998) (1)
A single intracoronary bolus of basic fibroblast growth factor increases myocardial perfusion bed in a porcine model of chronic ischaemia (1996) (1)
Spectrophotometric studies of the Zimmermann reaction. (1959) (1)
Inuit research raises concerns about tuberculosis eradication (2019) (1)
Clopidogrel pretreatment reduces platelet inflammatory marker expression in patients undergoing percutaneous coronary intervention (2003) (1)
Canada's new prime minister vows to cut surgery wait lists (2004) (1)
ABSENCE OF DIRECT MYOCARDIAL DEPRESSION BY PROTAMINE (1984) (1)
Higher Aspirin Dose is Associated with Reduced Mortality and More Serious Bleeding in Patients with Recent Cerebrovascular or Coronary Ischemic Events: Insights from the BRAVO Trial (2003) (1)
Bifurcation angle is an independent predictor of outcome after crush stenting of coronary bifurcation lesions (2006) (1)
Possible survival benefit from concomitant beta but not calcium blocker therapy during reperfusion for acute infarction in man (1990) (1)
The missing elements of the noncommunicable diseases action plan (2011) (1)
Ontario’s plan for electronic health records is at risk, official says (2010) (1)
Stroke in Patients With Acute Coronary Syndromes Incidence and Outcomes in the Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) Trial Clinical Investigation and Reports (1999) (1)
Medical procedure patents worry trade agreement critics (2014) (1)
Canadian digital health data breaches: time for reform (2020) (1)
UK unveils patient-centred electronic health strategy (2012) (1)
Priority Indicators for Adolescent Health Measurement – Recommendations From the Global Action for Measurement of Adolescent Health (GAMA) Advisory Group (2022) (1)
Marked survival benefit associated with statin pretreatment prior to percutaneous coronary intervention is dependent upon the preprocedural inflammatory status (2003) (1)
Pivotal role of early and sustained infarct vessel patency in patients with acute myocardial infarction. (1990) (1)
Leaked internal report criticizes government oversight of antimicrobial resistance (2011) (1)
Racial and ethnic differences in serum cotinine levels. (1998) (1)
Toxicology. Exposure to flame retardants on the rise. (2004) (1)
CIHR’s commitment to basic science questioned (2015) (1)
Reperfusion for acute myocardial infarction: 1997 and beyond. (1997) (1)
Genetic structure of community acquired methicillin-resistant Staphylococcus aureus USA300 (2012) (1)
Autonomy needed to improve Indigenous Canadian health (2020) (1)
988-4 Hemorrhagic Stroke Associated with High aPTTs Following Thrombolytic Therapy and Heparin or Hirudin (1995) (1)
Digitising the human embryo (2022) (1)
Incidence of Exacerbations and Hospitalizations Is Reduced and Time to Exacerbations Is Prolonged with Mometasone Furoate Dry Powder Inhaler Versus Beclomethasone Dipropionate Hydrofluoroalkane Aerosol in Patients with Mild Asthma (2010) (1)
The Genomics of Cardiovascular Disease (2008) (1)
Canada’s approach to biosimilars questioned (2015) (1)
Surgical Management of Hypertrophic Cardiomyopathy (2005) (1)
Initial report of rotational ablation: the Toronto Hospital experience. (1996) (1)
Genomics of Myocardial Infarction (2010) (1)
Will Oil Spell Trouble for Western Pacific Gray Whales? (2003) (1)
Is there a role for angiotensin-converting enzyme inhibitors in the treatment of chronic myocardial ischemia? (1990) (1)
THE FUTURIST Toward a personalized, learning healthcare system. (2016) (1)
901-17 Extrinsic Coagulation Pathway Inhibition Using Inactivated Factor Vila Limits Restenosis in the Rabbit Atherosclerosis Model (1995) (1)
Erratum: Pharmacogenomics in clinical practice and drug development (Nature Biotechnology (2012) 30 (1117-1124) DOI: 10.1038/nbt.2424) (2012) (1)
Treatment of acute myocardial infarction [1] (1993) (1)
The National Burden of Asthma in Children in the U.S.: Results from a Nationally Representative Study (2017) (1)
Oversight of opioid advertising in Canada remains lax despite new federal guidance (2018) (1)
A discussion with digital health pioneer Dr. Eric Topol (2013) (1)
Timing and risk factors for enzymatic myocardial infarctions in patients undergoing percutaneous intervention: Insights from TARGET (2003) (1)
Canadian hospitals make uneven strides in utilization of electronic health records (2010) (1)
Ischemia after thrombolysis is frequent, somewhat predictable, and pre-empted by early angiography (1996) (1)
Digitising brain age (2022) (1)
Conclusion: The Achievements and Promise of Health Psychology (2011) (1)
HEALTHCARE RESOURCE UTILIZATION ASSOCIATED WITH ELECTROCARDIOGRAPH (ECG) SENSOR PATCH SCREENING FOR ATRIAL FIBRILLATION (AF): RESULTS FROM THE MHEALTH SCREENING TO PREVENT STROKES (MSTOPS) TRIAL (2019) (1)
Cost and impact of scaling up female genital mutilation prevention and care programs: Estimated resource requirements and impact on incidence and prevalence (2021) (1)
TCT-639 NR4A3 as a gene expression marker of acute atherosclerotic plaque rupture in STEMI (2013) (1)
988-2 Thrombin Activity, but not Generation, is Inhibited by Intravenous Heparin Following Thrombolysis: Results from the GUSTO Hemostasis Substudy (1995) (1)
Workshop Report: The differing relevance to social work education of secular virtue ethics; and of spirituality, faith and religion: Are these two conflicting perspectives? (2008) (1)
Prescribing of Fluticasone Propionate/Salmeterol Combinations as Initial Therapy for Patients With Asthma in a Commercially-Insured Population (2007) (1)
The Organic Nitrates: Practical Problems In Their Use (1997) (1)
Reconsidering care for frail older people (2015) (1)
Diabetes registry overdue, if not obsolete (2012) (1)
The Multicenter Registry of Acute and Elective Gianturco-Roubin Stent Placement (2005) (1)
The Late Assessment of Thrombolytic Efficacy (LATE) Trial: Impact and Implications (1994) (1)
Digitising the vision test (2021) (1)
What is the normal size of the uterus? (1970) (1)
Abstract 16271: A Peripheral Blood Gene Expression Score for Obstructive Coronary Artery Disease is Significantly Associated With Major Adverse Cardiovascular Events and Revascularizations in the PREDICT Trial (2013) (1)
Bid to Save Kamchatka's Wildlife (2002) (1)
Ischaemic Heart Disease (2001) (1)
Wait still on for antimicrobial surveillance (2010) (1)
Can Hospital Rounds With Pocket Echocardiography By Cardiologists Reduce Standard Transthoracic Echocardiography? (2014) (1)
Canadian petrochemical plants blamed for gender imbalance (2006) (1)
The inter-relationship between creatinine clearance, cardiac troponin T and outcomes in patients with acute coronary syndromes (2002) (1)
CETA: A win for Canada or European pharma? (2014) (1)
Nutrition and integrated health care to highlight Canadian plan to fight child and maternal mortality, minister says (2010) (1)
Local Gene and Cell Delivery Devices (2007) (1)
Regional variations in treatment costs and resource utilization for uncomplicated acute myocardial infarction (UMI) (1996) (1)
CIHR’s face-to-face about-face (2017) (1)
On-site cardiac catheterization facilities and the use of coronary angiography after myocardial infarction. (1994) (1)
Federal Wi-Fi panel criticized for undisclosed conflict (2013) (1)
Traditional Risk Factors for Coronary Heart Disease—Reply (2004) (1)
Value of e-prescribing questioned (2011) (1)
Auscultatory and phonocardiographic findings in autologous fascia lata valves. (1971) (1)
A Multivariate Outcomes Analysis of Mometasone Furoate versus Fluticasone Propionate Outcomes in Mild Persistent Asthmatics with Prior Asthma Medication Use (2009) (1)
Abstract 18682: Short-term Decrease in Home Blood Pressure: Implications of Waiting Few Minutes Between Measurements (2017) (1)
Indonesia: Stratified health the norm (2013) (1)
Late results of aortocoronary bypass grafts in 100 patients with stable angina pectoris. (1974) (1)
Engineering Innovation in Global Health (2012) (1)
The Accuracy of Noninvasive Stress Myocardial Imaging for Detecting Coronary Artery Disease in Clinical Practice (2010) (1)
Are an excessive number of permanent pacemakers being inserted (1980) (1)
Clinical use of streptokinase and urokinase therapy for acute myocardial infarction. (1987) (1)
US biomedical and medical research under the Trump administration (2020) (1)
Thrombolytic therapy for acute myocardial infarction in women: Evidence for a 'gender gap' (1995) (1)
Improved Adherence and Asthma Control With Mometasone Furoate Over Fluticasone Propionate Among Adolescents and Young Adults With Mild Asthma (2010) (1)
Canada behind in regulating farmyard antibiotics (2014) (1)
CIHR hikes grants to young researchers (2016) (1)
Genetics of myocardial infarction. (2004) (1)
U.N. Faces Tough Sell on Chornobyl Research (2002) (1)
Canada debates medically assisted dying law (2016) (1)
Big data’s dirty secret (2013) (1)
Collateral flow and restenosis : appreciating hydraulics and outcomes of percutaneous coronary intervention (2000) (1)
Medical training and care under the rainbow umbrella (2012) (0)
Geoffrey Norman (2009) (0)
neutrophil function The mechanism and impact of thrombospondin-4 polymorphisms on (2013) (0)
India's war on polio (2005) (0)
Bringing homeless deaths to light (2017) (0)
Top users consume half of health budget (2014) (0)
Report criticized federal drug-control policies (2013) (0)
Chair of Wi-Fi safety panel steps down (2013) (0)
Global reductions in newborn and maternal deaths remain low (2011) (0)
King John and Rouen: royal itineration, kingship, and the Norman 'capital', c. 1199-c. 1204 (2008) (0)
A PERIPHERAL BLOOD GENE EXPRESSION SCORE FOR CORONARY ARTERY DISEASE IN NON-DIABETIC PATIENTS IDENTIFIES PATIENTS AT LOW RISK FOR MAJOR CARDIOVASCULAR EVENTS AND INTERVENTIONAL PROCEDURES IN THE NEXT 12 MONTHS (2012) (0)
Russia. Prestigious plant institute in jeopardy. (2003) (0)
Canada opposes harm reduction policies for drug users (2014) (0)
Comparing physician-specific two-year patient outcomes after coronary angiography: methodologic issues and results. (1999) (0)
The Cult of St Edmund, King and Martyr, and the Medieval Kings of England (2020) (0)
Interview with Eric J. Topol, M.D. (1995) (0)
Digital medicine: Digital health care for older adults (2021) (0)
Dilate or debulk? (1994) (0)
What he should say. Healthcare leaders offer suggestions for state of the union. (2013) (0)
Muddling thru models (2011) (0)
Confidentiality concerns delay UK patient data system (2014) (0)
Xenocide@@@Petain's Crime. (1992) (0)
Canadian Climate Plan Silent on Funding (2005) (0)
A CRISPR/Cas9-based enhancement of high-throughput single-cell transcriptomics (2022) (0)
Regarding "The Swiss Heroin Trials: scientifically sound?". (2000) (0)
CIHR audits suggest concerns with reform leadership (2016) (0)
Abstract 1494: Paraoxonase 1 Activity Predicts Prevalence, Severity and Progression of Coronary Artery Disease at All Levels of High-Density Lipoprotein Cholesterol (2006) (0)
Corrections Canada opts for secrecy as it considers call to relinquish authority over health care (2013) (0)
Researchers unite in demand for funding (2017) (0)
Russia Revives Sagging Research Program (2003) (0)
Canadian Medical Association champions private medicine (2006) (0)
Activation of peroxisome proliferator-activated receptor and gamma inhibits neointimal formation in a diabetic rat carotid artery injury model (2003) (0)
Canadian Medical Association champions private medicine. Commentary (2006) (0)
Canada clamps down on access to drug safety data (2012) (0)
Radiation oncology 2.0 (2021) (0)
US data on industry payments to doctors (2014) (0)
abciximab therapy Occurrence and clinical significance of pseudothrombocytopenia during (2011) (0)
Farm-grown superbugs? (2012) (0)
Medication costs driving seniors to food banks (2017) (0)
A randomized, controlled trial in patients with acute myocardial infarction (1989) (0)
George Karpati (2009) (0)
Canadian Editors Fired in Row With Association (2006) (0)
Book review: Dynamic Programming. Applications to Agriculture and Natural Resources. (1987) (0)
Faith, power and charity (2019) (0)
Making space for King John to pray: The evidence of the Royal itinerary (2016) (0)
What Should Clinicians Do to Engage the Public About Gene Editing? (2019) (0)
EMRs for specialists: Physicians take the helm (2013) (0)
[Coronary angioplasty in myocardial infarction: present status]. (1990) (0)
CIHR critics defend face-to-face peer review (2017) (0)
Abstract 19449: Real World Blood Pressure Variability in Over 56,000 Individuals With Nearly 17 Million Measurements (2016) (0)
Paris Takes Pragmatic Line as Poll Shows Isolation Fear (2003) (0)
Diabetes in Acute Coronary Syndrome (2004) (0)
Monitoring and Visualization in Cluster (1996) (0)
Dermo!: The Real Russian Tolstoy Never Used (1997) (0)
Privatizing funding for maternal, child health (2015) (0)
A Eurasian Tiger Threatens to Maul Kyoto (2004) (0)
Making Health AI Work in the Real World: Strategies, innovations, and best practices for using AI to improve care delivery (2021) (0)
Nuclear power. Ontario to mothball two CANDU reactors. (2005) (0)
Public Misinformation and Science Communication in Times of Public Health Crises. (2022) (0)
Supporting US public health experts (2020) (0)
Alarm growing over limited access to BC pharma data. (2013) (0)
Genome-wide structural variant analysis identifies risk loci for non-Alzheimer’s dementias (2023) (0)
Author Correction: Supporting US public health experts (2020) (0)
Chinese scientists and US leadership in the life sciences (2019) (0)
Jerome Kabakyenga: prioritising rural health research in Uganda (2009) (0)
Blood, sweat and tears in biotech — the Theranos story (2018) (0)
We were warned what to expect in the pandemic, shows health-care league table (2020) (0)
Thrombolytic Therapy for Acute Myocardial Intarction (2017) (0)
Predictive value of 60-minute ST segment resolution in electrocardiogram after lytic therapy in patients with acute myocardial infarction: results from the GUSTO V-RESTART study (2002) (0)
The United States thrombolysis and angioplasty trials for acute myocardial infarction (1990) (0)
Expression of 92 KDA Gelatinase in Human Atherosclerotic Lesions Following Recent Plaque Rupture (1995) (0)
THERAPY AND PREVENTION (2005) (0)
Abstract 1681: Haploinsufficiency of MEF2A Increases Risk of Atherosclerosis In Mice (2008) (0)
Atherosclerosis / Coronary Heart Disease Short-term Cholesterol Lowering Decreases Size and Severity of Perfusion Abnormalities by Positron Emission Tomography After Dipyridamole in Patients With Coronary Artery Disease : A Potential Noninvasive Marker of Healing Coronary Endothelium (2005) (0)
Embracing the future. We need another Flexner report to shake up and restructure healthcare. (2012) (0)
One year follow up results of the FINESSE trial of facilitated PCI (2008) (0)
Lack of improvement in ST segment resolution after the combination treatment of abciximab with reteplase compared to reteplase alone for acute myocardial infarction: results from the GUSTO V-RESTART substudy (2002) (0)
Abstract 15265: Intra- and Inter-Individual Changes in Daily Resting Heart Rate Over Two Years for 92,457 Individuals (2019) (0)
We were warned what to expect in the pandemic, shows health-care league table (2020) (0)
Bioinformatics, Genomics, and Functional Genomics: Overview (2011) (0)
Myeloperoxidase is a major source of eicosanoids at sites of inflammation (2002) (0)
A Change of Heart Daniel Levy & Susan Brink (2005) (0)
New Drugs and Technologies (2014) (0)
Study Design and Statistical Issues in Pharmacogenetics Research (2008) (0)
Mechanical activation of noncoding-RNA-mediated regulation of disease-associated phenotypes in human cardiomyocytes (2019) (0)
Maintenance of Certification Programs and the Interstate Medical Licensure Compact--Reply. (2015) (0)
Angiographic and clinical outcome after implantation of the low-pressure LP™ stent: results of the CONSERVE trial (2002) (0)
ASPIRIN: THE PROTOTYPIC CARDIOPROTECTIVE AGENT DOSING Considerable progress has been made (2003) (0)
A Multicenter, Randomized Angiographic Trial (2005) (0)
804-1 Heparin Pretreatment May Confer Additional Benefit in Patients Treated with 7E3 and PTCA for Unstable Coronary Syndromes (1995) (0)
Tissue plasminogen activator therapy in the community hospital (1988) (0)
Interventional cardiology and pharmacology at the crossroads : proceedings of a symposium held immediately prior to the 67th Scientific Sessions of the American Heart Association, Dallas, Texas, November 13, 1994 (1995) (0)
Prolongation of Activated Clotting Time (ACT) With Tirofiban Versus Abciximab and Its Association to Outcome: Results From TARGET (2002) (0)
Opening the window of facilitated percutaneous coronary intervention in acute infarction: The role of combined IIb/IIIa inhibition and thrombolytic therapy (2003) (0)
A simple risk score for prediction of 30-day mortality in patients with acute coronary syndrome: insights from GUSTO IV (2002) (0)
Breaking the thrombolytic gridlock: insights from the GUSTO trial. (1993) (0)
Is computed tomographic angiography prognostic in patients with cardiac symptoms? (2008) (0)
More than meets the eye: Using AI to identify reduced heart function by electrocardiograms. (2021) (0)
From reproduction to the right to die: bioethics now (2019) (0)
TARGET follow-up study. Authors' reply (2002) (0)
833-1 Use of angiotensin-converting enzyme inhibitors after acute myocardial infarction is associated with a striking reduction in 30-day and one-year mortality: Insights from GUSTO V (2004) (0)
1043-66 Procedural predictors of creatine kinase-MB elevations in the REPLACE-2 study (2004) (0)
Traditional risk factors for coronary heart disease. Authors' replies (2004) (0)
Amiodarone in congestive heart failure. (1995) (0)
An Analysis of Determinants of Improvement: Systolic Left Ventricular Function After Reperfusion Therapy for Acute Myocardial Infarction (1993) (0)
Restenosis — narrowing in on the cause and cure (2004) (0)
The future--panel discussion. (2004) (0)
Abstract 1881: Impact of Promoter and 9p21 Single Nucleotide Polymorphisms on Peripheral Blood Cell Expression of Genes Responsive to Levels of Obstructive Coronary Disease (2009) (0)
Abstract 3805: The Use of COX-2 Inhibitors and the Risk of Myocardial Infarction in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) Trial (2006) (0)
Genetic Basis of Acute Coronary Syndromes (2004) (0)
Comparative Evaluations of tPA vs SK with Particular Reference to the GUSTO-I Trial (2001) (0)
Impact of percutaneous revascularization on clinical outcome following acute myocardial infarction — An analysis of 40,745 patients (1996) (0)
A harsh look at the medical profession R Youngson I Schott (1997) (0)
The paradox of cigarette smoking and long-term benefit after coronary interventions with platelet IIb/IIIa receptor blockade (1996) (0)
Money back guarantees for non-reproducible results? There are better solutions to the "reproducibility crisis" in research (2016) (0)
·P-18 Need an endpoint for a clinical trial? Just ask (1990) (0)
Reuse of PTCA catheters is not associated with increased in-hospital complications (1996) (0)
The eminently preventable pattern of coronary heart disease: Focus on the four conventional risk factors (2003) (0)
Elevation Myocardial Infarction Treated With Fibrinolysis Association of Mortality With Years of Education in Patients With ST-Segment (2012) (0)
KICKBOXING A CARDIOMYOPATHY: A CASE WHERE MITOCHONDRIAL SEQUENCING PROVIDES NOVEL ANSWER FOR YOUNG ATHLETE AND HER FAMILY (2018) (0)
consistent with iron hypothesis in atherosclerosis ferritin light chain as a significant marker: evidence Proteomic approach to coronary atherosclerosis shows (2012) (0)
Eric J. Topol, MD: how to manage patients with unstable angina. Interview by Richard R. Kerr and Ray W. Gifford, JR., MD. (1994) (0)
The arterial inflammation hypothesis. Authors' reply (2002) (0)
Acute myocardial infarction: early and late percutaneous transluminal coronary angioplasty (1989) (0)
Wireless Health 2010 (2010) (0)
Implementation of mobile health tools--reply. (2014) (0)
P-456: The interaction between baseline pulse pressure and Killip class in patients presenting with acute myocardial infarction: Insights from GUSTO V (2003) (0)
Publication and promotion. Drafter and draftees. (1998) (0)
Molecular genetics of atherosclerosis and acute coronary syndromes (2011) (0)
[Dilated myocardiopathies: the relationship between the degree of cardiac dysfunction and ventricular arrhythmias. A clinical follow-up]. (1993) (0)
Abstract 289: Improved Disease Modeling Reveals 9p21 Risk Allele Regulates Connexins to Induce Arrhythmic Phenotypes (2017) (0)
Metabolism: New hormone regulates glucose (2016) (0)
Stents and sensibility (2007) (0)
A Whole Blood Molecular Signature for Acute Myocardial Infarction (2017) (0)
Lack of Adverse Clopidogrel-Atorvastatin Clinical (2004) (0)
Prevention of Myopia in Children (2017) (0)
Subject Index Vol. 98, 2002 (2003) (0)
1032-116 High Marginal Costs Associated with Routine Placement of Coronary Stents (1995) (0)
Are tirofiban and abciximab identical in efficacy?: reply (2005) (0)
Usefulness of coronary artery angioplasty strategies in acute myocardial infarction. (1990) (0)
Renal insufficiency and its relation to ischemic and bleeding outcomes with tirofiban versus abciximab in the TARGET trial (2002) (0)
Invisible showers (2004) (0)
Comparison of Differences in Outcome After Percutaneous Coronary Intervention in Men Versus Women <40 Years of Age (2004) (0)
TARGET follow-up study (2002) (0)
CORONARY ARTERY VASCULAR SMOOTH MUSCLE CELLS HAVE INCREASED EXPRESSION OF IL-1. (2023) (0)
Arthritis medications and cardiovascular events. Author's reply (2005) (0)
MYOCARDIAL PERFUSION IMAGING PERFORMANCE IN THE PREDICT MULTI-CENTER TRIAL; GENDER SPECIFIC ANALYSIS AND COMPARISON WITH THE CORUS CAD GENE EXPRESSION SCORE (2010) (0)
Chapter-13 Future Directions: Role of Genetics in Drug Th erapy (2013) (0)
990-49 Inadequate Pre-Hospital Medical Therapy in Patients Undergoing Percutaneous Coronary Revascularization: Results from the CAVEAT Trial (1995) (0)
[Cardiology online: impact and pitfalls of Internet medical news]. (2012) (0)
Aggregation and Coronary Thrombosis Trial of angioplasty with versus without eptifibatide. Integrilin to Minimize Platelet Modifiable risk factors for vascular access site complications in the IMPACT II (2011) (0)
The dawn of risk factors (2005) (0)
791-2 Regional Variations in the Use of Cardiac Procedures After Thrombolysis: New England is an Outlier in the GUSTO Trial (1995) (0)
Digitising tremor (2023) (0)
Inventing the future. (2014) (0)
History of heart failure and left ventricular ejection fraction strongly predicts adverse outcomes among patients undergoing contemporary percutaneous coronary intervention: insights from TARGET (2003) (0)
Putting the lid on phosphodiesterase 4 (0)
Myocardial Infarction Treated With Thrombolysis : Results From GUSTO-I Risk Factors for In-hospital Nonhemorrhagic Stroke in Patients With Acute (1998) (0)
Abstract 288: Novel Mechanisms of Non-coding Genomic Regulation Identified in Cardiac Disease-in-a-dish Models (2016) (0)
ATVB In Focus Platelet Activation and the Formation of the Platelet Plug (2003) (0)
ACTIVITY GUIDELINES AND REFERRAL PATTERNS TO CARDIAC REHABILITATION IN A LARGE CARDIOLOGY DEPARTMENT (1994) (0)
755-6 Neurosurgical Evacuation for Intracranial Hemorrhage Associated with Improved Outcome in GUSTO (1995) (0)
Acute Myocardial Infarction, Bernard J. Gersh, Shahbudin H. Rahimtoola (Eds.), in: Current Topics in Cardiology series. Elsevier Science Publishing Company, New York (1991), 524, with illus, $84 (1991) (0)
Angioplasty in Acute Myoeardial Infarction a (1987) (0)
Waiting for GUSTO: current status of thrombolytic therapy. Medical panel discussion (1993) (0)
Does proteinuria predict mortality after percutaneous revascularization in diabetics (2000) (0)
Does the presence of electrocardiographic left ventricular hypertrophy predict one-year mortality in non-ST elevation acute coronary syndromes? (2003) (0)
CONTINUOUS 12-LEAD ST-SEGMENT RECOVERY PREDICTS OUTCOME IN ACUTE MYOCARDIAL INFARCTION BETTER THAN SNAPSHOT ANGIOGRAMS OF TIMI FLOW (1998) (0)
Abstract 3081: CHARISMA (long-term dual anti-platelet therapy): The Impact of Risk Status, Prior History, and Proximity to Recent Cardiovascular Events (2006) (0)
P-103: Can pulse pressure risk stratify female patients presenting with acute myocardial infarction? (2003) (0)
Improved outcome of acute ST-segment elevation myocardial infarction in patients with prior coronary artery bypass surgery treated with combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition (2002) (0)
Risk stratification for patients undergoing elective percutaneous coronary intervention using plasma N-terminal pro-B-type natriuretic peptide assay: a clopidogrel for reduction of events during observation (CREDO) sub-study (2004) (0)
Title Page / Contjents (2000) (0)
Long-Term Mortality of Patients With Acute Myocardial Infarction in the United States and Canada Comparison of Patients Enrolled in Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I of declining mortality (2004) (0)
Arthritis medications and cardiovascular events [2] (multiple letters) (2005) (0)
Abstract 13075: Validation of a Gene Expression Test Score Using Coronary Artery Calcium and CT-Angiography as Reference Standard for Plaque Burden and Stenosis Evaluation (2011) (0)
The personal and clinical utility of polygenic risk scores (2018) (0)
Cardiology. Attention shifts to the white clot. (1997) (0)
A symposium : anticoagulant therapy : new promises and challenges (1998) (0)
[Surgical therapy of infectious endocarditis]. (1991) (0)
Wearable sensor data and self-reported symptoms for COVID-19 detection (2020) (0)
Abstract 18562: Inter-individual Variation in Duration, Frequency and Burden of Paroxysmal Atrial Fibrillation in 13,350 Individuals Undergoing Extended Cardiac Rhythm Monitoring (2017) (0)
Hirudin in Acute Coronary Syndromes: When Cents Override Good Sense (2004) (0)
Predictors and long-term mortality of atrioventricular block after acute myocardial infarction treated with thrombolysis (2003) (0)
Higher T-Wave Amplitude Associated With Better Prognosis in Patients Receiving Thrombolytic Therapy for Acute Myocardial Infarction (a GUSTO-I Substudy) 11This study was funded by grants from Bayer, New York, New York; CIBA-Corning, Medfield, Massachusetts; Genentech, South San Francisco, California (1998) (0)
CHAPTER 57 – Genomics of Myocardial Infarction (2009) (0)
Event-free hospitalization after early and sustained patency using combination thrombolytic therapy in acute myocardial infarction (1991) (0)
Predictors of abrupt closure and consequences of emergency endpoints in the IMPACT II trial (1996) (0)
Comprar Textbook of Interventional Cardiology, 6th Edition | Eric J. Topol | 9781437723588 | Saunders (2011) (0)
Digitising the aorta to prevent dissection (2023) (0)
Coronary Angioplasty (2005) (0)
Exciting interventions in individualized medicine. An interview with Eric Topol, MD, of the Scripps Translational Science Institute by Elaine Musgrave, PhD. (2009) (0)
The high risk coronary bend site stenosis undergoing PTCA: Correlates of procedural outcome (1990) (0)
711-5 Mechanism of Benefit of Platelet lib/ilia Receptor Inhibition in High Risk Angioplasty in the EPIC Trial: A Hierarchical Endpoint Analysis (1995) (0)
End Point of Thrombolytic Therapy Comparative Trials (2005) (0)
Analysis intheTAMI7Study Performance ofa Noninvasive MethodforReal-Time Detection ofFailed Myocardial Reperfusion (2011) (0)
of ’ I Cardiologyl Possible Survival Benefit from Concomitant Beta-but Not Calcium-Antagonist Therapy During Reperfusion for Acute Myocardial Infarction (2004) (0)
[Dilated myocardiopathy: value of isotopic studies for its clinical characterization]. (1992) (0)
Therapeutic Failure or Resistance to Aspirin (2016) (0)
[The remote noninvasive assessment of left ventricular diastolic pressure by pulsed Doppler echography--the importance of the time of mitral protodiastolic deceleration]. (1993) (0)
Plasma Angiotensin-Converting Enzyme Activity and Carotid Wall Thickening (2005) (0)
REPORTS ON THERAPY A Randomized Placebo-Controlled Trial of Combined Early Intravenous Captopril and Recombinant Tissue-Type Plasminogen Activator Therapy in Acute Myocardial Infarction (2016) (0)
THE DIAGNOSTIC YIELD OF CORONARY ANGIOGRAPHY REMAINS LOW, DESPITE PRIOR MYOCARDIAL PERFUSION IMAGING TESTING, IN PATIENTS WITH SUSPECTED OBSTRUCTIVE CORONARY ARTERY DISEASE: RESULTS OF THE PREDICT (PERSONALIZED RISK EVALUATION AND DIAGNOSIS IN THE CORONARY TREE) TRIAL (2012) (0)
Platelet llb/llla blockade with integrelin: Atherectomy patients (1996) (0)
847-3 Aspirin resistance is associated with a single nucleotide polymorphism in the P2Y1ADP receptor gene (2004) (0)
Percutaneous Revascularization of Ostial Saphenous Vein (2016) (0)
ptimal Timing for the Initiation of reTreatment With 300 mg Clopidogrel efore Percutaneous Coronary Intervention (2016) (0)
Abstract 15920: A Whole Blood Gene-Expression Based Surrogate Test for Smoking Status (2011) (0)
coronary artery disease by expression profiling Identification of new genes differentially expressed in (2015) (0)
Abciximab with reduced heparin dosing during coronary intervention Final results of the EPILOG trial (1997) (0)
Prior aspirin use potentiates the effect of GP IIb/IIIa inhibition in patients with non-ST elevation acute coronary syndromes (1998) (0)
Acute phase treatment of myocardial infarction: selecting patients for thrombolysis (1998) (0)
Comprar Management of the Patient in the Coronary Care Unit | Eric J. Topol | 9780781764391 | Lippincott Williams & Wilkins (2007) (0)
Temporal and Regional Differences in Therapy for Reinfarction Following Thrombolysis: Results from GUSTO I and ASSENT II (2000) (0)
Review finds that ablative therapies do not improve clinical or angiographic outcomes compared to balloon dilation (2004) (0)
Proteinuria in diabetics is a powerful predictor of death following percutaneous coronary revascularization (1998) (0)
Thrombolytic therapy for acute myocardial infarction : evolution of the therapeutic approach : 22 August 1995, Amsterdam, The Netherlands (1996) (0)
A Comparison of Static Serial vs Continuous ST-Segment Recovery to Predict Outcome After Lytics for MI (1998) (0)
How should intravenous thrombolytic agents for acute myocardial infarction be selected (1990) (0)
Erratum: Experimental models of coronary artery restenosis (J Am Coll Cardiol (1992) 19 (418-32)) (1992) (0)
Regional Variation in Outcomes as Determined by Investigators and Clinical Events Committee in an International Trial of Eptifibatide in Non-ST Segment Elevation Acute Coronary Syndromes (1998) (0)
CORONARY STENTING AND USE OF ABCIXIMAB. AUTHORS' REPLY (1998) (0)
Intravenous Fluosol intheTreatment ofAcuteMyocardial Infarction Results oftheThrombolysis andAngioplasty inMyocardial Infarction 9Trial (1994) (0)
Clopidogrel pretreatment does not influence the relative efficacy of bivalirudin with provisional GPIIb/IIIa blockade vs heparin with routine GPIIb/IIIa blockade. A REPLACE-2 substudy (2003) (0)
Predictive Value of Associations Between Carotid and Coronary Artery Disease in Patients With Acute Coronary Syndromes (2005) (0)
Modiﬁable Risk Factors for Vascular Access Site Complications in the IMPACT II Trial of Angioplasty With Versus Without Eptiﬁbatide (2016) (0)
Thrombolytic therapy for women with acute myocardial infarction: is there a gender gap? (1995) (0)
Deciphering the genetic basis of common diseases by integrated functional annotation of common and rare variants (2010) (0)
Does Periprocedural MI During PTCA Reduce Subsequent Clinical Restenosis (1998) (0)
P3-63: Early ventricular arrhythmias and mortality among patients with acute myocardial infarction and the protective effect of renin-angiotensin-aldosterone system antagonism: Insights from gusto-V (2006) (0)
Is It Possible to Recognize a Major Scientific Discovery (2016) (0)
[The role of coronary angioplasty in the treatment of ischemic cardiopathy. 1 of 2 parts]. (1994) (0)
Abstract 6083: Sex Differences in 1-Year Mortality Following Acute Coronary Syndromes (2008) (0)
Abciximab reduces long-term mortality following percutaneous, coronary intervention (2003) (0)
Particular benefit of platelet GPIIb/IIIa blockade and full heparin in patients with peripheral vascular disease undergoing PTCA (1998) (0)
Platelet Glycoprotein IIb/IIIa Inhibitors Reduce Mortality in Diabetic Patients With Non–ST-Segment-Elevation Acute Coronary Syndromes Clinical Investigation and Reports (2001) (0)
[Percutaneous coronary angioscopy]. (1993) (0)
[Experience with the Palmaz-Schatz intracoronary stent]. (1995) (0)
Influence of Various Percutaneous Coronary Interventional Devices on Postinterventional Luminal Shape and Plaque Surface Characteristics as Determined by Intravascular Ultrasound (2003) (0)
Eric Jeffrey Topol: a conversation with the editor. (1996) (0)
Rebuttal from Daniel Beard and (2013) (0)
Coronary bypass surgery improves global and regional left ventricular function following thrombolytic therapy for acute myocardial infarction. TAMI Study Group. (1991) (0)
A down economy provides opportunity, and your opportunity is here. (2009) (0)
Increased rates of stent thrombosis among patients with acute coronary syndromes: insights from two large oral IIb/IIIa antagonist trials (2001) (0)
Failure of conservative management post-thrombolysis: Profile of the TAMI-5 crossover population (1990) (0)
Abstract 18065: Prospective Evaluation of a Genetic Risk Score for Atrial Fibrillation in Patients Undergoing Extended Cardiac Rhythm Monitoring (2016) (0)
Coronary Artery Disease and Myocardial Infarction (2013) (0)
Medical Interventions in Unstable Angina: Does International Clinical Practice Match Evidence-Based Guidelines? (1997) (0)
Usefulness of coronary artery angioplasty strategies in acute myocardial infarction. (1990) (0)
Abciximab reduces death and myocardial infarction but not target vessel revascularization in diabetics undergoing percutaneous transluminal coronary angioplasty The EPILOG experience (1997) (0)
percutaneous coronary revascularization in diabetics The importance of proteinuria as a determinant of mortality following (2011) (0)
Impact of Peri-Stent Remodeling on In-Stent Neointimal Proliferation in Acute Myocardial Infarction (2004) (0)
Analysis ofCoronary Angioplasty Practice inthe United States Withan Insurance-Claims DataBase (1993) (0)
Heparin-induced thrombocytopenia syndrome complicating coronary angioplasty (1998) (0)
Continuing Medical Education Activity in Echocardiography (2012) (0)
Valvular and Congenital Heart Disease N-acetylcysteine reduces contrast-associated nephropathy but not clinical events during long- term follow-up (2004) (0)
Antithrombotic Therapy in Patients WithSaphenous Vein andInternal Mammary Artery Bypass Grafts (2015) (0)
The beginning of the end of fingersticks? (2018) (0)
VALVUIAR HEART DISEASE (2005) (0)
In-hospital outcome is improved in women after percutaneous coronary intervention and is similar to that in men in the era of routine platelet glycoprotein IIb/IIIa inhibition and stenting (2002) (0)
Borderline Hypertension andObesity: TwoPrehypertensive States withElevated Cardiac Output (1982) (0)
Functional Chest Pain of Presumed Esophageal Origin—Reply (2002) (0)
Abstract 2868: Sex, Clinical Symptoms and Angiographic Findings at Baseline in BARI 2D (2007) (0)
Sex Differences in 1-Year Mortality Following Acute Coronary Syndromes (2008) (0)
Protected coronary angioplasty: minimizing the hazards of high risk coronary interventions. (1990) (0)
Percutaneous Coronary Intervention in the Elderly (2005) (0)
The risks of percutaneous coronary intervention in recently implanted internal thoracic bypass grafts: a case report and review of the literature. (2002) (0)
Current Perspectives Direct Thrombin Inhibitors in Cardiovascular Medicine (2005) (0)
Diagnostic Implications of Lowering Target Heart Rate in Submaximal Exercise Testing (1991) (0)
InnaTtance of Thromboeyk Phase Afte ' ~ Adminl & traflon of ° hro (2016) (0)
Can we predict which vein grafts need distal protection during percutaneous coronary intervention (2005) (0)
RELATIONSHIP BETWEEN BLEEDING AND MORTALITY IN PATIENTS ON DUAL ANTIPLATELET THERAPY VS ASPIRIN ALONE: RESULTS FROM THE CHARISMA TRIAL (2011) (0)
Heavy hands : the ultimate exercise system (1982) (0)
Randomized Trial'' Characteristics on Arterial and Venous Bypass Graft Patency: Insight From a Response to Letter Regarding Article, ''Impact of Patient and Target-Vessel (2013) (0)
Clinical results and revascularization status five years following randomization to PTCA or CABQ in bypass angioplasty revascularization investigation (BARI) (1998) (0)
Abstract 4619: Time to Significant Gradient Reduction Following Septal Balloon Occlusion Predicts the Magnitude of Final Gradient Response During Septal Ethanol Ablation in Patients With Hypertrophic Obstructive Cardiomyopathy (2009) (0)
The Changing Role of PTCA in Patients with Acute Myocardial Infarction (1988) (0)
Hypoxanthine-guanine phosphoribosyltransferase-independent toxicity of azat~hioprine in human lymphoblasts (1984) (0)
The role of intravascular ultrasound in the diagnosis and treatment of patients with coronary artery disease (2003) (0)
Contents Vol. 98, 2002 (2003) (0)
Abstract 9131: Clinical, Biochemical and Genetic Predictors of Late Coronary Artery Bypass Graft Failure (2012) (0)
Abstract 2363: Antiarrhythmic Drug Therapy for Sustained Ventricular Arrhythmias Complicating Acute Myocardial Infarction (2009) (0)
IMPACT OF RESIDUAL MYOCARDIAL JEOPARDY ON LONG-TERM OUTCOME FOLLOWING CORONARY REVASCULARIZATION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (2010) (0)
Comparative 5 year incidence of ischemic events for PTCA and CABG in the Bypass Angioplasty Revascularization Investigation (BARI) (1996) (0)
PULMONARY CLEARANCE OF CIRCULATING CATECHOLAMINES IN NORMAL MAN AND IN PATIENTS WITH PULMONARY HYPERTENSION (1979) (0)
Does the extent of ST-segment depression predict short- and long-term mortality in patients with non-ST segment elevation acute coronary syndromes? Insights from the GUSTO IV (2003) (0)
Improved in-hospital outcomes after percutaneous coronary intervention in the era of routine glycoprotein IIb/IIIa inhibition and stenting (2002) (0)
1023-93 Anti-inflammatory effects of the V-protectant AGI-1067 in the Canadian antioxidant restenosis trial (CART-1) (2004) (0)
ortic Regurgitation fter Arterial Switch Operation (2006) (0)
Clinical Research Angiographic and Echocardiographic Correlates of Suitable Septal Perforators for Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy (2014) (0)
Exercise tests and ST changes. (1978) (0)
Quantitative Angiographic and Echocardiographic Correlates for Determining Suitable Septal Perforators for Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy (2013) (0)
Carbon footprint of a PV/T liquid collector (2016) (0)
Personality and Health Outcomes (2020) (0)
Here and now--state of the art: optimal antithrombotic strategy for percutaneous coronary intervention-panel discussion. (2004) (0)
A Retrospective Analysis of Clinical Characteristics, Hospitalization, and Humanistic Outcomes in Patients With and Without Clostridium Difficile-Associated Disease in US Long Term Care Facilities (2012) (0)
Azorubin in Aqueous and Methanolic Solutions (2004) (0)
Risk factors for ischemic stroke in patients with acute myocardial infarction treated with thrombolytic therapy (1996) (0)
[Role of pharmacologic stimulation with myocardial perfusion scintigraphy in the evaluation of patients with ischemic cardiopathy]. (1992) (0)
MECHANISMS OF SPIN DELOCALIZATION, AN EXPERIMENTAL STUDY OF GAMMA AND DELTA PROTON CONTACT SHIFTS (1974) (0)
PCN143 Real-World Assessment of the Treatment Patterns Associated with Un-Resectable Advanced and Metastatic Esophageal Cancer in China (2021) (0)
A skin patch for sensing blood pressures (2018) (0)
4. A Little More Arsenic in Your Water (2020) (0)
Scientists snatch body language. (1980) (0)
Dosing regimen of reteplase and costeffectiveness (2001) (0)
Rate of Infections, Costs and Healthcare Resource Use in Patients with Undiagnosed Primary Immune Deficiency (PI) (2008) (0)
Colectomy for Ulcerative Colitis in a Large Private Insurance Claims Database: Types of Colectomy and Associated Follow-Up Surgical Procedures (2006) (0)
AI2 GEO-SPATIAL RISK ASSESSMENT OF ASTHMA HEALTH RESOURCE USE AT THE MUNICIPAL LEVEL IN THE GREATER HELSINKI METROPOLITAN AREA OF FINLAND (2019) (0)
PIN25 CHRONIC RHINOSINUSITIS TREATMENT: A COMPARISON OF MOXIFLOXACIN AND LEVOFLOXACIN TREATMENT DURATION, OUTCOMES.AND CHARGES (2005) (0)
Preclinical Investigation of Agents Used in Current Restenosis Trials Preclinical Animal Mechanism of Animal and in vitro data model injury findings Platelet receptor and mediator inhibitors GR 32191 Yes Rat Balloon injury Platelet inhibition I Intimal hyperplasia * Sulotroban No (2005) (0)
Prolonged sinoatrial pauses. (1984) (0)
Introduction to the Special Issue on Theory in Nonverbal Communication (2019) (0)
Use of Fluticasone Propionate/Salmeterol Fixed Combination as Initial Asthma Controller Therapy in Children in a Commercially Insured Population (2008) (0)
8. Can We Afford a Little One? (2020) (0)
Abstract 13342: Patient Demographics, Clinical Characteristics, Medication Utilization, Medical Resource Use and Outcomes Associated with Patients with Symptomatic Peripheral Artery Disease (2014) (0)
9. Broken Calculators (2020) (0)
PREDICTING POST-DISCHARGE MORTALITY RISK AMONG RECENTLY HOSPITALIZED MEDICARE PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION (2019) (0)
The Impact of Adherence and Disease Control on Resource Use and Charges in Mild Persistent Asthma Patients Managed on Inhaled Corticosteroid Inhaler Agents (2009) (0)
Early pre-widowhood psychosocial predictors of mortality risk after widowhood: (633962013-893) (2006) (0)
Platelet Glycoprotein IIb/IIIa Receptor Inhibition in Non–ST-Elevation Acute Coronary Syndromes Early Benefit During Medical Treatment Only, With Additional Protection During Percutaneous Coronary Intervention Brief Rapid Communication (1999) (0)
PYROLYSIS OF 1-ARSABICYCLO(2.2.2)TRIENE DERIVATIVES (1977) (0)
Variability of Quantitative Digital Subtraction Angiography Before and After ercutaneous Transluminal Coronary Angioplas (0)
PIN26 IMPACT OF HIV AND HCV CO-INFECTION ON HOSPITALIZATION AND RESOURCE USE AMONG HEMOPHILIA ENROLLEES IN COMMERCIAL HEALTH PLANS (2007) (0)
L 11 today's practice 01cardiopulmonary medicine Acute Intervention for Myocardial lnfarction* (2017) (0)
Management of non-Q-wave myocardial infarction. (1998) (0)
Conditions associated with ST-segment elevation. (2004) (0)
Samir Damani Infarction Characterization of Circulating Endothelial Cells in Acute Myocardial (2012) (0)
PCN9 A Real-World Assessment of the Treatment Patterns, Health Resource Utilization and Outcomes Associated with Esophageal Cancer in the United States (2021) (0)
Patient-Reported Factors That Influence Diphenhydramine Use In Children and Adults In An Allergy Specialty Practice (2014) (0)
Title Sex and Gender in the 1980 s Heavy Metal Scene : Groupies , Musicians , and Fans Recall Their Experiences Permalink (2014) (0)
Health and economic benefits of achieving contraceptive and maternal health targets in Small Island Developing States in the Pacific and Caribbean (2023) (0)
Is insulin resistance associated with one-year target vessel revascularization rates results from CREDO IRS? (2003) (0)
Treatment patterns, healthcare resource use, economic, and survival outcomes associated with nonresectable advanced esophageal cancers in Taiwan. (2021) (0)
PCN154 Real-World Assessment of the Treatment Patterns, Healthcare Resource Use, and Survival Outcomes Associated with Non-Resectable Advanced Esophageal Cancers in South Korea (2021) (0)
Azorubin in aqueous and methanolic solutions; spectrophotometric studies. (1956) (0)
3. Justice Is Not Blind (2020) (0)
Adjuvant and neoadjuvant treatment patterns among resectable pancreatic cancer patients in the USA. (2022) (0)
Author Correction: Long COVID: major findings, mechanisms and recommendations. (2023) (0)
5. Maximizing Profits at Whose Expense? (2020) (0)
[Role of coronary angioplasty in the treatment of ischemic cardiopathy]. (1994) (0)
100. Towards Harmonized Measurement of Adolescent Health: An Assessment of Global-level Indicator Alignment (2023) (0)
Inhibition in Complex Atherosclerotic Lesions Pronounced Benefit of Coronary Stenting and Adjunctive Platelet Glycoprotein IIb/IIIa (2013) (0)
151P Treatment patterns, healthcare resource use, economic and survival outcomes associated with unresectable advanced metastatic gastric cancers in Taiwan (2020) (0)
Real-world neo-adjuvant with or without adjuvant treatment patterns among pancreatic ductal adenocarcinoma patients in the U.S. (2021) (0)
Building Commissioning in the USA (2006) (0)
Multivariate Analyses of Mometasone Furoate versus Fixed Dose Combination of Salmeterol and Fluticasone Propionate in Mild Persistent Asthma Using an Administrative Claims Database (2009) (0)
Commentary: Personality and health inequality: inconclusive evidence for an indirect hypothesis (2008) (0)
P201 Comorbidity burden of children with asthma in the U.S. (2017) (0)
Genome-Wide Linkage Analysis of Large Multiple Multigenerational Families Identifies Novel Genetic Loci for Coronary Artery Disease (2017) (0)
7. To Be Young Again (2020) (0)
A Deep and Intimate Inquiry of Genes Siddhartha Mukherjee The Gene: An Intimate History 2016 Scribner 608 pp. $32.00 (2016) (0)
SIMILAR LENGTHS OF STAY AND HOSPITAL COSTS FOR PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA TREATED WITH INTRAVENOUS MOXIFLOXACIN, 400 MG, OR LEVOFLOXACIN, 750 MG (2008) (0)
Evidence for enrollment selection bias in trials of primary angioplasty: Comparison of GUSTO IIb and RAPPORT (1998) (0)
Self-Healing Personalities (2016) (0)
Sudden death and pacemakers. (1989) (0)
The Determinants of Foreclosures for Single-Family Homes in the United States (2021) (0)
Treatment of acute myocardial infarction. (1993) (0)
What accounts for the high cost of care? it's the people: a Q&A with Eric Topol, MD. (2020) (0)
Treatment with Immune Globulin (IG) in Primary Immune Deficiency Patients: Dose Comparison Based on the Route of Administration (2009) (0)
Computer avatars, gestures, and personal charisma: (514472015-678) (2014) (0)
Sex and Gender in the 1980s Heavy Metal Scene: Groupies, Musicians, and Fans Recall Their Experiences (2014) (0)
A Multivariate Analysis of Clinical Determinants (2015) (0)
725-5 Improved Outcome in Patients with Prior Percutaneous Transluminal Coronary Angioplasty and an Evolving Myocardial Infarction (1995) (0)
ASSOCIATION BETWEEN CARDIAC, INFLAMMATORY, RENAL, AND HEPATIC BIOMARKERS AND OUTCOMES IN PATIENTS WITH A HEART FAILURE HOSPITALIZATION (2014) (0)
Genetic Studies of Genius and the Life Cycle Follow-Ups (2015) (0)
WOMEN ARE LESS LIKELY TO RECEIVE EVIDENCE-BASED LIPID LOWERING THERAPY: INSIGHTS FROM A MANAGED CARE POPULATION (2014) (0)
1. Your Money or Your Life? (2020) (0)
Book of the Year Award Committee (2010) (0)
Abstract 284: Association of Worsening Renal Function With Mortality and Heart Failure Readmissions in Patients Hospitalized With Acute Heart Failure (2015) (0)
INTRAVENOUS IIB/IIIA'S : CURRENT EXPERIENCE IN UNSTABLE ANGINA/NON Q WAVE MI AND PTCA (1999) (0)
6. I Want to Die the Way Grandpa Did (2020) (0)
Early Intravenous Heparin in Acute Myocardial Infarction (2005) (0)
Hematologic changes occurring with cardiac catheterization. (1988) (0)
Letter to The Editor: Aspirin Resistance Publications (2006) (0)
29th Conference of the EHPS - Cyprus 2015 - Principles of Behaviour Change in Health and Illness: Abstracts of the keynote talks (2015) (0)
Abstract 246: Potential for Healthy Survivor Bias Among Symptomatic Peripheral Artery Disease Patients with Long Follow-up: Comparing 1 Year Versus 3 Year Post-Index Outcomes (2015) (0)
755-3 Improved Prognosis for Heavy Weight Patients Receiving Thrombolysis in Acute Myocardial Infarction — Bigger is Better: Results from GUSTO (1995) (0)
The Personality Reader (2007) (0)
Health Psychology Childhood Sleep Duration and Lifelong Mortality Risk (2014) (0)
Components of Healthy Aging as Predictors of Mortality Risk: (645432007-001) (2007) (0)
Community psychology: Theoretical and empirical approaches: edited by Margaret S. Gibbs, Juliana Rasic Lachenmeyer and Janet Sigal. Gardner Press, New York, 1980. 410 pp. $15.80 (1981) (0)
Study Design and Statistical Issues in Pharmacogenetics Research From Candidate Genes to Genome-Wide Screens (2008) (0)
Standard- vs High-Dose Clopidogrel After Percutaneous Coronary Intervention—Reply (2011) (0)
Adding programs and system costs: the need for accurate estimates of the true costs of sexual and reproductive health and rights service provision (2022) (0)
Transfection of HEK 293 Cells , HASMCs , and Human Umbilical Vein Endothelial Cells (2003) (0)
Impact of Kidney Disease Severity on Length of Stay, Hospital Readmissions, Mortality, and Costs Associated with Patients Hospitalized with Heart Failure (HF) (2014) (0)
2013 reports of the regional associations. (2013) (0)
Angioplasty or thrombolysis in acute myocardial infarction: dilate or dissolve? (1995) (0)
Disease-free survival (DFS) as a surrogate endpoint (SE) for overall survival (OS) in early-stage resected esophageal/gastroesophageal junction cancer (EC/GEJC): An analysis of SEER-Medicare data. (2023) (0)
Abstract 13930: Three Out of Four High-risk Patients do not Attain LDL Cholesterol Goals: Insights From a Large U.S Managed Care Database (2013) (0)
Platelet glycoprotein II/IIIa receptor inhibitors in ischemic heart disease (1995) (0)
Randomized clinical trials and common sense. (1986) (0)
Classification Tree Analysis Of The Likelihood Of Clopidogrel Treatment In A Cohort Of Patients With Symptomatic Peripheral Artery Disease (2015) (0)
Abstract 326: High Potency Statins Underutilized in Patients with Atherosclerotic Cardiovascular Disease (ASCVD) (2014) (0)
Chimp Facial Action Coding: An Important Forward Brachiation in Method (2007) (0)
Abstract 10657: Fidelity to Antihypertensive Treatment Regimens in Patients with Comorbid Primary Hypertension and Diabetes in the United States: A Retrospective Cohort Analysis (2011) (0)
907-105 Selectin Blockade as an Adjunct to Thrombolytic Therapy Successfully Reduces Infarct Size Following Reperfusion in the Electrolytic Canine Coronary Artery Model (1995) (0)
The digital phenotype of vaccination (2022) (0)
P202 The association between asthma, obesity and outcomes among school-aged children in the U.S. (2017) (0)
Further notes on gravimetric serum total lipid determinations. (1969) (0)
Subcutaneous Use of Immune Globulin in Patients with Primary Immune Deficiency: A Retrospective Claims Database Analysis (2009) (0)
PCN21 A Real-World Assessment of the Treatment Patterns, Healthcare Resource Utilization (HCRU) and Outcomes Associated with Gastric Cancer (GC) and Gastroesophageal Junction Cancer (GEJC) in the United States (2021) (0)
Logic and logistics: conundrum in reperfusion treatment for acute myocardial infarction (1999) (0)
, Gene LRP 8 Disease and Myocardial Infarction in the A Novel Molecular Diagnostic Marker for Familial and Early-Onset Coronary Artery (2014) (0)
2. When the Towers Fell (2020) (0)
The relative safety and efficacy of clopidogrel in women and men: Meta-analysis of 79,613 patients enrolled in CREDO, CURE, CLARITY-TIMI 28, COMMIT, and CHARISMA (2007) (0)
The relation of quinidine-Induced elevation of serum digoxin concentration to the conversion of atrial fibrillation-flutter: A pilot study (1989) (0)
150P Real-world assessment of the treatment patterns associated with unresectable advanced and metastatic gastric cancer in China (2020) (0)
29th Conference of the EHPS - Cyprus 2015 - Principles of Behaviour Change in Health and Illness: Interviews with the keynotes speakers (2015) (0)
Effect of hemodialysis on left ventricular function in uremic cardiomyopathy. (1980) (0)
PIN24 ACUTE SINUSITIS OUTCOMES AND CHARGES: A COMPARISON OF TWO FLUOROQUINOLONES (2005) (0)
1063-54 Long-term clopidogrel therapy is particularly beneficial for patients requiring repeat revascularization after an initial percutaneous coronary intervention (2004) (0)
1120-65 Emboli protection improves thrombolysis in myocardial infarction perfusion score in saphenous vein graft intervention (2004) (0)
Charismatic Avatars and Nonverbal Communication Research in Emerging Media Technology: (599452013-001) (2013) (0)
Physicians Advising Investment Firms—Reply (2005) (0)
Patients With Mild Asthma and Concomitant Allergic Rhinitis (AR) Had Better AR and Asthma Treatment Success with Mometasone Furoate Nasal Spray when Compared with Leukotriene Receptor Antagonists, Non-Sedating Anti-Histamines (NSA) and Combinations of NSA and Decongestants (2010) (0)
COST MINIMIZATION ANALYSIS OF MOXIFLOXACIN, 400 MG, COMPARED WITH LEVOFLOXACIN, 750 MG, IN OUTPATIENT TREATMENT OF COMMUNITY-ACQUIRED PNEUMONIA, ACUTE BACTERIAL SINUSITIS, AND ACUTE EXACERBATIONS OF CHRONIC BRONCHITIS (2008) (0)
More on Bob Abelson (2007) (0)
Editorial: Diagnostic considerations in electromechanical dissociation. (1976) (0)
Self‐Healing and Disease‐Prone Personalities (2020) (0)
Prevention of reinfarction using half-dose reteplase and abciximab: observation from the GUSTO-5 trial (2002) (0)
The Role of Nitrates in Congestive Heart Failure (1991) (0)
A symposium : the fourth North American Conference on Nitroglycerin Therapy (1998) (0)
Cholesterol Wars: How Many Wins Does It Take? (2005) (0)
Therapy for stable angina pectoris (1984) (0)
Burden : Writing Group III High-Risk Patient for Primary Prevention : Noninvasive Tests of Atherosclerotic Prevention Conference V : Beyond Secondary Prevention : Identifying the (2008) (0)
Risk of ICH with combination therapy for acute MI (2004) (0)
[Multiple aneurysms of the coronary arteries. Report of a case]. (1993) (0)
Orthostatic atrial tachycardia: autonomic influence on atrial pacemakers. (1984) (0)
An Overview of Nitrate Tolerance: Past and Present Concepts1 (1993) (0)
Comparison of the safety and efficacy of the use of emboli protection device versus glycoprotein IIb/IIIa inhibitor during carotid stenting (2003) (0)
Genesis of Heart Sounds-Reply (1978) (0)
Letter: The fourth heart sound-a normal finding? (1975) (0)
Magnesium Deficiency as a Cause of Serious Arrhythmias-Reply (1978) (0)
[The pulsed Doppler evaluation of patients with dilated cardiopathy]. (1993) (0)
Pharmacology of nitro glycerin and long acting nitrates and their usefulness in the treatment of chronic congestive heart failure (1979) (0)
Use of coronary angiography and revascularization after acute myocardial infarction. (1997) (0)
Use of Nitrates Today (1987) (0)
PREDICTORS OF LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 MASS AND ACTIVITY LEVELS AMONG PATIENTS WITH STABLE AND ACUTE CORONARY SYNDROMES: A CREDO BIOMARKER SUBSTUDY (2010) (0)
Comparison of percutaneous coronary revascularization costs among HMO and non-HMO cardiologists practicing in the same institution (1999) (0)
[Diagnosis of coronary disease using echocardiography with inotropic dobutamine stimulation]. (1995) (0)
Medical therapy of ischemic heart disease : nitrates, bata blockers, and calium antagonists (1992) (0)
Heart failure disease management in an indigent (2001) (0)
Editorial: Mitral valve prolapse: a plea for unanimity. (1976) (0)
ACCF/AHA/CDC conference report on emerging infectious diseases and biological terrorism threats: the clinical and public health implications for the prevention and control of cardiovascular diseases. (2007) (0)
Prevention of cardiovascular disease (2003) (0)
Management of Patients With Chronic Stable Angina: A Report of the 2007 Chronic Angina Focused Update of the ACC/AHA 2002 Guidelines for the (2010) (0)
Cholesterol lowering : a practical guide to therapy (2003) (0)
Second Wi-Fi panel member’s conflicts are problematic (2013) (0)
Farmyard drug use a US battlefield and a Canadian wasteland (2012) (0)
WMA investigates its future president (2015) (0)
CIHR pledges to tackle primary health care (2010) (0)
Carbon Capture Probed (2005) (0)
CIHR “dismantling” Aboriginal health research (2015) (0)
Faith, power and charity: Personal religion and Kingship in Medieval England (2019) (0)
SCIENCE SCOPE: Canada on Kyoto: What a Gas (2006) (0)
History of the dukes of Normandy and the kings of England (2021) (0)
Ontario to Mothball Two CANDU Reactors (2005) (0)
Comparison of early pet metabolic imaging with recovery of cardiac contractile function after acute myocardial infarction (1991) (0)
The gods come home : China's traditional faiths persevere (2008) (0)
ATVB In Focus: Vascular Adhesion Molecules (2007) (0)
Obama promises to fix awed health insurance website (2013) (0)
Abstract 3732: The Influence of Aspirin Dose With or Without Clopidogrel on Efficacy and Safety in the CHARISMA Trial (2006) (0)
Former Supreme Court justice blasts minimum sentences for marijuana offenders (2012) (0)
Sweden leads EU in developing new antibiotics (2014) (0)
Putin Aims to Turn Science Cities Into Silicon Steppes (2003) (0)
Abiding worries over federal health research (2016) (0)
Ecology. Setting the forest alight. (2007) (0)
[Cardiac involvement in dystrophia myotonica. Comments apropos a case]. (1994) (0)
Nuclear weapons. Russia revives sagging research program. (2003) (0)
Germany Aids Sub Salvage (2003) (0)
CIHR plans to cut its advisory boards from 13 to four despite expert advice. (2014) (0)
Parliamentary report calls for action on Wi-Fi (2015) (0)
[Successful operation of aortic abscess ruptured into left atrium. Diagnostic importance of color coded Doppler echocardiography]. (1993) (0)
Canada wins legal battle to set patent rules (2017) (0)
POINT OF CARE DETECTION OF CIRCULATING MICROPARTICLES AND CELL FREE CIRCULATING DNA IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION (2013) (0)
of Hardware for PTCA (2006) (0)
Canada's federal budget under review (2018) (0)
The primacy of clinical effectiveness for cost effectiveness analysis (2003) (0)
Sensor-based surveillance for digitising real-time COVID-19 tracking in the USA (DETECT): a multivariable, population-based, modelling study (2022) (0)
Effects of four thrombolytic regimens in elderly patients (1998) (0)
Fast-Forward 5 Years: Topol on the Future of Patient Care (2014) (0)
Private telehealth foray into public system (2016) (0)
CIDA adopts new food security strategy (2010) (0)
Reperfusion and antithrombotic strategies for acute MI. (1995) (0)
The Economics and Policy of Organic Farming: What Can Be Learned From the European Experience? (2000) (0)
Scientists decry Canada’s outdated Wi-Fi safety rules (2015) (0)
Kingship and consent in England in the age of Magna Carta (2017) (0)
Should Canada focus on antimicrobial resistance? (2017) (0)
Introduction: Remembering English Saints in 2020 (2020) (0)
Samantha Nutt (2010) (0)
History of the Dukes of Normandy and the Kings of England by the Anonymous of Béthune (2021) (0)
2012 Gairdner International Awards go to US scientists (2012) (0)
Lipid-lowering drugs prescription of lipid-lowering drugs at hospital discharge following an acute coronary syndrome was associated with reduced short-term mortality (2001) (0)
Last chance for Kyoto (2003) (0)
TRIPS drug amendment a start (2017) (0)
The Cleveland Clinic Foundation interventional summit. (2004) (0)
Scientific publishing. Canadian editors fired in row with association. (2006) (0)
Exhibiting Restraint (2007) (0)
Pooled Analysis of Five Randomized Clinical Trials Adjunctive Treatment for Percutaneous Interventions of Aortocoronary Bypass Grafts : A Lack of Benefit From Intravenous Platelet Glycoprotein IIb / IIIa Receptor Inhibition as (2002) (0)
Limited options for redress (2013) (0)
Provinces call for improved senior care (2013) (0)
US Medicare billing info goes public (2014) (0)
Value of medical practice guidelines questioned (2010) (0)
P 2 Y 12 Assay : Impact on Thrombosis and Safety ( GRAVITAS ) Trial Intervention : A Time-Dependent Analysis of the Gauging Responsiveness With a Platelet Reactivity and Cardiovascular Outcomes After Percutaneous Coronary (2011) (0)
Climate change. A Eurasian tiger threatens to maul Kyoto. (2004) (0)
The status of research in invasive cardiology. (1992) (0)
Carabapenem-resistant bacteria a looming threat in Canada (2010) (0)
Biodiversity. Bid to save Kamchatka's wildlife. (2002) (0)
Canada resists banning flame retardant (2005) (0)
The renin-angiotensin axis during acute myocardial infarction treated with combined intravenous tissue plasminogen activator and captopril (1990) (0)
Coronary heart disease The impact of anthropomorphic indices on clinical outcomes in patients with acute ST-elevation myocardial infarction (2007) (0)
Thrombolytic therapy after GUSTO: medical roundtable. Discussion (1994) (0)
US doctors divided over health reforms (2010) (0)
Action awaits on antimicrobial misuse (2017) (0)
G8 Summit: a final test of credibility (2010) (0)
Russia's nuclear cities. Swords-to-plowshares program suffers meltdown. (2003) (0)
ScienceScope: Carbon Capture Probed (2005) (0)
UBC takes over Therapeutics Initiative after provincial cuts (2013) (0)
Pre-existing health conditions and severe COVID-19 infection: Analysis of commercial health insurance data from 690,000 infected patients (2021) (0)
The author responds (2012) (0)
Toakase Fakakovikaetau: pioneering paediatrician in Tonga (2009) (0)
Infectious disease experts expect the unexpected with respect to swine flu (2009) (0)
Controls over solitary confinement needed (2015) (0)
Characteristics and outcome of patients in whom reperfusion with intravenous tissue-type plasminogen activator fails: results of the Thrombolysis and Angioplasty (2005) (0)
773-2 Can Low-Temperature, High-Frequency Radio Energy PTCA Influence Restenosis? (1995) (0)
And the 2011 Gairdner International Award winners are… (2011) (0)
Abstract 13338: A Molecular Signature with the Potential for Identifying Impending Acute Myocardial Infarction (2014) (0)
Global goal for maternal health unlikely to be achieved (2013) (0)
Fluorinated chemicals need stricter control (2015) (0)
Harper skirts transparency on foreign aid (2014) (0)
Deep learning a person's risk of sudden cardiac death (2022) (0)
R. E. Just and R. D. Pope (eds). A Comprehensive Assessment of the Role of Risk in U.S. Agriculture. Kluwer Academic, Dordrecht, the Netherlands, 2002. ISBN: 0‐7923‐7567‐X, 586 pp., Price: Euro110 (2002) (0)
Military coup triggers health crisis in northern Mali (2012) (0)
US tries to stem antimicrobial resistance (2014) (0)
Inﬂuence of Genetic Polymorphisms on the Effect of High- and Standard-Dose Clopidogrel After Percutaneous Coronary Intervention The (2012) (0)
"Open" Journal to Open (2006) (0)
Swords-to-Plowshares Program Suffers Meltdown (2003) (0)
Russia. Haunted by Red October. (2003) (0)
Farming and the countryside: an economic analysis of external costs and benefits: Edited by N. Hanley. CAB International, Wallingford, Oxon, 1991. 328 pp. Price: $76, [pound sign]40 (hardback). ISBN 0 85198 713 3 (1993) (0)
Baronial Reform and Revolution in England 1258–1267, ed. Adrian Jobson (2018) (0)
FDA faces legal challenge over failure to disclose data on antibiotic resistance (2013) (0)
Small molecules vs. antibody IIb/IIIa receptor blockade in percutaneous coronary interventions: where is the difference? (2001) (0)
The cardiology intensive board review question book (2003) (0)
Does coronary angiographic morphology indicate plaque content (1991) (0)
Roadblocks to health reform in China (2011) (0)
Damani 1..9 (2012) (0)
968-26 In Vitro Antiproliferative Effect of Antisense Oligonucleotides: Are the Effects Specific and Reproducible? (1995) (0)
Second BC drug safety scientist reinstated (2014) (0)
Frederick Barbarossa: The Prince and the Myth (2018) (0)
A Poisoned Chalice?: Crown, Church, and Reputation in the Careers of King John’s Bishops (2020) (0)
Validity of reported genetic risk factors for acute coronary syndrome. (2007) (0)
Correction to Lancet Digit Health 2020; 2: e435–40 (2021) (0)
Calls for medically safe heroin mount in Canada (2017) (0)
Corrigendum: Molecular Autopsy for Sudden Death in the Young: Is Data Aggregation the Key? (2018) (0)
[Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction]. (2000) (0)
Controlling the costs of US health care (2006) (0)
Thrombolytic therapy for myocardial infarction: A perspective of clinical trialists (1992) (0)
UN goals trigger calls for reforming Canadian aid (2015) (0)
US Government agencies consider action on PFAS (2022) (0)
Infoway tacks towards “networked” patients (2011) (0)
Effect of heparin administration on fibrinogenolysis during thrombolytic therapy with tissue plasminogen activator for acute myocardial infarction (1993) (0)
Many eligible federal inmates won’t get new hepatitis treatment (2016) (0)
Global pledge not readily achieved (2012) (0)
Trudeau signals support for Canadian pharmacare (2019) (0)
One-year follow-up of mortality in the GUSTO IV trial evaluating the effects of 24 – 48 hours abciximab infusion in noninvasively managed acute coronary syndrome patients (2002) (0)
Shoval, King John's Delegation to the Almohad Court: Medieval Interreligious Interactions and Modern Historiography (1212) (Brepolis, 2016) (2017) (0)
South Africa ground zero for reforming drug patents (2014) (0)
Canada instrumental in watering down elements of noncommunicable diseases plan (2011) (0)

This paper list is powered by the following services:

Eric Topol

Eric Topol's AcademicInfluence.com Rankings

Why Is Eric Topol Influential?

Eric Topol's Published Works

Published Works

Other Resources About Eric Topol